Header Image
1. Prenatal stressors as ADHD risk factors

Sitemap

1. Prenatal stressors as ADHD risk factors

Author: Ulrich Brennecke
Review (June 2024): Dipl.-Psych. Waldemar Zdero

Even before birth, the unborn child can be damaged by toxic influences or diseases.
Many toxins and diseases that increase the risk of ADHD in offspring do so by affecting the dopaminergic system. Toxins can also increase the risk of ADHD even before conception through epigenetic mediation.
Psychological and physical stress (toxins, illnesses) have a fundamentally comparable effect on the stress systems (HPA axis, autonomic nervous system and others).
The % values given for a possible ADHD risk increase are an indication of the magnitude of the influence of the respective exposure. We are not aware of any values for entries without a % figure.

The consumption of nicotine, alcohol or stronger drugs during pregnancy increases the risk of ADHD in the offspring. Nicotine even increases the risk if the parents only smoked before conception.
Another source of risk is toxins that the mother comes into contact with during pregnancy. These include pesticides such as organophosphates or pyrethroids and chemicals such as lead, cadmium, thallium, bisphenols, polychlorinated biphenyls or polycyclic aromatic hydrocarbons.

Air pollution, especially particulate matter and nitrogen oxides, can also increase the risk of ADHD.
A high salt intake by the mother during pregnancy can increase the unborn child’s sensitivity to stress.

Various health factors in the mother, such as illnesses, obesity, stress, infections and hormonal disorders in the mother, are also associated with an increased risk of ADHD in the child. Thyroid hormones in particular should be closely monitored. Higher omega-3 fatty acid levels in the newborn could reduce the risk and severity of ADHD as well as autism spectrum disorders. Vitamin D3 deficiency during pregnancy and after birth is associated with dopaminergic brain abnormalities.
High exposure of the fetus or newborn to cortisol, through cortisol administration or maternal stress during pregnancy, can also increase the risk of ADHD.

It is well known that many medications can pose a risk to the unborn child during pregnancy. With regard to ADHD, paracetamol (acetaminophen), SSRIs (antidepressants), β-2 adrenaline receptor agonists, pregabalin, antibiotics and valproate are particularly relevant during pregnancy.
Finally, pregnancy circumstances such as first-born status or particularly short or long intervals from the previous pregnancy influence the child’s risk of ADHD.

Higher prenatal stress appeared to promote slower brain development during adolescence only in individuals with higher genetic susceptibility to ADHD (with a higher polygenic risk score for ADHD), while prenatal stress promoted faster brain development in individuals with lower genetic susceptibility to ADHD.1 Animal studies may provide further clues.

There appear to be gender differences for some of these risk factors.

Although the following collection is extensive, a number of other circumstances are likely to be associated with an increased risk of ADHD.
The various factors each represent only parts of a multi-layered risk mosaic and do not automatically lead to ADHD.

The extent to which the factors mentioned are causal for ADHD remains an open question. Several could also be a consequence of genetic causes that are passed on from mother to child and that influence the mother as much as the child. Example: Is smoking by a mother during pregnancy a cause of ADHD in the offspring or a result of genes in the mother that she passes on to the child at the same time? Methods that can help to clarify this are prenatal cross-fostering studies (egg donation and embryo donation from unrelated donors), prenatal cross-fostering studies (gestational surrogacy with an unrelated surrogate mother), children of identical twins, several pregnancies of the same mother with different environmental influences (e.g. with and without smoking) or comparisons between mother and father.2 In addition, animal studies should be taken into account that allow comparisons that are not possible in humans for ethical reasons.

The % values indicate the possible ADHD risk increase due to the respective cause.

For comparison: gene variants and ADHD

For comparison, the incidence of a small selection of ADHD risk gene variants follows.3 Unfortunately, it is not always reliably recognizable whether the % figure indicates the frequency change of the gene polymorphism in ADHD or the risk change of ADHD in the presence of the gene polymorphism.

Dopaminergic genes:

  • Dopamine beta-hydroxylase
    • Taql A: + 33 % (meta-analysis)4
    • rs2519152 no significant correlation (meta-analysis, k = 6)5
    • rs1611115 no significant correlation (meta-analysis, k = 4)5
    • rs1108580 no significant correlation (meta-analysis, k = 5)5
  • DRD4
    • 7R (= 48-bp): + 45 % (meta-analysis)4, + 34 %6 + 33 %7, + 33 % (meta-analysis, k = 26)5, + 20 %8, no correlation910 + 16 % (meta-analysis)4
    • 5R: + 68 %6
    • 4R: -10 %6
    • rs1800955: + 21 % (meta-analysis, k = 5)5
    • DRD4: no correlation 11
  • DRD5
    • 148-bp alleles: + 34 %6, + 27 %11, + 24 % (meta-analysis)4, + 23 % (meta-analysis, k = 9)5
    • 136-bp: - 43 %6
  • DRD3
    • rs6280 no significant correlation (meta-analysis, k = 6)5
  • DRD2
    • 3’flank TaqI allele: Unknown: + 65 % (not significant; meta-analysis, k = 6)5
    • no correlation for DRD29
  • DAT1/SLC6A3
    • 2R: + 25 % (meta-analysis, k = 5)5
    • rs27072: + 20 % (meta-analysis, k = 7)5
    • 10R (= 480-bp): ADHD risk + 17 % (meta-analysis, k = 18, n = 1,373, p = 0.004)12, + 13 % (meta-analysis)4, + 12 % (meta-analysis, k = 34)5, + 4 %6, no correlation10
    • rs6347: no significant correlation (meta-analysis, k = 6)5
    • no correlation for DAT1/SLC6A3119

Noradrenergic genes:

  • NAT/SLC6A2
    • rs5569: no significant correlation (meta-analysis, k = 5)5
    • rs2242447: no significant correlation (meta-analysis, k = 5)5
  • ADRA2A
    • rs1800544: no significant correlation (meta-analysis, k = 11)5
    • rs1800545: no significant correlation (meta-analysis, k = 4)5
    • rs553668: no significant correlation (meta-analysis, k = 4)5

Serotonergic genes:

  • 5HTTLPR/SLC6A
    • long: + 31 % (meta-analysis, k = 6)13, + 17 % (meta-analysis, k = 19)5
    • STin2 10R: no significant correlation (meta-analysis, k = 9)5
    • rs3813034: no significant correlation (meta-analysis, k = 5)5
  • HTR1B
    • rs6296: + 11 % (meta-analysis, k = 9)5
    • G861C: + 44 % (meta-analysis)4
  • HTR2A
    • rs6314: no significant correlation (meta-analysis, k = 6)5
    • rs6313: no significant correlation (meta-analysis, k = 6)5
    • rs6311: no significant correlation (meta-analysis, k = 6)5
  • Tryptophan hydroxylase 1
    • rs1800532: no significant correlation (meta-analysis, k = 4)5
  • Tryptophan hydroxylase 2
    • rs1843809: no significant correlation (meta-analysis, k = 4)5
    • rs1386493: no significant correlation (meta-analysis, k = 4)5

Other genes:

  • MAOA:
      • 94 % among Han Chinese14
  • CHRNA4
    • rs2273506: + 19 % (meta-analysis, k = 4)5
    • rs6090384: + 28 % (meta-analysis, k = 4)5
  • SNAP-25
    • rs3746544: + 15 % (meta-analysis, k = 7)5
    • rs362987: no significant correlation (meta-analysis, k = 5)5
    • rs363006: no significant correlation (meta-analysis, k = 7)5
    • rs1051312: no significant correlation (meta-analysis, k = 6)5
    • T1065G: + 19 % (meta-analysis)4
  • BDNF
    • rs6265: no significant correlation (meta-analysis, k = 8)5
  • COMT
    • rs4680: no significant correlation (meta-analysis, k = 16)5

In order to detect statistically significant gene variants, the usual significance threshold of 0.05 must be significantly increased, as this would find 250,000 to 500,000 randomly significant SNPs in view of the more than 10 million genetic variants. Therefore, a p-value of 5 x 10 to the power of -8 was applied (= 5e-8 = 0.00000005)3

We have begun to identify the possible pathways through which environmental factors can cause ADHD.

1.1. Toxins before conception as risks for ADHD - epigenetic inheritance

1.1.1. Nicotine consumption of one parent before conception (+ 259 %)

Children whose fathers smoked before pregnancy had a 2.59-fold risk of ADHD, compared to children whose fathers never smoked.
Children of parents who were exposed to smoking or passive smoking before pregnancy had 1.96 times the risk of A(D)HS.
Children whose parents were exposed to tobacco smoke both before and during pregnancy had a 2.01-fold risk of ADHD.15

Pathway: Epigenetics

Nicotine consumption by a parent before conception: epigenetic inheritance of nicotine damage causes ADHD symptoms in offspring over several generations

Mice whose fathers or mothers were chronically exposed to nicotine before conception showed hyperactivity, impaired nicotine-induced motor sensitization and reduced dopamine and noradrenaline levels in the striatum and PFC.161718 They also showed depressive and anxious behavior.1920

Nicotine consumption by the father or mother before conception causes epigenetic changes in the offspring

  • Of the dopamine D2 receptor.21
  • Of the dopamine transporter (DAT) m striatum and mPFC22
    • By downregulation of DAT expression due to increased methylation of the DAT gene.23 Increased DRD4 and 5-HT DNA methylation correlates with ADHD.24
  • Altered expression and dysfunction of nicotinic acetylcholine receptors (nAChRs)22
  • Hypersensitivity to nicotine-induced nAChR-mediated dopamine release22

The children of the first and second generation showed impairments typical of ADHD:

  1. Generation:
  • Significantly increased spontaneous locomotor activity (hyperactivity) (males and females)2122
    • Reduced DAT expression causes increased dopamine levels in the striatum, resulting in dephosphorylation of AKT via activation of D2 receptors, leading to increased activation of GSK3α/β and ultimately causing hyperactivity in the offspring of the mice.23
  • Risk-taking behavior22
  • Significant deficits in reversal learning (males and females)21
  • Significant attention deficits (males)21
  • Significantly reduced monoamine content in the brain (males)21
  • Reduced dopamine receptor mRNA expression (males)21
  • Increased nicotine preference22
  • Activity rhythm altered22 Note: This could be a link to the altered circadian rhythm in ADHD
  1. Generation:
  • Significant deficits in reversal learning (males)21
  • Hyperactivity22
  • Risk-taking behavior22
  • Increased nicotine preference22
  • Activity rhythm changed22

It can be assumed that the mechanisms are similar to those in humans.

1.1.2. Drug use by the mother before conception (+ 44 %)

Drug use (heroin, amphetamine, ketamine or other substances) by the mother before conception correlated with an increased risk of offspring (registry study, n = 1,969,006)25

  • by 43 % to 45 % for ADHD
  • by 5 % for ASS
  • by minus 18 % to minus 21 % for mental disability

1.1.3. Penicillin intake up to 2 years before conception

Penicillin intake by the mother increased the child’s risk of ADHD even if the intake took place 2 years before the pregnancy. Repeated penicillin intake further increased the risk of ADHD.26

Possible pathway: intestinal microbiome
Antibiotics influence the gut microbiome. The gut microbiome is passed on from the mother to the newborn during vaginal birth and breastfeeding (especially in the first three months). See there.

1.1.4. Silver nanoparticles over 4 generations

Offspring of rats that were orally administered silver nanoparticles were bred to be 1.8 times more hyperactive within 4 generations by selecting the hyperactive individuals.27 The offspring appeared to maintain hyperactivity over generations via the DNA methylation status in the mesencephalon.
It is unclear to us whether the increased hyperactivity in the 4th generation is a consequence of breeding or a consequence of the silver nanoparticles.

1.2. Toxins and harmful effects during pregnancy (up to + 778 %)

Toxic effects on unborn babies have been proven for:

1.2.1. Alcohol during pregnancy (up to + 778 %)

Around 5% of children in the USA are said to suffer from FASD, i.e. are affected by the mother’s alcohol consumption during pregnancy.28
The vast majority of studies have found that alcohol consumption by the mother during pregnancy significantly increases the likelihood of ADHD in her children.2930 up to 8.78-fold,31 Attention problems are also increased.32 In rats, the male offspring are particularly affected.33
A combination of alcohol and stress in the mother during pregnancy increased the likelihood of male rats developing female sexual behavior.34
47.2% of children with FAS (fetal alcohol syndrome) also had ADHD35
In a Taiwanese cohort study of 5-year-old children, the risk of ADHD was increased by 71%, but not statistically significant.36

There is evidence that alcohol consumption by the mother during pregnancy or while breastfeeding has a significant impact on the child’s dopamine system.37383940 The regulation of the neurotransmitters serotonin , glutamate, noradrenaline, acetylcholine and histamine is also affected4142 43

Individual studies found no connection between:

  • Alcohol consumption during pregnancy and ADHD.444546
  • Binge drinking in early pregnancy and ADHD risk in children aged 5 to 19 years.47
    One study found a correlation between ethoxyacetic acid (one of 6 degradation products of alcohol examined) in the mother’s urine and inhibition problems in the children.48
    A meta-analysis found that maternal alcohol consumption of less than 70 g/week during pregnancy did not increase the risk of ADHD.49 Boys were less at risk from alcohol during pregnancy than girls.

Neill et al deal with the differential diagnosis of ADHD and FASD (Fetal Alcohol Spectrum Disorder).50

Pathways of action among others: Modification of the endocannabinoid system in relation to VTA51

1.2.2. Nicotine during pregnancy (up to + 478 %)

1.2.2.1. Nicotine consumption of the mother during pregnancy (+ 49 % to + 478 %)

Prenatal smoking correlates with an increased risk of ADHD for the offspring5253 54 on the

  • 5.36-fold (increased by 436%)55 and an increased risk of bipolar Disorder by 533%, major depression by 92%, anxiety disorder by 3%. Not significantly increased: ASD and schizophrenia.
  • 4.78-fold (increased by 378 %)31
  • 3.34-fold for the 10% heaviest smoking mothers56
  • 2.7-fold (increased by 170 %)57
  • 2.5-fold (increased by 150 %)58
  • 2.33-fold (+ 133 %) for smoking during pregnancy and one year after; ASA risk not statistically significantly increased (25-year cohort study, n = 16,365)59
  • 2.21-fold with high nicotine exposure (cotinine value >50 ng/ml)56
  • 1.75-fold for heavy smokers60
  • 1.60-fold (increased by 60 %) in the overall average of female smokers60
  • 1.58-fold (increased by 58%; meta-analysis, n = 17,30461
  • 1.54-fold for light smokers 60
  • 1.54-fold (meta-analysis, k = 55, n = 4,016,522)62
  • 1.50-fold, even with passive smoking, but only for boys63
  • 1.50 times (here: risk of hyperactivity/impulsivity symptoms of the child)63
  • 1.49-fold64
  • 1.34-fold (OR) in a meta-analysis of k = 10 studies with n = 7,014; an OR of 2.19 each was found for CD and ODD65
  • 1.09-fold (OR) when maternal socioeconomic status, maternal age, maternal psychopathology, paternal age, paternal psychopathology, and infant birth weight were adjusted for gestational age

Other studies also found significantly increased risk values.66676817697071

Children with ADHD were more likely to have mothers who had smoked during pregnancy:

Two studies (with overlapping authors)275 , one study with a small number of subjects76, one larger study46 and one meta-analysis came to a different conclusion77, one study found rather weak evidence.78
Studies that distinguished maternal smoking during pregnancy from genetic influence found no evidence of a causal effect of prenatal smoking on ADHD risk79
However, there are several arguments against this:

  • the prenatal nicotine-exposed mouse is an animal model for ADHD8081 82 In addition, prenatal nicotine in the mouse model leads to reduced birth weight of the offspring83, which is an ADHD risk factor in its own right.
  • Studies have looked at prenatal smoking in relation to certain gene polymorphisms:
    • If there are no genetic risks, smoking by the mother during pregnancy increases the risk of ADHD for the child by 20 to 30 %.
    • The risk genes alone (if the mother does not smoke during pregnancy) increase the risk by 20 to 40 %.
    • However, if risk genes and maternal smoking coincide during pregnancy, the child’s risk of ADHD increases many times over:
      • DAT1-9R (440 bp): by a factor of 2.6
      • DRD4-7R by a factor of 2.9
      • Both together by a factor of 98485
        Another study confirms the involvement of DRD4-7R in gene-environment interactions.86
  • The ADHD risk of children of smoking mothers decreased somewhat when they stopped smoking:87
    • Overall risk compared to the offspring of non-smokers:
      • ADHD: OR = 2.07 = 207 %, learning disability: OR = 1.93 = 193 %
    • when giving up smoking in the first trimester
      • ADHD: OR = 1.72 = 172 %, learning disability: OR = 1.52 = 152 %
    • if you stop smoking in the second or third trimester
      • ADHD: OR = 2.13 = 213 %, learning disability: OR = 1.82 = 182 %
    • do not give up smoking
      • ADHD: OR = 2.17 = 217 %, learning disability: OR = 2.10 = 210 %
  • In rodents, nicotine consumed before conception causes ADHD in the offspring, and this ADHD is passed on epigenetically over several generations (see iben)

Rates of maternal smoking during pregnancy have been falling for a long time.59% of all pregnant women are said to have smoked between 1959 and 1966.79 In Germany, the rate of mothers smoking during pregnancy fell from 19.9 % in 1996 to 2006 to 10.9 % in 2007 to 2016.8889 In the USA, the prevalence of smoking during pregnancy fell from 15.2 % in 2000 to 13.8 % in 200590 and to 7.2 % in 2021 91 and to 5.4 % by self-report (subject to social desirability bias)92
The prevalence of smoking after childbirth fell from 18.1 % in 2000 to 16.4 % in 200590 and in 2021 to 7.2 % after childbirth and 12.1 % reported smoking before pregnancy according to self-report92
Smoking during pregnancy is also correlated with low education (2008: 4.3% if high school experience, 36% if no high school experience) and low socioeconomic status (2008: 7.4% if annual income $40k or more, 18.7% if annual income 150% of poverty line or less)93, both of which are ADHD risk factors in their own right.
Nevertheless, over 70 million women in the EU smoked during pregnancy in 2020.94

There are no studies on the extent to which smoking cessation during pregnancy has influenced ADHD prevalence. Although there are studies comparing the development of emotional problems 20 years apart95, we have yet to find such a study explicitly in relation to ADHD. As there is much more awareness of ADHD today, it will be difficult to compare prevalence retrospectively. In addition, smoking during pregnancy, although highly correlated, is not the only trigger for ADHD, so conclusions to the effect that decreasing smoking rates during pregnancy have shown no effect on ADHD rates3 are, in our view, so difficult to substantiate that they are barely usable as an argument against causality of smoking during pregnancy for ADHD.
While the correlation between smoking and depression was still low in 1952 and 1970, in 1992 the risk of depression among smokers was three times higher than among non-smokers.96 Subjects who became depressed started smoking more often, continued smoking more often and stopped smoking less often.

Paths of action:

Most experiments with prenatal nicotine exposure show a reduction in dopamine levels in the PFC and striatum.82 Under certain circumstances, increased dopamine levels were also shown.97 ADHD is neurophysiologically closely associated with reduced dopamine levels in the dlPFC (impaired working memory) and striatum (impaired motivation and motor hyperactivity).
Smoking by people with ADHD should be distinguished from this - this increases dopamine levels (at least in the striatum), as it reduces DAT, which is too pronounced in ADHD and reduces extracellular dopamine levels in the striatum. Acute smoking thus increases dopamine levels in the striatum.
Prenatal nicotine

  • reduces birth weight83, which is a separate ADHD risk factor.
  • increases the risk of apnea and hypoxia98
  • delays brain development99.
  • increases the risk of birth complications100101 , which is an ADHD risk factor in its own right.

Maternal smoking during pregnancy alters the glutamate NMDA receptors in the laterodorsal tegmentum of the offspring.102 Another study also found changes in glutamatergic signaling in the hippocampus due to increased glutamate receptor expression,94 which was associated with learning problems, attention problems and increased impulsivity.
ProBDNF proteolysis is impaired by an imbalance between proBDNF and BDNF and downregulation of the proBDNF processing enzyme furin. Glucocorticoid receptor activity is altered by decreased relative nuclear GR localization. The basal plasma corticosterone level is reduced. The HPA axis is disturbed. This affects the offspring themselves, but also their children, and is therefore inherited.103

A study of mice whose mothers were exposed to nicotine during pregnancy found evidence that nicotine causes various Consequences during pregnancy that persisted in the grandchildren’s generation, indicating epigenetic heritability:104

  • Deficits in the expression of corticostriatal DNA methyltransferase 3A (DNMT3A)
  • Downregulation of methyl-CpG-binding protein 2 (MeCP2) in frontal cortices and the hippocampus
  • Downregulation of histone deacetylase 2 (HDAC2) in frontal cortices and the hippocampus
  • Abnormalities in HDAC2 (Ser394) phosphorylation in frontal cortices, striatum and hippocampus
  • No change in the expression of ten-eleven translocase methylcytosine dioxygenase 2 (TET2)
  • No abnormalities in MeCP2 (Ser421) phosphorylation in frontal cortices, striatum and hippocampus

Maternal smoking increases fetal testosterone levels.105 Elevated prenatal testosterone levels are a risk factor for ADHD. More on this under Gender differences in ADHD.

Maternal smoking was associated with only ADHD, but not with only autism, compared to other environmental causes. Parental psychiatric history showed similar associations with all subgroups. Living in an urban area was most strongly associated with autism+ADHD and least strongly associated with ADHD only.106

It is possible that the effects of nicotine consumption by the mother during pregnancy could be compensated for by breastfeeding.107

1.2.2.1. Passive smoking during pregnancy

Even passive smoking, i.e. passive exposure of the mother to nicotine smoke during pregnancy, increases the unborn child’s risk of later ADHD symptoms63

  • 4.6-fold (+ 360 %)108
  • to 1.20 times (+ 20%)64

Similar results were found for the causation of dyspraxia (developmental coordination disorder) by passive smoking.109
Passive smoking during pregnancy in combination with maternal stress in the 5th year of the child’s life increased the risk of attention problems in the 7th year of life.110
One study found no evidence of a correlation.76

1.2.3. Polycyclic aromatic hydrocarbons (PAH) (+ 99 to + 406 %)

Prenatal exposure to polycyclic aromatic hydrocarbons appears to increase the damage caused by early childhood stress and promote later attention and memory problems111
High prenatal PAH exposure correlated with

  • Attention symptoms112 according to DSM-IV (OR = 5.06, + 406 %)113. dose-dependent114
  • ADHD total score according to DSM-IV (OR = 3.37, + 237 %)113115
  • Anxiety and depression112116

A meta-analysis found that 4 studies by one author indicated a 1.57-fold increase in the risk of ADHD due to PAH (OR 2.57), while the total number of all studies indicated a doubled risk (OR 1.99), which was not significant117

PAH/PAH enter the body through microplastics and nanoplastics, among other things.118

1.2.4. Lead disposition during pregnancy (up to + 243 %)

Lead disposition during pregnancy119120 121 affects the mesocorticolimbic circulation and increases the offspring’s risk of ADHD.122
Rat mothers were exposed to acute stress and lead during pregnancy. The effect on the offspring differed between lead exposure alone or lead exposure plus stress exposure. Male rat pups only showed increased corticosterone levels and decreased dopamine levels in the PFC when exposed to lead alone, female rat pups only when exposed to lead and stress in combination. Even short-term lead exposure of the dams caused this effect.123 In female rat pups, lead exposure and maternal stress contributed as cumulative factors to learning difficulties during pregnancy. These were neurophysiologically mediated by the glucocorticoid system to the mesocorticolimbic system.124
A doubling of lead in the umbilical cord blood increased hyperactivity 3.43-fold (+243%) at the age of 7 to 8 years only in boys, while girls showed no significant correlation125

Further studies also found evidence that lead exposure as well as stress during pregnancy affect the mesocorticolimbic dopamine/glutamate system of female offspring (less so in males) and mutually increase their effects.126 Under similar conditions, male rat pups showed a tendency to serotonergic disorders of the mesocorticolimbic system and altered delay discounting.127
Even a lead content in drinking water below the limit values is said to be problematic.120
In principle, lead water pipes are not very dangerous in areas with calcareous water, as limescale forms a reliable protective layer in the pipes. However, a descaling system for the drinking water must not be installed. Nevertheless, it is generally advisable to replace lead-containing water pipes during modernization work.

It is possible that the metabolism of cobalt, copper, lead, zinc and vanadium is altered in ADHD. Reduced cycle stability (determinism), duration (mean diagonal length) and complexity (entropy) of the exposure profiles were found.128

Lead is a divalent cation that mimics Ca2+ and activates PKC signaling.129

Arnsten130 describes lead as a toxin that causes symptoms confusable with ADHD.

Paths of action:

Lead appears to have a number of harmful neurophysiological effects, including on the dopaminergic system:

  • Impairment of the mesocorticolimbic dopaminergic system131
  • Impairment of dopamine receptors131
  • Impairment of attention regulation in the PFC132
  • Apoptosis133
  • Excitotoxicity133
  • Reduced cellular energy metabolism133
  • Impaired heme biosynthesis and anemia133
  • Oxidative stress133
  • Lipid peroxidation133
  • Changed activity of the second messenger system133
  • Altered neurotransmitter release133
  • Altered neurotransmitter receptor density133
  • Impaired neuropsychological functioning133
  • Impaired development and function of oligodendrocytes133
  • Abnormal myelin formation133
  • Abnormal neurotrophic factor expression133
  • Abnormal dendritic branching patterns133
  • Disorder of the blood-brain barrier133
  • Disorder of thyroid hormone transport into the brain133
  • Altered regulation of gene transcription133
  • Reduction of gray matter in the PFC, especially in the ACC134

Lead also appears to trigger the following behaviors:

  • Impulsiveness132
  • Sociopathic behavior135136
  • Irresponsible behavior135136
  • Criminal behavior135136
  • Lower IQ133
  • Impaired academic performance133

Lead poisoning is strongly correlated with crime rates and out-of-wedlock pregnancies in the USA.135136

Children with elevated blood lead levels are said to be particularly susceptible to other toxins in early childhood.137 In particular, warnings have been issued about lead in wall paints. During pregnancy, lead can be transferred from the mother to the child through the placenta.

1.2.5. Pesticides during pregnancy (up to + 171 %)

1.2.5.1. Contact with organochlorine compounds during pregnancy (up to + 171 %)

Exposure to hexachlorobenzene during pregnancy increased the risk of ADHD in Spanish children between 1997 and 1999. Children with HCB concentrations of more than 1.5 ng/ml at birth showed an increased risk of social competence problems (RR = 4.04; + 304 %) and ADHD (RR = 2.71; + 171 %). Cognitive and psychomotor performance remained unimpaired.138
A larger study of 7 European birth cohorts found no correlation between HCB or DDE (a breakdown product of DDT) in pregnancy or the first 2 years of life and ADHD.139 Another study found a 4.71-fold increase in Strengths and Difficulties Questionnaire scores at 7 to 8 years of age only in girls when p,p’-DDE was doubled in umbilical cord blood, while boys showed no significant association125
Children of mothers with high HCB serum blood levels in the first trimester (≥90th percentile) (but not if the mother was exposed to HCB during pregnancy) showed at 4 years:140

  • deteriorated perceptual performance
  • deteriorated general cognitive abilities
  • impaired executive functions
  • impaired working memory

Organochlorine compounds (dichlorodiphenyltrichloroethanes (DDT), dieldrin, heptachlor, endosulfan) showed an effect on neuronal development in prenatal exposure, which (in rodents), e.g:141

  • DAT increased
  • Increased dopamine reuptake
  • Loss of dopaminergic cells
  • Alterations at the presynapse in key dopaminergic proteins in response to OC pesticides in striatum or substantia nigra
  • Noradrenaline increased
  • Increased serotonin
  • GABA receptors reduced
  • NMDA receptors reduced
  • MGluR5 receptors altered
  • Altered GABAergic, glutamatergic and dopaminergic response to endosulfan in the PFC
  • Altered dopaminergic responses to heptachlor exposure identified

with impairments from, among others:

  • Attention processes
  • Cognitive performance
  • Memory
  • Social development
  • Mental and psychomotor development
  • Fine motor skills
  • Reflexes
  • Visual processing

Organochlorine compounds were nevertheless primarily associated with ASA.

Organochlorine compounds are said to have been widely replaced commercially by organophosphates by the end of the 2010s, but are very persistent and therefore still present in the environment.3

1.2.5.2. Organophosphate contact during pregnancy

The organophosphates chlorpyrifos and diazinon showed significant effects on neonatal brain development, including on the dopaminergic system.142 Prenatal exposure to the common pesticide chlorpyrifos impaired IQ and working memory in children aged 7143144 and executive functions.145

Organophosphates inhibit acetylcholinesterase (= the enzyme that breaks down acetylcholine).141 The organophosphate diisopropyl fluorophosphate (DFP) has been reported to increase dopamine and GABA receptors in addition to the known downregulation of cholinergic receptors. A single dose of 1 mg/kg DFP caused increased dopamine levels, a single toxic dose of 2 mg/kg DFP caused increased dopamine degradation. The levels returned to normal after 6 hours. Chronic administration of 1 mg/kg DFP resulted in decreased dopamine levels after 1 and 2 weeks, which returned to normal with continued administration. A single administration of DFP increased dopamine turnover in the striatum of rats, while chronic administration reduced it. The authors hypothesized that the changes in dopamine and GABA could be Consequences of downregulation of cholinergic receptors.146

Chlorpyrifos disrupts the serotonin system. Contact during pregnancy can trigger tremor in children and impair cognitive and neurobehavioral development.34

A measurement based on prenatal urinary dialkyl phosphate metabolites (diethyl phosphate and dimethyl phosphate) and an analysis of the maternal PON1 gene variants Q192R and L55M found no association between organophosphate contact of the mother during pregnancy and later ADHD in the child.147

A Norwegian cohort study found an increased risk of ADHD in the offspring when detected in the mother’s blood during pregnancy of:148

  • Di-n-butyl phosphate (DnBP)
  • Bis(1,3-dichloro-2-propyl) phosphate (BDCIPP)
  • Bis(2-butoxyethyl) phosphate (BBOEP)
    • only in boys. In girls, the risk decreases with increasing exposure.

Higher vitamin D levels in the mother appear to reduce the negative effect of the organophosphate chlorpyrifos on the risk of ADHD in the offspring.149150

Chlorpyrifos inhibits the endocannabinoid degradation inhibitor FAAS. Chlorpyrifos thus leads to altered exploratory and social behavior in young rats during puberty.151

Another Norwegian registry study found no evidence of an increased risk of ADHD in the offspring when the mother was exposed to organophosphates during the 17th week of pregnancy.152

1.2.5.3. Pyrethroid contact before or during pregnancy (up to + 76 %)

Pyrethroids are widely used as insecticides and pesticides.

Each doubling of the pyrethroid metabolite 3-phenoxybenzoic acid (3-PBA) in the mother’s urine at 28 weeks’ gestation increased the risk of ADHD in the offspring by 3% and the risk of any ADHD occurring among the 10% most severe ADHD cases by 13%.153

The pyrethroid deltamethrin apparently impairs the dopaminergic system in mice after early exposure:154

  • DAT reduced
  • D1 receptor reduced
  • Apoptosis

The pyrethroid deltamethrin damages long-term potentiation (LTP) at CA3-CA1 synapses in the hippocampus, a functional correlate of learning and memory.155

Furthermore, there were (with prenatal, but not with postnatal exposure)156 permanent changes in behavior with regard to:154

  • Movement activity
  • Acoustic startle reflex
  • Learning
  • Memory

3-PBA and chlorpyrifos reinforce each other’s effect on ADHD.153

Each measurement of trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane-1-carboxylic acid (trans-DCCA), a metabolite of permethrin, cypermethrin and cyfluthri (trans-isomers of pyrethroids), in urine increased the risk of offspring ADHD by 76%.153

Prenatal and lactational exposure to the pyrethroid pesticide deltamethrin at low doses (within the officially approved levels) in the adult mouse brain resulted in molecular disorders in signaling pathways regulating circadian rhythm and neuronal growth (MAP kinase) and behavioral changes relevant to neurodevelopmental disorders.157

1.2.5.4. Glyphosate contact during pregnancy

Glyphosate (e.g. Roundup) is a broad-spectrum herbicide from the group of phosphonic acids.
In rats, oral exposure of the mother to glyphosate (0.5 and 50 mg/kg body weight/day) during pregnancy and lactation (especially) affected the (female) offspring:158

  • Symptoms of depression
  • Anxiety symptoms
  • social deficits
  • reduced expression and hypermethylation of the tryptophan hydroxylase 2 gene in the hippocampus
    • Tryptophan hydroxylase is involved in serotonin synthesis in the brain
  • altered intestinal microbiota of the female offspring
    • reduced frequency of Akkermansia
    • increased abundance of Alistipes and Blautia
      (Bacteria involved in tryptophan metabolism and associated with depression and anxiety-like disorders)

This indicates that glyphosate is involved in depression and anxiety disorders. A link to ADHD has not yet been established.

Glyphosate is also suspected as a possible cause of ASD.159

1.2.5.5. Neonicotinides

Neonicotinids are the most widely used type of insecticide. There are indications that neonicotinides can affect the offspring during pregnancy.160 Neonicotinids lead to reduced brain regions, e.g. the striatum and the corpus callosum. The corpus callosum is often reduced in ADHD,

1.2.6. Phthalates during pregnancy (up to + 142 %)

According to most studies, phthalic acid esters increase the risk of ADHD for the unborn child,161162 163 although the links are still unclear.164165 An influence on the thyroid balance166 and the inflammatory pathway167 are discussed. Higher phthalate metabolites in the urine of pregnant women correlated with increased distractibility in preschool children168 and with impaired executive functions169.
Prenatal di-methoxyethyl phthalate (DMEP) exposure caused abnormal brain morphology and function in mice. DMEP significantly reduced the number of neurons in the parietal cortex by impairing neurogenesis and gliogenesis during cortex development and impaired dendritic spine architecture and synaptic activity in the parietal cortex. In addition, prenatal DMEP induced hyperactivity and reduced anxiety behavior in mice.170
Prenatal phthalate exposure combined with a genetic predisposition to phthalate-induced inflammation increased the offspring’s risk of ADHD by 2.42-fold and ASD by 2.15-fold at 11.5 years of age.167

1.2.7. Caffeine consumption during pregnancy (+ 130 %)

A study of n = 9,978 children found a correlation between prenatal caffeine intake, even at the widely recommended “safe” dose, and externalizing problems, especially conduct disorder, with very high Effect size, comparable to prenatal alcohol or cannabis. Internalizing problems were unchanged. In addition, with more than 3 cups of coffee per day, the BMI and the consumption of soft drinks was increased in the children. Prenatal caffeine exposure correlated with structural changes in the brain, including increased thickness of the posterior and inferior frontal cortex and altered depth of the parieto-occipital sulcus.171 Greater caffeine consumption during pregnancy correlated with increased internalizing and externalizing symptoms in parents.
A review found no correlation between caffeine consumption during pregnancy and ADHD in 4 out of 5 studies.172

Caffeine consumption of 10 cups of coffee a day or more correlated with a 130% increased risk of ADHD in children.173

One study found a small increase in risk from caffeinated soft drinks during pregnancy, but not from coffee or tea174

Caffeine consumption during pregnancy below 10 cups a day did not increase the risk of ADHD 175 176 177 178 179 46180

Children of mothers who drank tea continuously throughout pregnancy had higher scores for cognition, fine motor skills and gross motor skills than children whose mothers only drank tea in the first trimester of pregnancy. Tea consumption in the second and third trimester was more strongly associated with the results than tea consumption in the first trimester. Coffee consumption showed no significant correlation with the cognitive development of the children.181

Caffeine consumption during pregnancy correlates with an increased BMI of the children.182183179

1.2.8. Drug use by the mother during pregnancy (up to + 80 %)

Children who were prenatally exposed to multiple drug use by their mothers and who subsequently grew up in institutions were found to be three times more likely to develop ADHD between the ages of 17 and 22.184

7.7% of mothers used cannabis during pregnancy (meta-analysis, k = 17, n = 534,445).185
A meta-analysis found a relatively small risk increase of 13% for ADHD, 4% for ASD, 29% for psychosis, 34% for anxiety and a 28% reduced risk for depression due to maternal cannabis use during pregnancy (k = 17, n = 534,445)185
Cannabis use during pregnancy is associated by several studies with an increased risk of ADHD in children.186187
A study of n = 141,570 children of n = 117,130 mothers with found a reduced risk of offspring for ADHD (minus 16%) and disruptive behavior disorder (DBD, minus 17%).188

Drug use (heroin, amphetamine, ketamine or other substances) by the mother during pregnancy correlated with an increased risk of offspring (registry study, n = 1,969,006)25

  • by 77 % to 80 % for ADHD
  • by 35 % to 41 % for mental disabilities
  • by minus 7 to minus 12 % for ASS

1.2.9. Copper (+ 51 %)

Copper accumulation in the placenta increased the risk of ADHD by 51%.189

1.2.10. Cadmium during pregnancy (+ 22 % to + 36 %)

Exposure to cadmium during pregnancy increased the risk of ADHD for 6-year-old girls, but not for boys. Doubling the mother’s exposure to cadmium during pregnancy increased the risk of ADHD for girls by 22.3%.190
Cadmium accumulation in the placenta increased the risk of ADHD by 36%.189
A doubling of cadmium in the umbilical cord blood increased emotional problems 1.53-fold (+ 53%) at the age of 7 to 8 years only in boys, while girls showed no significant correlation125

Possible route of action: blood-brain barrier.191

1.2.11. Manganese (up to + 34 %)

There is weak evidence of relevance in ADHD, although elevated manganese levels were only found in the hair, but not in blood levels, of people with ADHD.192
A doubling of the manganese content in teeth from both the prenatal and postnatal period increased the risk of attention problems and ADHD symptoms in the school years by 5%. Manganese from childhood showed no influence.193
An animal model with developmental manganese exposure showed that manganese can cause permanent attention and sensorimotor deficits resembling ADHD-I. Oral methylphenidate was able to fully compensate for the deficits caused by early manganese exposure.194
Manganese accumulation in the placenta increased the risk of ADHD by 34%.189

1.2.12. Air pollution during pregnancy (up to + 26 %)

One study found changes in the immune system of offspring due to air pollution.195
A study of approximately 43,000 families in Shenzen found positive correlations of ADHD from the age of 3 with exposure to196

  • Cooking vapors
  • Tobacco smoke
  • Vapors from house renovations
  • Mosquito coils (burnt mosquito pyramids; especially in combination with incense smoke)
  • Incense smoke (especially in combination with mosquito repellent smoke)

Another study found no increase in risk from air pollution in relation to ADHD.197

A meta-analysis found that more studies (without reference to pregnancy) affirmed a link between air pollution and ADHD than denied it.198

1.2.12.1. Particulate matter (+ 26 %)

Introduction to air pollution and particulate matter at Air pollution in childhood

A cohort study of 425,736 births on prenatal particulate matter exposure using satellite data found that an increase in PM2.5 concentration of 10 μg/m³ during the first trimester increased the risk of ADHD by 26% and that this increased further at PM2.5 concentrations above 16 μg/m³.199
Air pollution from particulate matter during pregnancy correlated in one study with a reduced volume of the corpus callosum and a tendency towards increased hyperactivity.200 Another study found a link between particulate matter and ADHD at low levels of particulate matter exposure, while higher levels caused more severe brain damage.115

In rats, inhaled printer particles led to a 5-fold increase in dopamine levels, probably due to increased synthesis rather than decreased degradation.201

Diesel exhaust particles led to functional impairment of dopamine neurons in laboratory tests. Prenatal ingestion with the air we breathe had the same effect in mice:202

  • In the striatum
    • Reduced dopamine metabolism
    • Reduced levels of dopamine metabolites
  • In the amygdala
    • Increased dopamine levels
    • Increased dopamine metabolite levels
  • In the nucleus accumbens
    • Increased dopamine levels

Traffic ultrafine particulate matter in the air breathed after birth had the following effects on female mice:202

  • Increased dopamine turnover in the hippocampus

Pre- and postnatally, particulate matter and gaseous pollutants reduced the expression of oxytocin receptors in the hippocampus203 and hypothalamus in rodents, with reduced maternal care behavior.204 Oxytocin and vasopressin communication appears to be disrupted by endocrine disrupting chemicals205, many of which are present in outdoor air.202

Studies found an association between PM2.5 and hyperactivity/attention symptoms (OR = 1.12)206, hyperactivity207, ADHD symptoms208 and between PM2.5 in the first trimester and a tendency towards attention problems and hyperactivity.209

Other studies found no link between PM2.5 and ADHD210211212

A meta-analysis reports a correlation between PM10 and ASD.213 One study differentiated the risk increase for ASD according to PM1 (+ 86 %), PM2.5 (+ 76 %) and PM10 (+ 68 %).214

Particulate matter resul

1.2.12.2. Nitrogen oxides (nitrogen oxides) (+ 26 %)

Several studies found a correlation between nitrogen oxide exposure during pregnancy and ADHD.111

  • NOx correlated with hyperactivity, with a stronger association between ADHD and NO than between ADHD and NO2. (NO: aOR = 1.26)212
  • NO2 exposure during pregnancy correlated strongly with ADHD symptoms, such as
    • Impulsiveness
      • Interrupting others208
      • Inability to wait your turn when playing208
    • Attention problems
      • Carelessness when crossing the road208
      • Attention impaired at the age of 4-5 years215
    • Hyperactivity207
    • Oppositional behavior (not an original ADHD symptom)

Other studies found no significant or clear correlations between NOx and ADHD 210 206211
One study found a correlation with ASD in children, but not with ADHD.216

Emissions of nitrogen oxides in Germany fell by almost 2/3 between 1990 and 2020.217

1.2.12.3. Ozone

Ozone caused in rats:202

  • In the substantia nigra
    • Reduced number of dopamine neurons
  • In the hippocampus
    • Reduced expression of the serotonin receptors 5-HT1A, 5-HT1B and 5-HT4
    • Increased expression of the serotonin receptor 5-HT2C
  • In the hypothalamus
    • Reduced serotonin levels

No correlation with ADHD has yet been found in humans.207111

1.2.13. Polychlorinated biphenyls / polychlorinated biphenyl ethers (+ 23 %)

Polychlorinated biphenyls (PCBs) can increase the risk of ADHD.218 PCBs inhibit dopamine synthesis as well as the storage of dopamine in the vesicles and its release, thereby causing dopamine levels to be too low. Polychlorinated biphenyls cause hyperactivity and impulsivity (in rats even at sub-toxic doses).219 Polychlorinated biphenyls can act directly on dopaminergic processes to disrupt the dopamine system and produce Parkinson’s-like symptoms.220 Further studies also found dopamine-reducing effects of PFAS.221222 as well as influences on the acetylcholine, serotonin and glutamate neurotransmitter balance.223
PFOS can cross the placenta and the blood-brain barrier.224
Children of mothers with high PCB serum blood levels in the first trimester (≥90th percentile) (but not if the mother was exposed to PCBs during pregnancy) showed at 4 years:140

  • impaired working memory
  • unchanged: Perceptual performance, general cognitive abilities, executive functions

A review study of k = 30 meta-analyses analyzed the association between prenatal exposure to PFOA and PFOS and ADHD in children aged 4-11 years225
A statistically significant increase in the risk of ADHD was found in girls, but not in boys.
It is also possible that newer PFAS alternatives increase the risk of ADHD.226
A larger study of 7 European birth cohorts found no correlation between PCB-153 in pregnancy or the first 2 years of life and ADHD.139

PFOS also increase the risk of obesity. This risk adds up to that of a high-fat diet (HFD). A combination of HFD and PFOS worsened general behavior, such as time spent in the center and rearing, while PFOS alone affected distance traveled. PFOS may thus promote hyperactivity, while a combination of PFOS and HFD altered social behaviors such as rearing and retreating. PFOS exposure affects calcium signaling, MAPK signaling pathways, ion transmembrane transport and developmental processes. The combination of HFD with PFOS enhances the effect of PFOS in the brain and affects signaling pathways related to ER stress, axon guidance and elongation, and neuronal migration. PFOS and HFD increase the effects on inflammatory pathways, regulation of cell migration and proliferation, and MAPK signaling pathways.224

1.2.14. Perfluoroalkyl compounds (PFAS) in pregnancy (up to + 23 %)

A long-term study found no correlation between exposure to perfluoroalkyl during pregnancy and ADHD. There were weak - positive and negative - correlations with working memory functions in childhood.227 A meta-analysis also found no significant correlation between maternal PFAS exposure and the prevalence rate of early childhood ADHD. Nevertheless, the odds ratio was partially increased:228

  • Perfluorooctanoic acid (PFOA): 1.00
  • Perfluorooctane sulfonate (PFOS): 1.01
  • Perfluorohexane sulfonate (PFHxS): 1.08
  • Perfluorononanoic acid (PFNA): 1.13
  • Perfluorodecanoic acid (PFDA): 1.23

The PFOS concentration in the children’s blood and the PFNA concentration in the mothers’ blood correlated with the prevalence of early childhood ADHD.

Another study found a correlation of perfluorooctanoic acid (PFOA) and AD(H)DS, but not of perfluorooctane sulfonate (PFOS) with ADHD or ASD.229 Another study found an increased risk of ADHD in school children with low to moderate exposure to PFAS at 2 years of age.230

1.2.15. Thallium during pregnancy

High thallium exposure in the second trimester of pregnancy increased the risk of ADHD for 3-year-old boys, but not for girls.231

1.2.16. Bisphenols during pregnancy

Bisphenol A (BPA) increases the risk of ADHD (meta-analysis, k = 32, n = 15,669).232
Bisphenol A is one of the most commonly produced synthetic compounds in the world. BPA is found in epoxy resins and polycarbonate plastics, which are often used to store food and baby bottles.233
BPA can cross the placenta234235 236 and is found in human breast milk.237 BPA affects the gut-brain axis and the blood-brain barrier.238233239240241

BPA can:

  • impair memory (meta-analysis, k = 22)242
  • impair cognitive abilities (meta-analysis, k = 22)242
  • bind to estrogen receptors233242
  • various structural and molecular changes in the brain cause233
  • promote oxidative stress233
  • change the expression level of several important genes and proteins233
  • Neurotransmitters impair233
    • Change neurotransmitter levels (meta-analysis, k = 22)242
  • Cause excitotoxicity233
  • Promote neuroinflammation233
  • damage the function of the blood-brain barrier233
  • trigger neuronal damage233
  • Promote apoptosis233
  • disrupt intracellular Ca2+ homeostasis233
  • reactive oxygen species (ROS) increase233
  • influence intracellular lactate dehydrogenase release233
  • reduce the axon length233
  • cause microglial DNA damage233
  • Trigger astrogliosis233
  • cause significantly reduced myelination233
  • acts as a broad-spectrum endocrine disruptor243
  • is metabolized via glucuronidation243
    • this involves the attachment of glucose to the target molecule and is catalyzed by uridine-5’-diphospho-glucuronosyltransferases (UGTs)
    • the pathway between BPA glucuronidation efficiency and disease could be direct or indirect
      • direct pathway: free BPA is the actual culprit; impaired BPA detoxification causes increased BPA levels in sensitive tissues, where it can act as an endocrine disruptor
      • indirect pathway: BPA is not the causative agent, but BPA serves as a marker for the reduced glucuronidation efficiency of other compounds that are degraded by a similar combination of UGTs and efflux transporters as BPA
  • inhibit the ERK-CREB-BDNF signaling pathway (meta-analysis, k = 22)242
  • alter the expression of synaptic proteins (meta-analysis, k = 22)242
  • affect the morphology of pyramidal neurons in the hippocampus (meta-analysis, k = 22)242
  • Dysregulate thyroid hormones (meta-analysis, k = 22)242

Exposure to BPA increases the risk of neurological disorders, including

  • neurovascular disorders (e.g. stroke)233
  • neurodegenerative diseases (e.g. Alzheimer’s and Parkinson’s)233243
  • Neurodevelopmental diseases
    • ADHD243; (meta-analysis, k = 32, n = 15,669).232
      • another meta-analysis found no clear result from pre- or postnatal exposure in children and adolescents (k = 46; n = 21,896)244
    • ASS233243
  • Depression233
  • emotional problems233
  • States of anxiety233
  • cognitive disorders233
  • polycystic ovary syndrome (PCOS)243

Bisphenol-A (BPA) is a glucocorticoid receptor agonist and is associated with changes in the HPA axis response. In female rats, prenatal BPA correlated with increased basal corticosterone levels and decreased glucocorticoid receptor expression in the hypothalamus. In response to stress, these female rats showed anxious coping behavior and a dampened corticosterone response with a lack of downregulation of glucocorticoid receptor expression in the hypothalamus. In contrast, BPA-exposed male rats showed no altered basal HPA axis function, but were unable to upregulate CRH-1 receptor expression in the pituitary gland in response to acute stress.34 The dose given to the rat mothers during pregnancy and lactation was very low at 40 micrograms/kg/day.245
5 milligrams / cubic meter in the air we breathe causes eye irritation.246 A review confirmed evidence that bisphenol-A during pregnancy can increase the risk of ADHD in children, especially boys.165

BPA and BPS caused greatly increased dopamine (3 to 5-fold) and greatly decreased serotonin (by 80 %) in mouse placentas. GABA remained unchanged.247 BPA is an endocrine disruptor and mimics estrogenic activity. Thus, BPA affects various dopaminergic processes to increase mesolimbic dopamine activity, leading to hyperactivity, attention deficits and increased susceptibility to drug abuse.220

1.2.17. Dioxin exposure during pregnancy

Children who were exposed to dioxin during pregnancy have an increased risk of ADHD.248

1.2.18. Prenatal exposure to sulphur dioxide

Prenatal exposure to sulfur dioxide (SO2) correlated with DNA methylation and increased ADHD symptoms 249250
According to a review111, two other studies found no significant correlation.212207

1.2.19. Polybrominated diphenyl ethers

Polybrominated diphenyl ethers (PBDEs) are organic chemicals containing bromine. They were used as flame retardants in many plastics and textiles.
Their concentration in breast milk increased exponentially between 1972 and 1998.
The German industry voluntarily abandoned its use in 1986. Sweden banned its production and use in 1999.
Throughout the EU, pentaBDE and octaBDE may only be placed on the market or used up to a maximum of 0.1 percent by weight since 2003.

Prenatal PBDE exposure appears to increase ADHD symptoms in girls.251

1.2.20. Low urine fluoride content of the mother

One study found an inverse correlation between fluoride levels in the mother’s urine and cognitive problems in the offspring at the age of 11. The higher the fluoride content, the lower the cognitive problems.252 This was not consistent with the results of other studies, which found an increased risk of ADHD with increased urinary fluoride levels in the children themselves.253254

1.3. Illnesses of the mother/parents (up to + 370 %)

Psychiatric disorders in the family increased the child’s risk of ADHD 9.37-fold.108

Children with ADHD were more likely to have mothers who had health impairments during pregnancy:73

  • Maternal illnesses during pregnancy:
    In 34.4% of children with ADHD, the mother had a medical condition during pregnancy, compared with 14.4% of children who were not affected.
    • Children with ADHD: 34.7 %
      Diseases of the mother during pregnancy were in the following trimester:
      • 1st/2nd trimester only: 56.4 %
      • 3rd trimester only: 12.7 %
      • Entire pregnancy: 30.9 %
    • Non-affected children: 14.4 %
      Diseases of the mother during pregnancy were in the following trimester:
      • 1st/2nd trimester only: 0 %
      • 3rd trimester only: 33.3 %
      • Entire pregnancy: 66.7 %
  • Other pregnancy problems:
    • Children with ADHD: 14.5%
    • Non-affected children: 3.8 %

A 25-year observational cohort study, n = 16,365, found no statistically significant increase in risk of ADHD due to maternal illness independent of pregnancy, but a 1.52-fold (+ 52%) increase in risk of ASD.59 Furthermore, infections of the mother during pregnancy were not a risk factor for ADHD, but for ASD of the offspring: 1.33-fold (+ 33 %)(25-year cohort study, n = 16,365)59

1.3.1. Itrahepatic cholestasis (ICP) in pregnancy (+ 7 % to + 370 %)

Intrahepatic cholestasis in pregnancy (ICP) is the most common obstetric liver disease. It is associated with an increased risk of iatrogenic premature birth and adverse Consequences for the child.255
An ICD increased the risk of ADHD / ASD:

  • before the 28th week of pregnancy
    • 2.62 times the risk of ADHD (+ 162 %)
    • 1.69-fold ASS risk (+ 69 %)
  • 28th to 36th week of pregnancy
    • 1.36 times the risk of ADHD (+ 36% (+ 37%))
    • 1.37-fold ASS risk
  • after the 36th week of pregnancy
    • 1.07 times the risk of ADHD (+ 7 %)
    • 1.13-fold ASS risk (+ 13 %)

Of 30 people with ADHD in children with citrin-induced cholestasis, 14 were found to have ADHD (47%).256 Assuming an ADHD prevalence of 10% in children, this results in a 370% increased risk of ADHD.

1.3.2. Parental asthma during and outside pregnancy (+ 13% to + 330%)

Asthma in the mother during pregnancy increases the risk of ADHD and ASD in the offspring.257 A cohort study of 961,202 children showed a 41% increased risk of ADHD if the mother had asthma and a 13% increased risk if the father had asthma. An asthma episode in the mother during pregnancy increased the risk of ADHD by 21%, and an asthma episode after pregnancy by 25%.258 Another study also found an increased risk of ADHD in the offspring of mothers with asthma, especially for girls.259
Children of mothers in the COPSAC2000 birth cohort (all of whom have asthma) have 3.3 times the risk of ADHD at 20%.260
Children of n = 106,163 mothers who had asthma during pregnancy showed a risk of:261

  • ADHD + 49 %
  • ASS + 33 %
  • motor development disorders + 37 %
  • Learning disorders + 51 %

1.3.3. Increased or decreased thyroxine levels

1.3.3.1. Increased or decreased thyroxine levels in the mother (up to + 310 %)

Abnormal thyroid hormone levels during pregnancy can have profound effects on the development of the child’s brain and cognition262263 and impair

  • Neurodevelopmental processes264
    • Cell differentiation
    • Neurite growth
    • Synaptogenesis
    • Myelination
  • Neurotransmitter systems265
    • monoaminergic system
    • cholinergic system
    • which can lead to attention deficits and hyperactivity

Even transient subclinical thyroid abnormalities during pregnancy can have serious consequences.266 Correction of severe maternal hypothyroidism before the 3rd semester of pregnancy appears to prevent cognitive impairments267 and premature births .268

Studies on mice with a mutated human thyroid receptor TRb 1 gene (TRbeta transgenic mice)269 found that these

  • normal thyroid hormone levels of triiodothyronine (T3) and thyroxine (T4) (euthyroid) except for a short period during postnatal development
  • into adulthood
    • Changes in the dopaminergic system (increased dopamine turnover)
    • ADHD symptoms
      • Hyperactivity
      • Inattention
    • ADHD symptoms are reduced by MPH

One study found a 7% increased risk of ADHD in children with untreated mild thyroxine deficiency in the mother during early pregnancy.270 In another study, reduced or untreated normal thyroxine levels in the mother showed no effect on ADHD in the children. In contrast, thyroxine treatment of the mother, especially with excessive thyroxine levels due to overdose, appears to increase the risk of ADHD in the children.271 Another study also found evidence of thyroxine as a possible cause of ADHD,272 another study found no influence of the mother’s thyroxine levels during pregnancy.273
A Norwegian cohort study found a 2.27-fold risk of ADHD (+127%) for thyroid hormone T3 levels in the mother at 17 weeks’ gestation within the top 1/5 compared to the lowest 1/5. For free T4, both increased and decreased levels were risk-increasing: the top 1/5 as well as the lowest 1/5 showed a 1.6-fold risk of ADHD in the offspring.274

In male mice, a study found a significantly reduced dopamine and serotonin turnover in the striatum, nucleus accumbens, hypothalamus and hippocampus as a consequence of prenatal thyroxine deficiency.275 Dopamine deficiency in the striatum / nucleus accumbens is responsible for hyperactive symptoms in ADHD.

One study found no influence of maternal hyperthyroidism or hypothyroidism detected and treated before the birth of the child on the child’s risk of ADHD or ASD.
However, maternal hyperthyroidism, which was first diagnosed and treated after the birth of the child, increased the risk of ADHD in the child by 23%, while hypothyroidism diagnosed in this way increased the risk of ASD by 34%.276

1.3.3.2. Reduced and increased TSH values in newborns (+ 14 % in boys to + 310 % in girls)

Children with congenital hypothyroidism (congenital hypothyroidism, connatal hypothyroidism) showed an incidence of ADHD of 3.97% (versus 1.87%, + 112%) and of ASD of 0.71% (versus 0.13% = + 346%).277
A cohort study from Norway found an increased risk of ADHD later in life in newborns with low or high TSH levels, but only in girls. TSH values in the lowest 20% group increased the risk of ADHD in girls 3.1-fold, in boys by only 14%.278

Primary hypothyroidism in rodents reduced the gucose transporter GLUT1 in the brain, did not alter GLUT3 and compensatory increased hexokinase enzyme activity. However, these changes were only pronounced in the immediate neonatal period and disappeared after weaning279

1.3.4. Maternal weight and eating disorders before or during pregnancy (+14% to +280%)

1.3.4.1. Severe maternal obesity before or during pregnancy (+ 14 % to + 280 %)

Massive maternal obesity during pregnancy increased the risk of later ADHD in the child

  • by a factor of 2.8.280
  • by 62 %281
  • by 57 % for ADHD and 42 % for ASD282
  • by 46% for ADHD and CD, by 67% for eating disorders, by 55% for specific developmental disorders, by 44% for affective disorders, by 33% for anxiety disorders (aHR = 1.33) and by 23% for other behavioral and emotional disorders283
    • Being overweight (rather than obese) increased the risk of mental retardation by 26%, affective disorders by 15%, ADHD or CD by 12%, and other behavioral and emotional disorders by 9%283

The children’s risk of ADHD increased284

  • by 23 % to 28 % due to overweight
  • by 47 % to 89 % due to obesity
  • by 88 % to 95 % due to severe obesity of the mother

Children of mothers who were overweight or underweight during pregnancy had an increased risk of mental disorders in a Finnish register study (n = 392,098 mothers, 649,956 children):285

  • Severely overweight mother (BMI 35.0 and higher)
    • ADHD and CD: 1.88 (+ 88 %)
    • ASS: 1.74 (+ 74 %)
    • Social functioning problems and tics: 1.31 (+ 31 %)
    • Affective disorders: 1.67 (+ 67 %)
    • Fear: 1.51 (+ 51 %)
    • Feeding problems as an infant or child: 1.10 (+ 10 %, not statistically significant)
    • Sleep disorders: 0.99 (minus 1 %, not statistically significant)
    • Mental disability: 2.04 (+ 104 %)
    • Specific developmental disorders: 1.83 (+ 83 %)
  • Overweight mother (BMI 30 to 34)
    • ADHD and CD: 1.48 (+ 48 %)
    • ASS: 1.51 (+ 51 %)
    • Social functioning problems and tics: 1.24 (+ 24 %)
    • Affective disorders: 1.31 (+ 31 %)
    • Fear: 1.29 (+ 29 %)
    • Feeding problems as an infant or child: 1.06 (+ 6 %, not statistically significant)
    • Sleep disorders: 1 (+ 0 %, not statistically significant)
    • Mental disability: 1.61 (+ 61 %)
    • Specific developmental disorders: 1.48 (+ 48 %)
  • slightly overweight mother (BMI 24 to 29)
    • ADHD and CD: 1.19 (+ 19 %)
    • ASS: 1.16 (+ 16 %)
    • Social functioning problems and tics: 1.01 (+ 1 %, not statistically significant)
    • Affective disorders: 1.16 (+ 16 %)
    • Fear: 1.11 (+ 11 %)
    • Feeding problems as an infant or child: 0.96 (minus 4%, not statistically significant)
    • Sleep disorders: 1.08 (+ 8 %, not statistically significant)
    • Mental disability: 1.25 (+ 25 %)
    • Specific developmental disorders: 1.20 (+ 20 %)
  • Underweight mother (BMI 18.5 and lower)
    • ADHD and CD: 1.05 (+ 5 %, not statistically significant)
    • ASS: 1.11 (+ 11 %)
    • Social functioning problems and tics: 1.18 (+ 18 %)
    • Affective disorders: 1.01 (+ 2 %, not statistically significant)
    • Fear: 1.10 (+ 10 %)
    • Feeding problems as an infant or child: 1.07 (+ 7 %, not statistically significant)
    • Sleep disorders: 0.98 (minus 2%, not statistically significant)
    • Mental disability: 1.33 (+ 33 %)
    • Specific developmental disorders: 1.18 (+ 18 %)

Even an excessive BMI of the mother before pregnancy increased the risk of ADHD in the later offspring.286 A BMI of 25 to 30 increased the child’s risk of ADHD by 14%, a BMI of 30 to 35 by 96% and a BMI of more than 35 by 82%.287
Other fluctuations in the mother’s weight before and at the end of pregnancy do not appear to influence the risk of ADHD.66 In rats, however, there are indications of an influence on the dopamine balance of the offspring.288
A Norwegian registry study found only slight evidence of an influence of the mother’s pre-pregnancy BMI on the child’s risk of ADHD289

If high blood pressure was added to obesity, this led to an increased risk of:283

  • + 219 % for affective disorders
  • + 140 % for specific developmental disorders
  • + 246 % for ASS
  • + 174 % for ADHD or CD

Children of mothers with chronic hypertension and overweight had a higher risk of SDD (aHR = 1.58) and ADHD or CD (aHR = 1.43) compared with the reference group (Figure 1 and Table S2). Nevertheless, the effect sizes of the combined exposure were not larger than those of the individual exposure to chronic hypertension or obesity.

1.3.4.2. Eating disorders during pregnancy (+ 53 % to + 112 %)

Children of mothers with eating disorders during pregnancy had an increased risk of mental disorders in a Finnish register study (n = 392,098 mothers, 649,956 children):285

  • Anorexia of the mother
    • ADHD and CD: 1.53 (+ 53 %)
    • ASS: 1.56 (+ 56 %)
    • Social functioning problems and tics: 2.16 (+ 116 %)
    • Affective disorders: 1.46 (+ 46 %)
    • Fear: 1.63 (+ 63 %)
    • Feeding problems as an infant or child: 1.24 (+ 24 %, not statistically significant)
    • Sleep disorders: 2.12 (+ 112 %)
    • Mental disability: 1.08 (+ 8 %, not statistically significant)
    • Specific developmental disorders: 1.37 (+ 37 %)
  • Bulimia of the mother
    • ADHD and CD: 1.94 (+ 94 %)
    • ASS: 1.75 (+ 75 %)
    • Social functioning problems and tics: 2.48 (+ 148 %)
    • Affective disorders: 1.92 (+ 92 %)
    • Fear: 1.88 (+ 88 %)
    • Feeding problems as an infant or child: 1.88 (+ 88 %)
    • Sleep disorders: 2.35 (+ 135 %)
    • Mental disability: 0.89 (minus 11%, not statistically significant)
    • Specific developmental disorders: 1.09 (+ 9 %, not statistically significant)
  • eating disorder of the mother not otherwise specified
    • ADHD and CD: 2.12 (+ 112 %)
    • ASS: 2.04 (+ 104 %)
    • Social functioning problems and tics: 2.79 (+ 179 %)
    • Affective disorders: 2.30 (+ 130 %)
    • Fear: 2.19 (+ 119 %)
    • Feeding problems as an infant or child: 2.69 (+169 %)
    • Sleep disorders: 3.34 (+ 234 %)
    • Mental disability: 1.18 (+ 16 %, not statistically significant)
    • Specific developmental disorders: 1.54 (+ 54 %)
  • any eating disorder of the mother
    • ADHD and CD: 1.73 (+ 73 %)
    • ASS: 1.68 (+ 68 %)
    • Social functioning problems and tics: 2.18 (+ 118 %)
    • Affective disorders: 1.66 (+ 66 %)
    • Fear: 1.79 (+ 79 %)
    • Feeding problems as an infant or child: 1.59 (+59 %)
    • Sleep disorders: 2.36 (+ 138 %)
    • Mental disability: 1.16 (+ 16 %, not statistically significant)
    • Specific developmental disorders: 1.28 (+ 28%, not statistically significant)

1.3.5. Pre-eclampsia (gestosis) in pregnancy (+ 23 % to + 277 %)

The % figure in the heading was calculated by omitting the lowest and highest values.

Pre-eclampsia impairs the oxygen supply to the fetus and is often associated with high blood pressure in the mother. Both are also risk factors for ADHD in the offspring.

Pre-eclampsia (gestosis) during pregnancy increases the risk of ADHD in the child290291

  • by 408 %108
  • by 277 % (RR 2.77)292
  • by 30 to 188 %293
  • by 43 % (cohort study)294
  • by 29 % (meta-analysis, k = 15)295
  • by 19 %296

The risk of pre-eclampsia was increased at normal weight:

    • 48 % for mental disability283
    • 43 % for special developmental disorders283
  • for ASS
    • by 43 %283
    • by 27 % (meta-analysis, k = 15)295 - + 23 % for ADHD or CD283
    • 35 % for epilepsy (meta-analysis, k = 15)295
    • 34 % for other behavioral and emotional disorders283

The risk of pre-eclampsia was increased in those who were overweight compared to both the reference group and those who had either only pre-eclampsia or only obesity:283

    • 123 % for affective disorders
    • 85 % for anxiety disorders
    • 82 % for special developmental disorders
    • 115 % for other behavioral and emotional disorders

Obesity increased the risk of pre-eclampsia:283

    • 94 % for ADHD or CD
    • 98 % for other behavioral and emotional disorders

High blood pressure during pregnancy increased the risk of ADHD by 24% (HR: 1.24), of ASD by 29% (HR: 1.29) and of mental retardation by 58% (HR: 1.58). The cause was mostly pre-eclampsia.297291

Pre-eclampsia together with a urinary tract infection increased the risk by 53%.296

Gestational gestosis in slightly premature infants increased the risk of the offspring having impairments in gross and fine motor skills, adaptability, language and social-emotional response, as well as abnormal rates.
While at the age of 3 to 6 months no deviations in the areas mentioned were detectable, at the age of 12 months there was a significant deterioration in gross motor skills and fine motor skills with a significantly reduced risk of abnormal speech values.298

Several reviews confirm an increased risk of ADHD due to pre-eclampsia in pregnancy.299300

Pre-eclampsia is associated with changes in the adenosine system, including adenosine transporters and adenosine receptors. SHR are born in a pre-eclampsia-like situation due to maternal hypertension. Caffeine (an adenosine antagonist) in 7-day-old SHR prevented the negative Consequences of preeclampsia (hyperactivity, worsened social interaction, worsened contextual fear conditioning), while it enhanced these symptoms in Wistar rats301
Hypoxia (lack of oxygen) increases adenosine. Adenosine antagonists can prevent or remedy the negative Consequences of hypoxia. More on this under ⇒ Adenosine In the chapter Neurological aspects.

High levels of the (weak) adenosine antagonist theobromine correlated negatively with pre-eclampsia302

Maternal pre-eclampsia as a risk factor for ADHD in offspring has been confirmed in different populations and using different methods. For example, both a population-based case-control study in Western Australia [41] and research from the Millennium Cohort Study (MCS) [42] show that preeclampsia is associated with an increased risk of ADHD in offspring. Genitourinary infections in the mother associated with pre-eclampsia increase the likelihood of ADHD, suggesting that maternal comorbid conditions increase this risk [43]. A similar finding is reported in a large cohort study with data from over 7200 children from the Avon Longitudinal Study of Parents and Children, which found that maternal preeclampsia almost tripled the risk of ADHD in children aged 7 and 10 years, confirmed by log-binomial regression and generalized estimating equation models [44]. A meta-analysis summarizes these findings and confirms that intrauterine exposure to preeclampsia consistently increases the risk of ADHD in all studies [34]. Overall, exposure to maternal preeclampsia probably increases the risk of ADHD in the offspring.

1.3.6. Mental stress of the mother during pregnancy (+ 72 % to + 210 %; with 5HTTLPR + 800 %)

Stress of the mother during pregnancy increased the risk of ADHD in the children

  • by 400 % (OR = 5.02).303
  • by 210% for boys born to mothers who had a child or spouse during pregnancy 304
  • by 147% in boys born to mothers who had suffered the death of a child or spouse in the 0-6 months prior to pregnancy304
  • by 100 %305
  • aDHD symptoms increased by 95% at 16 years, but no increased hyperactivity symptoms at 8 years (minus 13%)306
  • by 72% for boys born to mothers who had suffered the unexpected death of a child or spouse304
  • by 72 %307
  • by 60 %; no statistically significant increase in ASA risk (25-year cohort study, n = 16,365)59
  • by 31% due to maternal stress in the third trimester (and by 58% for ASA)308

Persistent and severe (anxiety-induced, perceived threatening = cortisolergic) stress significantly increases the risk of screaming children309 (see also 2.2.2.3.2), anxiety disorders and ADHD.310311312313314
Persistent stress (here: financial problems) is more harmful than short-term stress (here: loss of a loved one).315
High anxiety/threatening perceived stress also significantly increases the risk of borderline PS in children.

Children with ADHD were more likely to have mothers who experienced stress or emotional problems during pregnancy:73

  • Children with ADHD: 53.8%
    If stress/emotional problems occurred, they were in the following trimester:
    • 1st/2nd trimester only: 36.0 %
    • 3rd trimester only: 6.7 %
    • Entire pregnancy: 57.3 %
  • Non-affected children: 27.6 %
    If stress/emotional problems occurred, they were in the following trimester:
    • 1st/2nd trimester only: 28.6 %
    • 3rd trimester only: 24.9 %
    • Entire pregnancy: 28.6 %

Hair cortisol levels of mothers and their children showed a transmission of psychological stress experiences from mothers to their children.316
A study found no increased psychiatric disorders at age 9 in children of women exposed to one month of repeated rocket fire on civilians during the 2006 Lebanon War.317 It is possible that one month of repeated stress is not a sufficiently intense stressor.

The cortisol released by the mother during anxiety/threatening stress is absorbed by the unborn child and leads to permanent damage to the HPA axis, which regulates stress reactions by means of cortisol.318319

Severe maternal anxiety in pregnancy during the 12th to 22nd week after the last menstrual period significantly increased the risk of ADHD, while severe anxiety in the 32nd to 40th week did not increase the risk.320 Elevated maternal cortisol levels in the 3rd trimester of pregnancy increased the offspring’s risk of ASD symptoms only in boys at 3 years of age, but were no longer significant at 5 years of age. ADHD symptoms were not elevated at either age 3 or age 5.321
So it seems to depend very much on the time of the stress experience.

Severe anxiety in the mother during pregnancy increased the unborn child’s risk of ADHD depending on its COMT gene variant (gene-environment interaction).322
In mothers with the ADGRL3 (latrophilin 3, LPHN3) gene variants (SNPs)

  • rs6551665
  • rs1947274
  • rs6858066 or
  • rs2345039

even low levels of stress during pregnancy resulted in a significantly increased risk of ADHD for the child.323

A combination of the 5HTTLPR L/L genotype and stress during pregnancy caused an eight times higher risk of ADHD-C or ADHD-HI.324

Children with ADHD whose mothers were exposed to moderate and severe stress during pregnancy tend to develop more severe ADHD symptoms.325

Early prenatal stress increases levels of immune response genes, including the proinflammatory cytokines IL-6 and IL-1β, particularly in male placentas. Male infants show stress-induced locomotor hyperactivity, a hallmark of dopaminergic dysregulation, which was ameliorated by maternal treatment with nonsterioid anti-inflammatory drugs. In addition, the expression of dopamine D1 and D2 receptors was altered by early prenatal stress in male offspring.326 This emphasizes the effect of early stress on the dopaminergic system.

High cortisol exposure of the fetus or newborn can cause methylation of the GAD1 / GAD67 gene, which encodes the key enzyme for glutamate-to-GABA synthesis, glutamate decarboxylase 1, and lead to increased glutamate levels. This epigenetic mechanism may increase the risk of ADHD in children.327 Exposure to glucocorticoids during hippocampal development in pregnancy influences the starting point of the stress response through epigenetic changes via mRNA and methylation.328 Another study reports that the maternal psychological stress-mediated increase in risk to the unborn child for developmental disorders such as ADHD may be mediated by mRNA expression of glucocorticoid pathway genes in the placenta.329
Another study also describes epigenetic changes in the unborn child due to the mother’s psychological stress during pregnancy.330
One study found no significant risk increase for mental disorders up to the age of 10 years due to increased glucocorticoid exposure in unborn babies.331
Exposure of the mother to a natural disaster during pregnancy increased the risk of ADHD.332

In primates, the stress hormone cortisol is converted into its inactive form by the enzyme hydroxysteroid 11-β-dehydrogenase 2 (HSD11B2). This conversion in the placenta also protects the fetus.333334 However, chronic maternal stress (as well as malnutrition or hypoxia) reduces HSD11B2 expression in the placenta.334 Fetuses of chronically stressed mothers are therefore exposed to high cortisol concentrations, which triggers developmental delays and neurodevelopmental disorders such as ADHD.335336334 In rodents, the expression of Hsd11b1, which encodes an enzyme that regulates the activity of stress-related hormones in the neocortex, is reduced instead.337

Maternal stress during pregnancy or birth complications such as maternal infections during pregnancy or lack of oxygen during birth also increase the risk of other disorders such as schizophrenia.338

1.3.7. Fever of the mother during pregnancy (+ 31 % to + 164 %)

A cohort study of 114,000 children showed that fever in the first trimester of pregnancy increased the risk of ADHD by 31%, and multiple fevers by 164%. However, fever only increased inattention, not hyperactivity/impulsivity - this also applied to the second trimester. The results were independent of whether the mother took paracetamol (acetaminophen) or not.339

1.3.8. PTSD during pregnancy (+ 132 %)

According to a Swedish cohort study, post-traumatic stress disorder in the mother during pregnancy is associated with a 2.32-fold risk of ADHD in the offspring.340

1.3.9. Chemical / drug intolerance (+ 110 % to 130 %; ASS + 201 % to 470 %)

Children of mothers with chemical / drug intolerance (positive result of the Quick Environmental Exposure and Sensitivity Inventory (QEESI), a validated screening tool for chemical intolerance) had 2.3 times the risk of ADHD and 3.01 times the risk of ASD.341342

1.3.10. Depression of parents before / during / after pregnancy (up to + 100 %)

In boys in particular, the severity of the mother’s depression during pregnancy as well as higher cyclothymic, irritable and anxious temperament levels in the mother appear to be relevant risk factors for the development of ADHD.343

A cohort study found

  • Parental depression increased the risk of offspring depending on the time of onset of depression for (data in HR):344
    • ADHD (prenatal 1.95 = increased by 95 %, any time: 1.98 = increased by 98 %, postnatal: 2.0 = increased by 100 %)
    • ASD (prenatal 1.76, any time1.52)
    • Tic disorders (prenatal 1.52, any time 1.40)
    • Developmental delay (prenatal 1.40, any time 1.32, postnatal 1.24)
    • Language development disorder (prenatal 1.29, any time 1.17)
    • Developmental coordination disorder (HR: 1.73, any time 1.76, postnatal 1.78)
    • Mental disability (any time 1.26)

ADHD risk was increased (meta-analysis, k = 21, 796,157 mother-child pairs)345

  • by 67% due to antenatal depression of the mother (prenatal)
  • by 53 % due to postnatal depression of the mother (after birth)

A large-scale study found no causal influence of maternal depression, anxiety disorder or infection during pregnancy on the risk of neurodevelopmental disorders (ASD, ADHD, mental retardation, cerebral palsy or epilepsy) in the child.346

1.3.11. Polycystic ovary syndrome (PCOS) in pregnancy (+ 31 to + 95 % in boys)

Children of women with polycystic ovary syndrome (PCOS) appear to have an increased risk of ADHD.347348

It is possible that a connection could result from the fact that one treatment method is the use of dopamine agonists.349350 Another connection could be that PCOS is associated with hyperandrogenemia. Elevated prenatal testosterone levels are a risk factor for ADHD. More on this under Gender differences in ADHD.

One study found a 95% increased risk of ADHD in 3-year-old boys born to mothers with PCOS, while this was not increased in 3-year-old girls.351 This also suggests a link with sex hormones, although increased testosterone levels during pregnancy also cause increased ADHD symptoms in female offspring. More on this at Gender differences in ADHD. It is also known that ADHD shows up later in girls than in boys.
A Chinese study found a 31% increased risk of ADHD in boys aged 3 to 6 (only).352 As ADHD can often only be diagnosed from the age of 6, we suspect a higher rate at school age.

Women with PCOS had an increased risk of ADHD themselves, although no link was found between testosterone and ADHD symptoms353

1.3.12. Reduced C-reactive protein (CRP) (+ 92 %)

Children of mothers whose CRP levels were in the lowest third of the subject group had an almost doubled risk of ASD and ADHD compared to children of mothers from the middle third of CRP.354

1.3.13. Unhealthy diet of the mother during pregnancy (+ 60 %)

An unhealthy or “westernized” dietary intake by the mother during pregnancy increased the children’s likelihood of ADHD by more than 60%.355
Since stress increases the preference for “convenient food”, we believe that the correlation could possibly also be an indirect reflection of an increased stress load on the mother during pregnancy, since stress changes food preferences in the direction of quickly digestible foods and convenient food.

1.3.14. Systemic lupus erythematosus (SLE) (+ 60 %)

Children of mothers who suffered from systemic lupus erythematosus (SLE) were found to have a 60% increased risk of ADHD.356
ADHD, for its part, is associated with a 2.17-fold risk of lupus.357

1.3.15. Threatened miscarriage (up to + 51 %)

If there was a threat of miscarriage during pregnancy, this increased the risk of

  • ADHD by 51 %358
  • ADUS by 21 % (adjusted) to 31 %359
  • ASS by 55 %.358

1.3.16. Diabetes of one parent; diabetes during pregnancy (+ 40 %)

A cohort study of over 5 million people found an increased risk of ADHD in children if a parent had diabetes.360

Diabetes in the mother before or during pregnancy increases the offspring’s risk of ADHD361, in the case of gestational diabetes mellitus as well as pre-existing type 1 diabetes mellitus or type 2 diabetes mellitus,362 and also for ASD.363364365
Diabetes mellitus or type 1 diabetes mellitus in the mother before pregnancy increased the children’s risk of ADHD by 40 %, type 1 diabetes mellitus in the father by 20 %.
Another study found a 2.4-fold ADHD risk in children of mothers with diabetes mellitus and a 3.7-fold ADHD risk in male offspring of mothers with diabetes mellitus. No differences were found between gestational diabetes and other diabetes.366
Children of non-insulin-treated severely obese mothers with type 2 diabetes were 2 times more likely to have psychiatric disorders than offspring of normal-weight mothers. Children of insulin-treated severely obese mothers with pregestational diabetes were 2.7 times more likely to have psychiatric disorders than offspring of normal-weight mothers.367

1.3.17. Migraine in parents (+ 37 %)

A cohort study of n = 250,517 participants found an increased risk for children of mothers, but not fathers, with migraine:368

  • ADHD (+ 37 %)
  • Bipolar Disorder (+ 35 %)
  • Depression (+ 33 %)

1.3.18. Anemia of the mother during pregnancy (+ 31 %)

A cohort study of 532,232 children over 23 years of age showed that maternal anemia in the first 30 weeks of pregnancy increased the risk of ADHD by 31%, while anemia in later weeks of pregnancy barely increased the risk (by 1.4%). 369

In a small Lebanese correlational study (n = 119), maternal anemia during pregnancy increased the risk of ADHD 3.7-fold (OR = 3.654).303

1.3.19. Infections of the mother during pregnancy

1.3.19.1. Infections in general (+ 30 %)

A meta-analysis found a 30% increase in the risk of ADHD in the offspring due to infections in the mother during pregnancy.370 A register-based cohort study (n = 2,885,662 of which n = 1,864,660 were full siblings) found a slight increase of 14 % (ASD + 19 %; mental retardation + 21 %), which was lost when twins were controlled for371
Mycoplasma antibodies at birth were associated with a 30% increased risk of ADHD later in life.372

1.3.19.2. Viral infections

A viral infection of the mother during pregnancy increases the risk of ADHD for the offspring373 and can influence the development of the unborn child’s dopaminergic system, e.g.:374

  • Measles
  • Varicella
  • Rubella
    • Subclinical rubella infection of the mother during pregnancy also increases the child’s risk at the age of 8 to 9 years for375
      • ASS
      • ADHD
      • Developmental disorders
  • Enterovirus 71
  • Herpes virus 6
  • Influenza A
  • Cytomegalovirus (+ 30 %)372

A connection seems less certain for

  • Streptococcal infection
  • Inflammation of the middle ear (otitis media)

Birth complications such as maternal infections during pregnancy, maternal stress during pregnancy or lack of oxygen during birth also increase the risk of other disorders376, such as schizophrenia338, ASD377 or depression.376

1.3.19.3. Urinary tract infections (+ 29 %)

A urinary tract infection in the mother during pregnancy was associated with a 29% increased risk of ADHD.296 Chlamydia/non-onococcal urethritis, trichomoniasis, urinary tract infections and candidiasis increased the risk of ADHD, while gonorrhea did not.

A urinary tract infection and pre-eclampsia increased the risk by 53%.296

Another study also found an increased risk of ADHD as a result of urinary tract infections in the mother during pregnancy378

1.3.20. Fetal inflammatory response syndrome (FIRS) (+ 27 %)

Children born to a mother with fetal inflammatory response syndrome (FIRS, an inflammation of the placenta during pregnancy) had an increased risk of:379

  • neuropsychiatric disorders diagnosed (OR = 1.21)
  • ASS (OR = 1.35)
  • ADHD (OR = 1.27)
  • Conduct disoder (OR = 1.50)
  • PTBS (OR = 2.46)

1.3.21. High blood pressure during pregnancy (+ 24 %)

High blood pressure during pregnancy significantly increases the risk of ADHD in the offspring.300. Hypertension during pregnancy increased the risk of ADHD by 24% (HR: 1.24), ASD by 29% (HR: 1.29) and mental retardation by 58% (HR: 1.58). The cause was mostly pre-eclampsia.297 High blood pressure during pregnancy increased the risk of depression by 130%.380

If obesity was added to chronic high blood pressure, this led to an increased risk of:283

    • 246 % for ASS
    • 219 % for affective disorders
    • 140 % for specific developmental disorders
    • 174 % for ADHD or CD

If overweight (instead of obesity) was added to high blood pressure during pregnancy, this resulted in an increased risk of (compared to high blood pressure or obesity alone):283

    • 143 % for anxiety disorders
    • 145 % for ADHD or CD

If obesity was added to gestational hypertension, this resulted in an increased risk of (compared to unaffected individuals):283 (Effect sizes of combined exposure were not greater than those of individual exposure to gestational hypertension or obesity):

    • 60 % for anxiety disorders
    • 40 % for ADHD or CD
    • 84 % for affective disorders
    • 76 % for specific developmental disorders

High blood pressure is associated with genetically inherited ADHD risks. It will therefore be necessary to differentiate whether high blood pressure during pregnancy causally increases the risk of ADHD or whether elevated blood pressure during pregnancy is an expression of the underlying genetic burden that mediates ADHD.

1.3.22. Insatiable nausea (hyperemesis gravidarum) (+ 16 %)

Insatiable nausea and vomiting of the mother during pregnancy led to an increased risk of ADHD in the offspring by 16% (in 2 cohort studies) to 287%381

1.3.23. Mineral and vitamin deficiency during pregnancy

Find out more at Vitamins, minerals, dietary supplements for ADHD And Nutrition and diet for ADHD in the chapter Treatment and therapy.

1.3.23.1. D3 deficiency during pregnancy

Vitamin D3 deficiency during pregnancy and after birth causes permanent maldevelopment of the brain, particularly the dopaminergic system 382 383 384385

In a meta-analysis, studies with larger sample sizes and stricter definitions of vitamin D deficiency showed positive associations for ADHD386387 and schizophrenia.387 D3 deficiency during pregnancy reduces dopamine turnover in the offspring’s brain388 with a reduction in COMT.389

**D3 deficiency during pregnancy increases risk: 7 studies **

A study in Finland found a clear correlation between a reduced D3 level in the mother during pregnancy and ADHD in the children. The risk increase reached over 50 %.390
The incidence of ADHD-like symptoms in children decreased by 11% for every 10 ng/ml increase in maternal 25(OH)D levels.391 A relatively low maternal 25(OH)D level at 24 weeks gestation increased the risk of ADHD and ASD and ASD severity. High D3 supplementation (2,800 iU/day) during pregnancy did not increase the risk of ADHD or ASD392
The severity of the offspring’s ADHD symptoms correlated with the level of maternal 25(OH)D deficiency 393394
Decreased maternal D3 levels at 35 to 37 weeks of gestation correlated significantly with increased ADHD signs in the children at 6 months and 2 years of age.314
It remains to be seen whether D3 deficiency has different effects in other weeks of pregnancy, as later mental disorders are particularly related to those regions of the brain that are undergoing a developmental boost in the respective week of pregnancy. More on this at Exposure to stress at different stages of brain development In the chapter Stress damage - effects of early / prolonged stress.
Rodents whose mothers had a vitamin D deficiency showed typical ADHD symptoms:395

  • Hyperactivity
  • Impulsiveness
  • Reduced social behavior
  • Changed frequency of ultrasound vocalization
  • More frequent self-pollution
  • Reduced grooming of puppies
  • Reduced growth factors NGF and GDNF
  • Thinner cortical layers and larger lateral ventricles
  • Smaller size of the hippocampus and smaller lateral ventricles

D3 deficiency during pregnancy does not increase the risk of ADHD: 3 studies

Reduced vitamin D3 serum levels in the mother at 30 weeks’ gestation correlated significantly with depression in the offspring up to the age of 22, but not with ADHD396
A comprehensive long-term study in Spain on vitamin D3 deficiency during pregnancy found no correlation between low D3 blood levels in the mother during pregnancy and ADHD in children aged 5 to 18 years.397 Similarly, a Norwegian cohort study found no correlation between maternal vitamin D levels during pregnancy and the offspring’s later risk of ADHD, but did find a correlation between ASD and (Consequences) lower vitamin D levels and ADHD and (Consequences) lower omega-3 levels.398

1.3.23.2. Omega-3 fatty acid levels

1.3.23.2.1 In the newborn

A meta-study found evidence that higher levels of omega-3 fatty acids in newborns can reduce the risk and severity of ADHD and autism spectrum disorders. It is possible that an adequate supply of omega-3 fatty acids in the last trimester of pregnancy could counteract this399

1.3.23.2.2. During pregnancy

Another study found a 13% increased risk of ADHD in offspring at the age of 7 due to an increased omega 6 to omega 3 ratio (high omega 6 and low omega 3 levels).400

1.3.24. Lack of sleep during pregnancy

Girls born to mothers with less than 8 hours of sleep in the last trimester of pregnancy were more likely to show hyperactivity, inattention and ADHD totals.401
Sleep problems during pregnancy correlated with an increased risk of neurodevelopmental disorders and sleep problems in early childhood.402, in particular

  • reduced and poorer sleep in the second trimester of pregnancy correlated with ADHD
  • major sleep problems in the first trimester correlated with ADHD
  • Sleep problems in the third trimester correlated with the child’s sleep problems

1.3.25. Testosterone during pregnancy

Prenatal testosterone exposure correlated significantly with inattention and hyperactivity/impulsivity in the offspring.403 Elevated maternal testosterone levels during pregnancy correlated significantly with increased ADHD signs in the children at 6 months and 2 years of age.314

1.3.26. Inflammation of the mother during pregnancy

Perinatal inflammation correlates with increased ADHD symptom scores in children aged 8-9 years and increases genetic predisposition to ADHD (the Polygenic Risc Score).404405

One possible pathway: IL-6

Among other things, inflammation increases IL-6 (interleukin 6). IL-6 can cross the placenta and the blood-brain barrier of the fetus. In mice, administration of IL-6 without inflammation on days 3 to 6 (corresponding to the third trimester of pregnancy in humans406.):407

  • increased ultrasound vocalization in males
  • reduced ultrasonic sounds in females
  • reduced social interaction in males
  • almost doubled self-care in males
  • increased tactile sensitivity in females

1.3.27. Bipolar Disorder in parent

Having a parent with bipolar disorder increased the children’s risk of ADHD.408

1.4. Mother’s medication during pregnancy as ADHD risk (up to + 250 %)

Children with ADHD were more likely to have mothers who took medication during pregnancy:73

Medication taken by the mother during pregnancy:

  • ADHD: 43.5 %
    If stress/emotional problems occurred, they were in the following trimester:
    • 1st/2nd trimester only: 36.2 %
    • 3rd trimester only: 14.5 %
    • Entire pregnancy: 49.3 %
  • Not affected: 31.4 %
    If stress/emotional problems occurred, they were in the following trimester:
    • 1st/2nd trimester only: 31.1 %
    • 3rd trimester only: 46.9 %
    • Entire pregnancy: 21.9 %

The following list is only exemplary and by no means complete.

1.4.1. Paracetamol (acetaminophen) in pregnancy (+ 37 % to + 250 %)

50% of all women use paracetamol during pregnancy.409
Taking paracetamol (in North America and Iran: acetaminophen) during pregnancy increased the risk of ADHD by up to 37%. Even short-term use is harmful according to two very comprehensive studies with a total of over 110,000 participants.410411 Further studies confirm this.412413414 Critically, Gilman et al. While the previous studies were based on the mothers’ reports of intake, a study based on blood levels found a 2.3 to 3.5-fold risk of ADHD and a 1.6 to 4.1-fold risk of ASA in the children if taken in the second or third trimester of pregnancy.415416

The risk of ADHD from paracetamol (acetaminophen) increases when taken417

  • By 19 % in the second trimester of pregnancy
  • By 28 % in the first and second trimester
  • By 20 % in the first to third trimester

A cohort study of 116,000 children showed that fever in the first trimester of pregnancy increased the risk of ADHD by 31%, and multiple fevers by 164%. However, fever only increased inattention, not hyperactivity/impulsivity - this also applied to the second trimester. The results were independent of whether the mother took paracetamol (acetaminophen) or not.339
A meta-analysis confirms the increased risk of ADHD and ASD in offspring when taking paracetamol during pregnancy418

A meta-analysis of 22 studies with n = 367,775 participants found an increased risk of ADHD due to paracetamol during pregnancy, which remained unchanged by other factors (such as parental diagnoses)419

One study questions the previous critical results by focusing on parents’ ADHD diagnoses that have not been taken into account to date.420 Damkier is also doubtful.421422 Another study found no evidence of an increased risk of ADHD or ASD from paracetamol during pregnancy.423 A review also found no association424

A long-term study analyzed paracetamol, methionine, serine, glycine and glutamate in umbilical cord plasma and found that increased paracetamol levels increased the risk of ADHD in parallel with the increase in 8-hydroxy-deoxyguanosine levels in umbilical cord blood. Increased levels of methionine, glycine, serine and 8-hydroxy-deoxyguanosine in cord blood correlated with a significantly higher likelihood of ADHD in childhood. Methionine and glycine each mediated 22% of the association between elevated acetaminophen levels and later ADHD.425
The damage to the development of the offspring caused by paracetamol during pregnancy appears to be mediated by changes in the endocannabinoid pathway426
Paracetamol is also suspected as a possible cause of ASA.159
In any case, the evidence that paracetamol increases the risk of ADHD during pregnancy is so strong that pregnant women should be warned against taking it.427

Ibuprofen, on the other hand, is not thought to pose an ADHD risk to the unborn child.

Possible pathway: Cannabinoid pathway / CB1R.428

1.4.2. SSRI, antidepressants during pregnancy (0 % to + 63 %)

According to two meta-analyses of 18 studies, SSRIs during pregnancy correlate with a significantly increased risk of ADHD (OR = 1.26 = approx. + 26 %) and ASD (OR = 1.42 = approx. + 42 %) in children. It is not clear whether this results from the SSRIs or from an inheritance of psychological problems of the mother for which she was treated with SSRIs, as the risk of ADHD (OR = 1.63 = approx. + 63 %) and ASD (OR = 1.39 = approx. + 39 %) was also increased in the children if the mother took SSRIs or SNRIs before pregnancy but not during pregnancy.429430 a caring SSRI should be used with extreme caution during pregnancy.
A meta-analysis found no increased risk of ADHD in children in 7 of 8 studies of SSRIs during pregnancy.431 The same applies to another study.432 According to one study, antidepressants during pregnancy increased the likelihood of later ADHD in the child by 1.81 times.433

1.4.3. Valproic acid during pregnancy (+ 39 %)

Valproic acid increased the risk of ADHD in offspring by 39% (meta-analysis, k = 22)434 It also increased the risk of congenital malformations by 147% to 830%, autism by 70% to 338%, impaired motor development by 600% and mental retardation and low IQ by 140% to 338%.
Offspring of mice that received valproic acid during pregnancy showed significantly increased hyperactivity and changes in the dentate gyrus.435436 In addition, there are indications of changes in the histaminergic system and social behavior.437
Valproic acid during pregnancy increases the risk of ADHD, ASD, reduced cognitive abilities and speech disorders in the offspring.438 In addition, it causes congenital malformations such as neural tube defects, cardiac anomalies, urogenital malformations (e.g. hypospadias, skeletal malformations and orofacial clefts) in 10 % of children, depending on the dose, especially at more than 600 mg/day. High doses of folic acid before and during pregnancy could reduce the risk. The concentration of valproin in breast milk appears to be low, which is why breastfeeding does not pose a risk.

1.4.4. Corticoids during pregnancy (+ 30 %)

Glucocorticoid administration during pregnancy increased the risk of ADHD in the offspring by 30%.439 The risk of ASD was increased by 30 % to 50 %, the risk of depression, anxiety and stress-related disorders by 40 % to 50 % and the risk of mental retardation by 30 %.
Corticoid administration during pregnancy leads to long-term changes in the unborn child’s brain and increases the risk of ADHD.440 The children suffer a lifelong alteration of the dopaminergic system and the HPA axis, apparently caused by changes in the expression and ratio of MR and GR receptors.441 In our opinion, the ADHD symptoms described in these children could possibly be the consequence of HPA axis alteration.
Corticosteroid receptor hypothesis of depression

High cortisol exposure of the fetus or newborn can cause methylation of the GAD1 / GAD67 gene, which encodes the key enzyme glutamate-to-GABA-synthesizing glutamate decarboxylase 1 and leads to increased glutamate levels. This epigenetic mechanism may increase the risk of ADHD in children.327

Exposure to betamethasone during pregnancy only marginally increased the risk of ADHD in the offspring.442443

Dexamethasone during pregnancy in mice increased spontaneous activity in female offspring, while reducing it in males. Dexamethasone during pregnancy downregulated dopamine signaling and upregulated glutamate and GABA signaling in females.444

1.4.5. β-2-Adrenaline receptor agonists in pregnancy (+ 30 %)

Taking β-2 adrenaline receptor agonists (beta-2 sympathomimetics) during pregnancy increases the risk of ADHD for the child by up to 30%.445

1.4.6. Pregabalin during pregnancy (+ 29 %)

Prenatal pregabalin exposure increased the risk of ADHD by 29%, but this was attenuated when active comparators were taken into account.446

1.4.7. Antibiotics during pregnancy (+ 14 % to + 19 %)

Several meta-analyses found a 14% increased risk of ADHD due to the mother taking antibiotics during pregnancy 447448
Exposure to antibiotics in the womb increased the child’s risk of: (meta-analysis, k = 30, n = 7,047,853)449

  • ADHD: + 19 %
  • ASS: + 9 %

Penicillin use by the mother during pregnancy increased the child’s risk of ADHD. The ADHD risk was increased by penicillin even when taken 2 years before pregnancy. Repeated penicillin intake further increased the risk of ADHD.26

Pathway of action: alteration of the microbiome.450

1.4.8. Antiepileptic drugs: Valproate in pregnancy (+ 12 %)

Valproate during pregnancy is said to increase the risk of ADHD for the unborn child.451
Valproates are the salts of valproic acid.

When antiepileptic drugs were taken during pregnancy, a cohort study found an increased risk of neurodevelopmental disorders in children up to the age of 6 (which is still too early to diagnose all people with ADHD):

  • Sodium valproate together with other antipsychotics: 15 %
  • Sodium valproate as monotherapy: 12 %
  • Lamotrigine 6.3 % (no statistically significant increase due to the small number of participants in this group)
  • Carbamazepine 2% (no significant increase)
  • Children who were not exposed to any of these drugs during pregnancy: 1.8%

ASD was the most common diagnosis. 2% of children of medicated mothers were diagnosed with ADHD by the age of 6 and 1.5% with dyspraxia. No child in the controls had an ADHD diagnosis.452

A large-scale cohort study found an increased risk of ASD (+ 110%) and ADHD (+ 43%) in children of mothers who had taken antiepileptic drugs during pregnancy. The risk was mainly due to valproate.453 Compared to mothers with epilepsy who did not take antiepileptic drugs during pregnancy, which only increased the risk of ASD by 38%.

The use of the antiepileptic drug topiramate during pregnancy is being discussed in relation to a possible increase in the risk of ADHD for the offspring454

1.4.9. Estrogens, progestins

Before they were banned in the 1970s and 1980s, millions of pregnant women worldwide were given synthetic sexuahomones such as oestrogens or progestogens.
Some progestins are still prescribed today.

Children of women treated in this way have an increased risk of:455

  • ADHD
  • ASS
  • Psychoses
  • Schizophrenia
  • bipolar disorders
  • severe depression
  • States of anxiety
  • Eating disorders

The other offspring of the people with ADHD are also affected (3rd generation: especially ADHD, ASD, bipolar disorder). In the 4th generation, which is still very young, the first signs are visible, such as dyspraxia, which is often a harbinger of ADHD
Estrogens and progestins appear to mediate their damage epigenetically via hypermethylation of the ZFP57 and ADAMTS9 genes, which are important for neurological development.

1.5. Congenital disorders

1.5.1. Congenital atrial septal defect or ventricular septal defect (+ 275 %)

Children with a congenital atrial septal defect or ventricular septal defect are 3 to 4 times more likely to have inattention and hyperactivity symptoms. One study found an SDHD prevalence of 15% compared to the control group of 4% (+ 275%).456

1.6. Other pregnancy circumstances (up to + 100 %)

1.6.1. First-born status (+ 31 to + 100 %)

See under First-born status In the article Physical ADHD risk factors

1.6.2. Particularly short or long intervals to the previous pregnancy (+ 25 % to + 30 %)

Particularly short or particularly long intervals between pregnancies with the preceding sibling increased the risk of ADHD by 30% (less than 6 months) or 12% (60 - 119 months) to 25% (120 months and more).457

1.6.3. Protein deficiency during pregnancy and after birth

Rats whose mothers were fed a low-protein diet 15 days before conception and then continued to do so during lactation were significantly more susceptible to early childhood stressors (intraperitoneal injection of deltamethrin, lipopolysaccharide, or both) to develop ADHD symptoms such as hyperactivity, attention problems, and decreased anxiety.458

1.6.4. Western diet in the first and second trimester of pregnancy

A Western diet (high in fat, refined grains and processed foods, low in fruit and vegetables; also known as the Standard American Diet (SAD)) in the first and second trimester of pregnancy is associated with an increased risk of ADHD and ASD in the offspring.459

1.6.5. High salt consumption during pregnancy

A high salt intake from food during pregnancy could increase the unborn child’s sensitivity to stress.460

1.7. Pregnancy factors without increased risk of ADHD

The following factors were found to have no influence on the unborn child’s risk of ADHD:

  • Iodine/creatinine ratio in the mother’s urine during pregnancy
    • A large study of 3 cohorts found no effect on ADHD or ASD risk461
  • Migration of the mother
    • A meta-analysis found no evidence of an increased risk of ADHD due to maternal migration, but this was not the case with ASD.462
  • Iron level of the mother
    • One study found no effect of the mother’s iron levels during pregnancy on the child’s risk of ADHD at age 7463
  • Artificial insemination464465 through sperm donation466 or intracytoplasmic sperm injection (ICSI)467
  • non-ionizing magnetic field radiation during pregnancy
    • A study that had initially found an increased ADHD rate in offspring of mothers who were most exposed to non-ionizing magnetic field radiation (“electro-smog”) during pregnancy (in a 24-hour measurement)468 has been withdrawn469. The updated version finds no correlation between particularly high non-ionizing magnetic field radiation and ADHD.
  • A cohort study found no ADHD risk increase with non-steroidal anti-inflammatory drugs (NSAIDs) in pregnancy.470
  • Benzodiazepines during pregnancy appear to increase the risk of internalizing problems in children (anxiety, emotional reactivity, somatic complaints), but not externalizing problems (hyperactivity, aggressiveness).471 A cohort study comparing siblings with and without benzodiazepine use by the mother during pregnancy found no significant risk increase for ADHD or ASD due to benzodiazepines; the authors rather suspect a connection with a genetic disposition of the mother.472 A meta-analysis also came to the conclusion that no relevant increase in the risk of ADHD in the offspring has been found for benzodiazepines during pregnancy, even though one study indicated a slight increase with benzodiazepine monotherapy in the last trimester of pregnancy.473 One study found a slight increase of 15% in the risk of ADHD when taking benzodiazepines during pregnancy.474
  • prenatal oxytocin exposure does not appear to affect ADHD and ASD risk475
  • Bionutrients during pregnancy476
  • Triptans during pregnancy477

This list of maternal medication during pregnancy as an ADHD risk is only exemplary and by no means complete.

1.8. Pregnancy factors with risk reduction for ADHD

1.8.1. Maternal sports during pregnancy > 20 minutes / day (up to minus 56 %)

Among n = 4,184 children aged 3 to 6 years, a reduced risk of ADHD was found when mothers during pregnancy daily:478

  • did 20 to 40 minutes of sports: minus 56 %
  • did more than 40 minutes of sports: minus 51 %

compared to children of mothers who did less than 20 minutes of sports per day.
Since ADHD is usually not diagnosed until the age of 7 and up, the overall effect is likely to be even greater.

1.8.2. Fiber intake of the mother during pregnancy (up to minus 20 %)

A high-fiber diet for the mother during pregnancy reduced the offspring’s risk of ADHD by up to 20 %.479
This was independent of genetic predisposition to ADHD, unhealthy diet and socio-demographic factors.

Fiber increases short-chain fatty acids in the intestine, which generally reduces the risk of mental health problems. More on this in the section Microbiome and short-chain fatty acids (SCFA) in ADHD Of the article Gut-brain axis as a cause of ADHD

1.8.3. Mediterranean diet (up to minus 64 %)

The mother’s adherence to the Mediterranean diet during pregnancy reduced the risk of behavioral problems at the age of 4 years:480

  • Overall problems (OR = 0.42)
  • Externalizing symptoms (OR = 0.29)
  • Attention problems (OR = 0.32)
  • ADHD (OR = 0.36)
  • oppositional defiant behavior (OR = 0.06)
  • depressive problems (OR = 0.38)

  1. López-Vicente M, Szekely E, Lafaille-Magnan ME, Morton JB, Oberlander TF, Greenwood CMT, Muetzel RL, Tiemeier H, Qiu A, Wazana A, White T (2024): Examining the interaction between prenatal stress and polygenic risk for attention-deficit/hyperactivity disorder on brain growth in childhood: Findings from the DREAM BIG consortium. Dev Psychobiol. 2024 May;66(4):e22481. doi: 10.1002/dev.22481. PMID: 38538956.

  2. Rice, Langley, Woodford, Smith, Thapar (2018): Identifying the contribution of prenatal risk factors to offspring development and psychopathology: What designs to use and a critique of literature on maternal smoking and stress in pregnancy. Dev Psychopathol. 2018 Aug;30(3):1107-1128. doi: 10.1017/S0954579418000421.

  3. Thapar A, Cooper M, Eyre O, Langley K (2013): What have we learnt about the causes of ADHD? J Child Psychol Psychiatry. 2013 Jan;54(1):3-16. doi: 10.1111/j.1469-7610.2012.02611.x. PMID: 22963644; PMCID: PMC3572580. REVIEW

  4. zitiert nach Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P (2005). Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005 Jun 1;57(11):1313-23. doi: 10.1016/j.biopsych.2004.11.024. PMID: 15950004. REVIEW

  5. Gizer IR, Ficks C, Waldman ID (2009): Candidate gene studies of ADHD: a meta-analytic review. Hum Genet. 2009 Jul;126(1):51-90. doi: 10.1007/s00439-009-0694-x. PMID: 19506906. REVIEW

  6. Li D, Sham PC, Owen MJ, He L (2006): Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet. 2006 Jul 15;15(14):2276-84. doi: 10.1093/hmg/ddl152. PMID: 16774975. METASTUDY

  7. Smith TF (2010): Meta-analysis of the heterogeneity in association of DRD4 7-repeat allele and AD/HD: stronger association with AD/HD combined type. Am J Med Genet B Neuropsychiatr Genet. 2010 Sep;153B(6):1189-99. doi: 10.1002/ajmg.b.31090. PMID: 20468072. METASTUDY

  8. Gornick MC, Addington A, Shaw P, Bobb AJ, Sharp W, Greenstein D, Arepalli S, Castellanos FX, Rapoport JL (2007): Association of the dopamine receptor D4 (DRD4) gene 7-repeat allele with children with attention-deficit/hyperactivity disorder (ADHD): an update. Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):379-82. doi: 10.1002/ajmg.b.30460. PMID: 17171657. n = 448

  9. Kustanovich V, Ishii J, Crawford L, Yang M, McGough JJ, McCracken JT, Smalley SL, Nelson SF (2004): Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5. Mol Psychiatry. 2004 Jul;9(7):711-7. doi: 10.1038/sj.mp.4001466. PMID: 14699430.

  10. Gabriela, John, Magdalena, Ariadna, Francisco, Liz, Lino, Josefina, Ernesto, Carlos (2009): Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients. Neurosci Lett. 2009 Feb 27;451(3):257-60. doi: 10.1016/j.neulet.2009.01.004. PMID: 19146920.

  11. Johansson S, Halleland H, Halmøy A, Jacobsen KK, Landaas ET, Dramsdahl M, Fasmer OB, Bergsholm P, Lundervold AJ, Gillberg C, Hugdahl K, Knappskog PM, Haavik J (2008): Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs. Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1470-5. doi: 10.1002/ajmg.b.30662. PMID: 18081165. n = 698

  12. Yang B, Chan RC, Jing J, Li T, Sham P, Chen RY (2007): A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3’-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 5;144B(4):541-50. doi: 10.1002/ajmg.b.30453. PMID: 17440978. METASTUDY

  13. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005 Jun 1;57(11):1313-23. doi: 10.1016/j.biopsych.2004.11.024. PMID: 15950004. REVIEW

  14. Guan L, Wang B, Chen Y, Yang L, Li J, Qian Q, Wang Z, Faraone SV, Wang Y (2009): A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: suggesting multiple susceptibility genes among Chinese Han population. Mol Psychiatry. 2009 May;14(5):546-54. doi: 10.1038/sj.mp.4002139. PMID: 18180757.

  15. Liu D, Ren Y, Wu T, Shen H, Yan P, Meng Y, Zhang Q, Zhang J, Bai P, Zhao J (2022): Parental smoking exposure before and during pregnancy and offspring attention-deficit/hyperactivity disorder risk: A Chinese child and adolescent cohort study. Front Public Health. 2022 Oct 10;10:1017046. doi: 10.3389/fpubh.2022.1017046. PMID: 36299741; PMCID: PMC9589153. n = 2.477 Familien

  16. Yohn, Caruso, Blendy (2019): Effects of nicotine and stress exposure across generations in C57BL/6 mice, Stress, 22:1, 142-150, DOI: 10.1080/10253890.2018.1532991

  17. McCarthy, Zhang, Wilkes, Vaillancourt, Biederman, Bhide (2022): Nicotine and the developing brain: Insights from preclinical models. Pharmacol Biochem Behav. 2022 Feb 14:173355. doi: 10.1016/j.pbb.2022.173355. PMID: 35176350.

  18. Dai J, Wang Z, Xu W, Zhang M, Zhu Z, Zhao X, Zhang D, Nie D, Wang L, Qiao Z (2017): Paternal nicotine exposure defines different behavior in subsequent generation via hyper-methylation of mmu-miR-15b. Sci Rep. 2017 Aug 4;7(1):7286. doi: 10.1038/s41598-017-07920-3. PMID: 28779169; PMCID: PMC5544724.

  19. Zhang M, Xu W, He G, Zhang D, Zhao X, Dai J, Wu J, Cao Y, Wang Z, Wang L, Qiao Z (2018): Maternal nicotine exposure has severe cross-generational effects on offspring behavior. Behav Brain Res. 2018 Aug 1;348:263-266. doi: 10.1016/j.bbr.2018.04.033. PMID: 29698694.

  20. Deng L, Wang Q, Lou Y (2023): Maternal nicotine intoxication before pregnancy induces depressive- and anxiety-like behaviors as well as cognitive deficits in male offspring and correlates with neurobiological changes. Brain Behav. 2023 Jul;13(7):e3052. doi: 10.1002/brb3.3052. PMID: 37161637; PMCID: PMC10338757.

  21. McCarthy, Morgan, Lowe, Williamson, Spencer, Biederman, Bhide (2018): Nicotine exposure of male mice produces behavioral impairment in multiple generations of descendants. PLoS Biol 16(10): e2006497. https://doi.org/10.1371/journal.pbio.2006497

  22. Buck, Sanders, Wageman, Knopik, Stitzel, O’Neill (2019): Developmental nicotine exposure precipitates multigenerational maternal transmission of nicotine preference and ADHD-like behavioral, rhythmometric, neuropharmacological, and epigenetic anomalies in adolescent mice. Neuropharmacology. 2019 May 1;149:66-82. doi: 10.1016/j.neuropharm.2019.02.006. PMID: 30742847; PMCID: PMC7096676.

  23. Zhang M, Zhang D, Dai J, Cao Y, Xu W, He G, Wang Z, Wang L, Li R, Qiao Z. Paternal nicotine exposure induces hyperactivity in next-generation via down-regulating the expression of DAT. Toxicology. 2020 Feb 15;431:152367. doi: 10.1016/j.tox.2020.152367. Epub 2020 Jan 13. PMID: 31945395.

  24. van Mil, Steegers-Theunissen, Bouwland-Both, Verbiest, Rijlaarsdam, Hofman, Steegers, Heijmans, Jaddoe, Verhulst, Stolk, Eilers, Uitterlinden, Tiemeier (2014): DNA methylation profiles at birth and child ADHD symptoms. J Psychiatr Res. 2014 Feb;49:51-9. doi: 10.1016/j.jpsychires.2013.10.017. PMID: 24290898.

  25. Chen VC, Lee CT, Wu SI, Gossop M (2024): Neurobehavioral disorders among children born to mothers exposed to illicit substances during pregnancy. BMC Med. 2024 Dec 18;22(1):581. doi: 10.1186/s12916-024-03762-9. PMID: 39696283; PMCID: PMC11656950.

  26. Holmgaard S, Kiilerich P, Borbye-Lorenzen N, Skogstrand K (2024): Maternal pre-pregnancy and prenatal penicillin, neonatal inflammation and growth factors are associated to ADHD in the offspring. Brain Behav Immun Health. 2024 Feb 10;36:100739. doi: 10.1016/j.bbih.2024.100739. PMID: 38425710; PMCID: PMC10901857. n = 553.766

  27. Ishido M, Higashi K, Mori H, Ueno M, Kurokawa K (2025): DNA methylation profiles of transgenerational rat hyperactivity primed by silver nanoparticles: Comparison with valproate model rats of autism. Behav Brain Res. 2025 Feb 4;477:115293. doi: 10.1016/j.bbr.2024.115293. PMID: 39419183.

  28. Koehlmoos TP, Lee E, Wisdahl J, Donaldson T (2023): Fetal alcohol spectrum disorders prevention and clinical guidelines research-workshop report. BMC Proc. 2023 Aug 15;17(Suppl 12):19. doi: 10.1186/s12919-023-00272-z. PMID: 37580722; PMCID: PMC10426045.

  29. Pagnin, Zamboni Grecco, Furtado (2018): Prenatal alcohol use as a risk for attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci. 2018 Oct 23. doi: 10.1007/s00406-018-0946-7. n = 81

  30. van de Bor (2019): Fetal toxicology. Handb Clin Neurol. 2019;162:31-55. doi: 10.1016/B978-0-444-64029-1.00002-3.

  31. Hoang HH, Tran ATN, Nguyen VH, Nguyen TTB, Nguyen TAP, Le DD, Jatho A, Onchonga D, Duong TV, Nguyen MT, Tran BT (2021): Attention Deficit Hyperactivity Disorder (ADHD) and Associated Factors Among First-Year Elementary School Students. J Multidiscip Healthc. 2021 Apr 30;14:997-1005. doi: 10.2147/JMDH.S301091. PMID: 33958873; PMCID: PMC8096448.

  32. Wang, Martin, Lei, Hausknecht, Ishiwari, Richards, Haj-Dahmane, Shen (2020): Prenatal Ethanol Exposure Leads to Attention Deficits in Both Male and Female Rats. Front Neurosci. 2020 Jan 24;14:12. doi: 10.3389/fnins.2020.00012. PMID: 32038156; PMCID: PMC6992663.

  33. Perkins AE, Dart E, Kaiser D (2024): Prenatal Alcohol Exposure Disrupts Performance in a Differential Reinforcement of Low Rates Task Specifically in Adolescent Male Rats. Dev Psychobiol. 2024 Dec;66(8):e22555. doi: 10.1002/dev.22555. PMID: 39467264.

  34. Cowell, Wright (2017): Sex-Specific Effects of Combined Exposure to Chemical and Non-chemical Stressors on Neuroendocrine Development: a Review of Recent Findings and Putative Mechanisms. Current environmental health reports, 4(4), 415-425. REVIEW

  35. Gerstner T, Saevareid HI, Johnsen ÅR, Løhaugen G, Skranes J (2023): Sleep disturbances in Norwegian children with fetal alcohol spectrum disorders (FASD) with and without a diagnosis of attention-deficit hyperactivity disorder or epilepsy. Alcohol Clin Exp Res. 2023 Feb 21. doi: 10.1111/acer.15009. Epub ahead of print. PMID: 36811179. n = 53

  36. Chen CY, Shih PY, Su CT, Cheng CF, Lee MC, Lane HY (2025): Association between infant feeding and ADHD development in childhood: a birth cohort study in Taiwan. J Child Psychol Psychiatry. 2025 Jun;66(6):881-891. doi: 10.1111/jcpp.14100. PMID: 39707757; PMCID: PMC12062847. n = 19.721

  37. Fransquet, Hutchinson, Olsson, Wilson, Allsop, Najman, Elliott, Mattick, Saffery, Ryan (2016): Triple B Research Consortium. Perinatal maternal alcohol consumption and methylation of the dopamine receptor DRD4 In the offspring: the Triple B study. Environ Epigenet. 2016 Dec 7;2(4):dvw023. doi: 10.1093/eep/dvw023. PMID: 29492300; PMCID: PMC5804537. n = 844

  38. Schneider, Moore, Barnhart, Larson, DeJesus, Mukherjee, Nickles, Converse, Roberts, Kraemer (2005): Moderate-level prenatal alcohol exposure alters striatal dopamine system function in rhesus monkeys. Alcohol Clin Exp Res. 2005 Sep;29(9):1685-97. doi: 10.1097/01.alc.0000179409.80370.25. PMID: 16205369.

  39. Lee, Park, Ryu, Shin, Ko, Han, Koren, Cho (2015): Changes in the methylation status of DAT, SERT, and MeCP2 gene promoters in the blood cell in families exposed to alcohol during the periconceptional period. Alcohol Clin Exp Res. 2015 Feb;39(2):239-50. doi: 10.1111/acer.12635. PMID: 25656446.

  40. Shabanov, Lebedev, Bychkov (2012): [The effect of ethanol exposure in pregnancy on maturation of monoaminergic systems in the developing rat bran]. Ross Fiziol Zh Im I M Sechenova. 2012 Feb;98(2):202-11. Russian. PMID: 22650063.

  41. Schneider, Moore, Barr, Larson, Kraemer (2011): Moderate prenatal alcohol exposure and serotonin genotype interact to alter CNS serotonin function in rhesus monkey offspring. Alcohol Clin Exp Res. 2011 May;35(5):912-20. doi: 10.1111/j.1530-0277.2010.01421.x. PMID: 21294753; PMCID: PMC3083456.

  42. De Nicolò, Carito, Fiore, Laviola (2014): Aberrant behavioral and neurobiologic profiles in rodents exposed to ethanol or red wine early in development. Curr. Dev. Disord. Rep. 2014;1:173–180. doi: 10.1007/s40474-014-0023-5.

  43. Kazemi, Huang, Avci, Akay, Akay (2021): Investigating the effects of chronic perinatal alcohol and combined nicotine and alcohol exposure on dopaminergic and non-dopaminergic neurons in the VTA. Sci Rep. 2021 Apr 22;11(1):8706. doi: 10.1038/s41598-021-88221-8. PMID: 33888815; PMCID: PMC8062589.

  44. Haan, Sallis, Ystrom, Njølstad, Andreassen, Reichborn-Kjennerud, Munafò, Havdahl, Zuccolo (2021): Maternal and offspring genetic risk score analyses of fetal alcohol exposure and attention-deficit hyperactivity disorder risk in offspring. Alcohol Clin Exp Res. 2021 Sep 6. doi: 10.1111/acer.14692. PMID: 34486127.

  45. Schwenke, Fasching, Faschingbauer, Pretscher, Kehl, Peretz, Keller, Häberle, Eichler, Irlbauer-Müller, Dammer, Beckmann, Schneider (2018): Predicting attention deficit hyperactivity disorder using pregnancy and birth characteristics. Arch Gynecol Obstet. 2018 Sep 8. doi: 10.1007/s00404-018-4888-0. n = 573

  46. Haan E, Sallis HM, Zuccolo L, Labrecque J, Ystrom E, Reichborn-Kjennerud T, Andreassen O, Havdahl A, Munafò MR (2022): Prenatal smoking, alcohol and caffeine exposure and maternal-reported attention deficit hyperactivity disorder symptoms in childhood: triangulation of evidence using negative control and polygenic risk score analyses. Addiction. 2022 May;117(5):1458-1471. doi: 10.1111/add.15746. PMID: 34791750; PMCID: PMC7613851.

  47. Kjaer Weile, Wu, Hegaard, Kesmodel, Henriksen, Nohr (2019: Alcohol intake in early pregnancy and risk of Attention-Deficit Hyperactivity Disorder (ADHD) in children up to 19 years of age: a cohort study. Alcohol Clin Exp Res. 2019 Nov 19. doi: 10.1111/acer.14243. n = 48.072

  48. Reilhac, Garlantézec, Lacroix, Rouget, Warembourg, Monfort, Le Gléau, Cordier, Viel, Chevrier (2019): Prenatal exposure to glycol ethers and response inhibition in 6-year-old children: The PELAGIE cohort study. Environ Res. 2019 Nov 21:108950. doi: 10.1016/j.envres.2019.108950.

  49. San Martin Porter, Maravilla, Betts, Alati (2019): Low-moderate prenatal alcohol exposure and offspring attention-deficit hyperactivity disorder (ADHD): systematic review and meta-analysis. Arch Gynecol Obstet. 2019 Aug;300(2):269-277. doi: 10.1007/s00404-019-05204-x. REVIEW

  50. O’Neill J, O’Connor MJ, Kalender G, Ly R, Ng A, Dillon A, Narr KL, Loo SK, Alger JR, Levitt JG (2022): Combining neuroimaging and behavior to discriminate children with attention deficit-hyperactivity disorder with and without prenatal alcohol exposure. Brain Imaging Behav. 2022 Feb;16(1):69-77. doi: 10.1007/s11682-021-00477-w. PMID: 34089460; PMCID: PMC8643366.

  51. Hausknecht K, Shen YL, Wang RX, Haj-Dahmane S, Shen RY (2017): Prenatal Ethanol Exposure Persistently Alters Endocannabinoid Signaling and Endocannabinoid-Mediated Excitatory Synaptic Plasticity in Ventral Tegmental Area Dopamine Neurons. J Neurosci. 2017 Jun 14;37(24):5798-5808. doi: 10.1523/JNEUROSCI.3894-16.2017. PMID: 28476947; PMCID: PMC5473200.

  52. Wells AC, Lotfipour S (2023): Prenatal nicotine exposure during pregnancy results in adverse neurodevelopmental alterations and neurobehavioral deficits. Adv Drug Alcohol Res. 2023 Aug 11;3:11628. doi: 10.3389/adar.2023.11628. PMID: 38389806; PMCID: PMC10880762. REVIEW

  53. Willoughby MT, Pek J, Greenberg MT; Family Life Project Investigators (2012): Parent-reported Attention Deficit/Hyperactivity symptomatology in preschool-aged children: factor structure, developmental change, and early risk factors. J Abnorm Child Psychol. 2012 Nov;40(8):1301-12. doi: 10.1007/s10802-012-9641-8. PMID: 22581375; PMCID: PMC3461245.

  54. Elvin ÖD, Aydan ÇV, Güzel EÇ, Topçu B (2024): Evaluation of the relationship between the frequency of attention deficit, hyperactivity disorder symptoms and nutritional habits in children. Med J Malaysia. 2024 Sep;79(5):538-546. PMID: 39352155.

  55. Zhang Z, Yu J, Li Q, Zhao Y, Tang L, Peng Y, Liu Y, Gan C, Liu K, Wang J, Chen L, Luo Q, Qiu H, Ren H, Jiang C (2025): Unraveling the causal pathways of maternal smoking and breastfeeding in the development of neuropsychiatric disorders: A Mendelian randomization perspective. J Affect Disord. 2025 Mar 15;373:35-43. doi: 10.1016/j.jad.2024.12.075. PMID: 39716673. n = 397.732

  56. Sourander A, Sucksdorff M, Chudal R, Surcel HM, Hinkka-Yli-Salomäki S, Gyllenberg D, Cheslack-Postava K, Brown AS (2019): Prenatal Cotinine Levels and ADHD Among Offspring. Pediatrics. 2019 Mar;143(3):e20183144. doi: 10.1542/peds.2018-3144. PMID: 30804074; PMCID: PMC6398365.

  57. Banerjee TD, Middleton F, Faraone SV (2007): Environmental risk factors for attention-deficit hyperactivity disorder. Acta Pædiatrica 2007;96, 1269–74. Zitiert nach Philipsen, Heßlinger, Tebartz van Elst (2008): AufmerksamkeitsdefizitHyperaktivitätsstörung im Erwachsenenalter – Diagnostik, Ätiologie und Therapie (ÜBERSICHTSARBEIT), Deutsches Ärzteblatt, Jg. 105, Heft 17, 25. April 2008, Seite 311 – 317, 313

  58. Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP (2006): Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect. 2006 Dec;114(12):1904-9. doi: 10.1289/ehp.9478. PMID: 17185283; PMCID: PMC1764142. n = 4.704)

  59. Lebeña A, Faresjö Å, Jones MP, Bengtsson F, Faresjö T, Ludvigsson J (2024): Early environmental predictors for attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD) and their co-occurrence: The prospective ABIS-Study. Sci Rep. 2024 Jun 26;14(1):14759. doi: 10.1038/s41598-024-65067-4. PMID: 38926504; PMCID: PMC11208583.

  60. Huang L, Wang Y, Zhang L, Zheng Z, Zhu T, Qu Y, Mu D (2018): Maternal Smoking and Attention-Deficit/Hyperactivity Disorder in Offspring: A Meta-analysis. Pediatrics. 2018 Jan;141(1):e20172465. doi: 10.1542/peds.2017-2465. PMID: 29288161. REVIEW

  61. He Y, Chen J, Zhu LH, Hua LL, Ke FF (2017): Maternal Smoking During Pregnancy and ADHD: Results From a Systematic Review and Meta-Analysis of Prospective Cohort Studies. J Atten Disord. 2020 Oct;24(12):1637-1647. doi: 10.1177/1087054717696766. PMID: 29039728. METASTUDY, n = 17.304

  62. Mohammadian M, Khachatryan LG, Vadiyan FV, Maleki M, Fatahian F, Mohammadian-Hafshejani A (2025): The association between maternal tobacco smoking during pregnancy and the risk of attention-deficit/hyperactivity disorder (ADHD) in offspring: A systematic review and meta-analysis. PLoS One. 2025 Feb 7;20(2):e0317112. doi: 10.1371/journal.pone.0317112. PMID: 39919144; PMCID: PMC11805386. METASTUDY

  63. Minatoya, Araki, Itoh, Yamazaki, Kobayashi, Miyashita, Sasaki, Kishi (2019): Prenatal tobacco exposure and ADHD symptoms at pre-school age: the Hokkaido Study on Environment and Children’s Health. Environ Health Prev Med. 2019 Dec 7;24(1):74. doi: 10.1186/s12199-019-0834-4.

  64. Itoh M, Kobayashi S, Nishihara S, Miyashita C, Yamazaki K, Tamura N, Suyama S, Ikeda A, Itoh S, Ait Bamai Y, Yamaguchi T, Masuda H, Hanley S, Kishi R (2024): Association between prenatal tobacco exposure and attention-deficit/hyperactivity disorder related characteristics at 6 and 8 years: a birth cohort in Japan. BMJ Open. 2024 Dec 26;14(12):e087406. doi: 10.1136/bmjopen-2024-087406. PMID: 39725438; PMCID: PMC11683938. n = 7.217

  65. Godleski S, Shisler S, Colton K, Leising M (2024): Prenatal Tobacco Exposure and Behavioral Disorders in Children and Adolescents: Systematic Review and Meta-Analysis. Pediatr Rep. 2024 Aug 31;16(3):736-752. doi: 10.3390/pediatric16030062. PMID: 39311325; PMCID: PMC11417955. REVIEW

  66. Schwenke, Fasching, Faschingbauer, Pretscher, Kehl, Peretz, Keller, Häberle, Eichler, Irlbauer-Müller, Dammer, Beckmann, Schneider (2018): Predicting attention deficit hyperactivity disorder using pregnancy and birth characteristics. Arch Gynecol Obstet. 2018 Sep 8. doi: 10.1007/s00404-018-4888-0.

  67. Wang, Hu, Chen, Xue, Du (2019): Prenatal Tobacco Exposure Modulated the Association of Genetic variants with Diagnosed ADHD and its symptom domain in children: A Community Based Case-Control Study. Sci Rep. 2019 Mar 12;9(1):4274. doi: 10.1038/s41598-019-40850-w.

  68. Zambrano-Sánchez, Martínez-Cortés, Poblano, Dehesa-Moreno, Vázquez-Urbano, Del Río-Carlos (2019): Maternal smoking during pregnancy and physiological anxiety in children with attention deficit hyperactivity disorder. Appl Neuropsychol Child. 2019 Jul 3:1-8. doi: 10.1080/21622965.2019.1632708.

  69. McIntosh DE, Mulkins RS, Dean RS (1995): Utilization of maternal perinatal risk indicators in the differential diagnosis of ADHD and UADD children. Int J Neurosci. 1995 Mar;81(1-2):35-46. doi: 10.3109/00207459509015297. PMID: 7775071. n = 265

  70. Xavier J, Singh S, Kumari P, Ravichandiran V (2022): Neurological repercussions of neonatal nicotine exposure: A review. Int J Dev Neurosci. 2022 Feb;82(1):3-18. doi: 10.1002/jdn.10163. PMID: 34913189. REVIEW

  71. Xie T, Mao Y (2024): The causal impact of maternal smoking around birth on offspring ADHD: A two-sample Mendelian randomization study. J Affect Disord. 2024 Jan 22:S0165-0327(24)00215-5. doi: 10.1016/j.jad.2024.01.196. Epub ahead of print. PMID: 38266926. n = 246.888

  72. Fleming M, Fitton CA, Steiner MFC, McLay JS, Clark D, King A, Mackay DF, Pell JP (2017): Educational and Health Outcomes of Children Treated for Attention-Deficit/Hyperactivity Disorder. JAMA Pediatr. 2017 Jul 3;171(7):e170691. doi: 10.1001/jamapediatrics.2017.0691. PMID: 28459927; PMCID: PMC6583483. n = 766.244

  73. Lipińska, Słopień, Pytlińska, Słopień, Wolańczyk, Bryńska (2021): The role of factors associated with the course of pregnancy and childbirth in attention deficit hyperactivity disorder (ADHD). Psychiatr Pol. 2021 Jun 30;55(3):659-673. English, Polish. doi: 10.12740/PP/OnlineFirst/110686. PMID: 34460889. n = 311

  74. Deng, Yang, Wang, Zhou, Wang, Zhang, Niu (2022): Identification and Characterization of Influential Factors in Susceptibility to Attention Deficit Hyperactivity Disorder Among Preschool-Aged Children. Front Neurosci. 2022 Jan 31;15:709374. doi: 10.3389/fnins.2021.709374. PMID: 35173570; PMCID: PMC8841729. n = 7.938

  75. Thapar, Rice (2020): Family-Based Designs that Disentangle Inherited Factors from Pre- and Postnatal Environmental Exposures: In Vitro Fertilization, Discordant Sibling Pairs, Maternal versus Paternal Comparisons, and Adoption Designs. Cold Spring Harb Perspect Med. 2020 Mar 9:a038877. doi: 10.1101/cshperspect.a038877.. PMID: 32152247.

  76. Zakariyah A, Al Qutub S, Kazim S, Alharbi R, Alharthi H, Alharbi H, Albassami M, Hanbazazh M, Mahnashi M (2024): Exposure to Smoking as a Predictor of ADHD Subtypes Among Children Within Saudi Arabia: An Observational Study. Tob Use Insights. 2024 Sep 9;17:1179173X241283765. doi: 10.1177/1179173X241283765. PMID: 39258266; PMCID: PMC11384971. n = 217

  77. {Haan, Westmoreland, Schellhas, Sallis, Taylor, Zuccolo, Munafò (2022): Prenatal smoking, alcohol and caffeine exposure and offspring externalizing disorders: a systematic review and meta-analysis. Addiction. 2022 Apr 6. doi: 10.1111/add.15858. PMID: 35385887.

  78. Fuemmeler BF, Glasgow TE, Schechter JC, Maguire R, Sheng Y, Bidopia T, Barsell DJ, Ksinan A, Zhang J, Lin Y, Hoyo C, Murphy S, Qin J, Wang X, Kollins S (2022): Prenatal and Childhood Smoke Exposure Associations with Cognition, Language, and Attention-Deficit/Hyperactivity Disorder. J Pediatr. 2022 Dec 10:S0022-3476(22)01115-5. doi: 10.1016/j.jpeds.2022.11.041. PMID: 36513211.

  79. Rice, Langley, Woodford, Smith, Thapar (2018): Identifying the contribution of prenatal risk factors to offspring development and psychopathology: What designs to use and a critique of literature on maternal smoking and stress in pregnancy. Dev Psychopathol. 2018 Aug;30(3):1107-1128. doi: 10.1017/S0954579418000421. REVIEW

  80. Contreras D, Piña R, Carvallo C, Godoy F, Ugarte G, Zeise M, Rozas C, Morales B (2022): Methylphenidate Restores Behavioral and Neuroplasticity Impairments in the Prenatal Nicotine Exposure Mouse Model of ADHD: Evidence for Involvement of AMPA Receptor Subunit Composition and Synaptic Spine Morphology in the Hippocampus. Int J Mol Sci. 2022 Jun 26;23(13):7099. doi: 10.3390/ijms23137099. PMID: 35806103; PMCID: PMC9266648.

  81. Zhu J, Fan F, McCarthy DM, Zhang L, Cannon EN, Spencer TJ, Biederman J, Bhide PG (2017): A prenatal nicotine exposure mouse model of methylphenidate responsive ADHD-associated cognitive phenotypes. Int J Dev Neurosci. 2017 May;58:26-34. doi: 10.1016/j.ijdevneu.2017.01.014. PMID: 28179105.

  82. Alkam, Mamiya, Kimura, Yoshida, Kihara, Tsunoda, Aoyama, Hiramatsu, Kim, Nabeshima (2017): Prenatal nicotine exposure decreases the release of dopamine in the medial frontal cortex and induces atomoxetine-responsive neurobehavioral deficits in mice. Psychopharmacology (Berl). 2017 Jun;234(12):1853-1869. doi: 10.1007/s00213-017-4591-z.

  83. Aoyagi Y, Momoi N, Kanai Y, Go H, Abe Y, Miyazaki K, Tomita Y, Hayashi M, Endo K, Mitomo M, Hosoya M (2020): Prenatal nicotine exposure affects cardiovascular function and growth of the developing fetus. J Obstet Gynaecol Res. 2020 Jul;46(7):1044-1054. doi: 10.1111/jog.14294. PMID: 32428988.

  84. Neuman, Lobos, Reich, Henderson, Sun, Todd (2007): Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol Psychiatry. 2007 Jun 15;61(12):1320-8.

  85. Dryden (2007): Prenatal smoking increases ADHD risk in some children. Erläuterung zu Neuman et al.

  86. Sánchez-Mora, Richarte, Garcia-Martínez, Pagerols, Corrales, Bosch, Vidal, Viladevall, Casas, Cormand, Ramos-Quiroga, Ribasés (2015): Dopamine receptor DRD4 gene and stressful life events in persistent attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2015 Sep;168(6):480-491. doi: 10.1002/ajmg.b.32340.

  87. Li Q, Cai X, Zhou H, Ma D, Li N (2024): Maternal smoking cessation in the first trimester still poses an increased risk of attention-deficit/hyperactivity disorder and learning disability in offspring. Front Public Health. 2024 Jul 16;12:1386137. doi: 10.3389/fpubh.2024.1386137. PMID: 39081356; PMCID: PMC11286595.

  88. RKI: Rauchen in der Schwangerschaft – Querschnittergebnisse aus KiGGS Welle 2 und Trends - Fact sheet - JoHM 1/2018 german

  89. RKI: Smoking during pregnancy. Results of the cross-sectional KiGGS Wave 2 study and trends english

  90. Tong VT, Jones JR, Dietz PM, D’Angelo D, Bombard JM; Centers for Disease Control and Prevention (CDC). Trends in smoking before, during, and after pregnancy - Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 31 sites, 2000-2005. MMWR Surveill Summ (2009): 2009 May 29;58(4):1-29. PMID: 19478726.

  91. Allen H, Daw J (2025): Perinatal Smoking Patterns From Preconception to 1-Year Post Partum. JAMA Netw Open. 2025 Jan 2;8(1):e2454974. doi: 10.1001/jamanetworkopen.2024.54974. Erratum in: JAMA Netw Open. 2025 Feb 3;8(2):e253405. doi: 10.1001/jamanetworkopen.2025.3405. PMID: 39821402; PMCID: PMC11742529.

  92. Kipling L, Bombard J, Wang X, Cox S (2024): Cigarette Smoking Among Pregnant Women During the Perinatal Period: Prevalence and Health Care Provider Inquiries - Pregnancy Risk Assessment Monitoring System, United States, 2021. MMWR Morb Mortal Wkly Rep. 2024 May 2;73(17):393-398. doi: 10.15585/mmwr.mm7317a2. PMID: 38696343; PMCID: PMC11065467.

  93. Gilman SE, Breslau J, Subramanian SV, Hitsman B, Koenen KC (2008): Social factors, psychopathology, and maternal smoking during pregnancy. Am J Public Health. 2008 Mar;98(3):448-53. doi: 10.2105/AJPH.2006.102772. PMID: 17600245; PMCID: PMC2253564.

  94. Polli, Ipsen, Caballero-Puntiverio, Østerbøg, Aznar, Andreasen, Kohlmeier (2020): Cellular and Molecular Changes in Hippocampal Glutamate Signaling and Alterations in Learning, Attention, and Impulsivity Following Prenatal Nicotine Exposure. Mol Neurobiol. 2020 Jan 8. doi: 10.1007/s12035-019-01854-9.

  95. Collishaw S, Maughan B, Natarajan L, Pickles A (2010): Trends in adolescent emotional problems in England: a comparison of two national cohorts twenty years apart. J Child Psychol Psychiatry. 2010 Aug;51(8):885-94. doi: 10.1111/j.1469-7610.2010.02252.x. PMID: 20497281.

  96. Murphy JM, Horton NJ, Monson RR, Laird NM, Sobol AM, Leighton AH (2003): Cigarette smoking in relation to depression: historical trends from the Stirling County Study. Am J Psychiatry. 2003 Sep;160(9):1663-9. doi: 10.1176/appi.ajp.160.9.1663. PMID: 12944343.

  97. Polli, Kohlmeier (2019): Prenatal nicotine exposure in rodents: why are there so many variations in behavioral outcomes? Nicotine Tob Res. 2019 Oct 9. pii: ntz196. doi: 10.1093/ntr/ntz196.

  98. Robinson DM, Peebles KC, Kwok H, Adams BM, Clarke LL, Woollard GA, Funk GD (2002): Prenatal nicotine exposure increases apnoea and reduces nicotinic potentiation of hypoglossal inspiratory output in mice. J Physiol. 2002 Feb 1;538(Pt 3):957-73. doi: 10.1113/jphysiol.2001.012705. PMID: 11826179; PMCID: PMC2290085.

  99. Al-Hachim GM, Mahmoud FA (1985): Prenatal nicotine and CNS development. Epilepsia. 1985 Nov-Dec;26(6):661-5. doi: 10.1111/j.1528-1157.1985.tb05708.x. PMID: 4076070.

  100. Balsevich G, Poon A, Goldowitz D, Wilking JA (2014): The effects of pre- and post-natal nicotine exposure and genetic background on the striatum and behavioral phenotypes in the mouse. Behav Brain Res. 2014 Jun 1;266:7-18. doi: 10.1016/j.bbr.2014.02.038. PMID: 24607511.

  101. Pauly JR, Sparks JA, Hauser KF, Pauly TH (2004): In utero nicotine exposure causes persistent, gender-dependant changes in locomotor activity and sensitivity to nicotine in C57Bl/6 mice. Int J Dev Neurosci. 2004 Aug-Oct;22(5-6):329-37. doi: 10.1016/j.ijdevneu.2004.05.009. PMID: 15380832.

  102. Polli, Kohlmeier (2019): Alterations in NMDAR-mediated signaling within the laterodorsal tegmental nucleus are associated with prenatal nicotine exposure. Neuropharmacology. 2019 Aug 19;158:107744. doi: 10.1016/j.neuropharm.2019.107744.

  103. Buck, O’Neill, Stitzel (2019): Developmental nicotine exposure elicits multigenerational disequilibria in proBDNF proteolysis and glucocorticoid signaling in the frontal cortices, striata, and hippocampi of adolescent mice. Biochem Pharmacol. 2019 Aug 9;168:438-451. doi: 10.1016/j.bcp.2019.08.003.

  104. Buck, O’Neill, Stitzel (2020): Developmental nicotine exposure engenders intergenerational downregulation and aberrant posttranslational modification of cardinal epigenetic factors in the frontal cortices, striata, and hippocampi of adolescent mice. Epigenetics Chromatin. 2020 Mar 5;13(1):13. doi: 10.1186/s13072-020-00332-0. PMID: 32138755; PMCID: PMC7059320.

  105. Rizwan S, Manning JT, Brabin BJ (2007): Maternal smoking during pregnancy and possible effects of in utero testosterone: evidence from the 2D:4D finger length ratio. Early Hum Dev. 2007 Feb;83(2):87-90. doi: 10.1016/j.earlhumdev.2006.05.005. PMID: 16814493.

  106. Kalkbrenner AE, Zheng C, Yu J, Jenson TE, Kuhlwein T, Ladd-Acosta C, Grove J, Schendel D (2024): Method for Testing Etiologic Heterogeneity Among Non-Competing Diagnoses, Applied to Impact of Perinatal Exposures on Autism and Attention Deficit Hyperactivity Disorder. Epidemiology. 2024 Jul 18. doi: 10.1097/EDE.0000000000001760. PMID: 39024025.

  107. Batstra L, Neeleman J, Hadders-Algra M (2003): Can breast feeding modify the adverse effects of smoking during pregnancy on the child’s cognitive development? J Epidemiol Community Health. 2003 Jun;57(6):403-4. doi: 10.1136/jech.57.6.403. PMID: 12775783; PMCID: PMC1732491.

  108. Guedria A, Guedria M, Ben Fredj M, Ayoub R, Ben Abid H, Mhalla A, Slama H (2025): Factors associated with attention-deficit/hyperactivity disorder among Tunisian children. Front Psychiatry. 2025 Feb 7;16:1462099. doi: 10.3389/fpsyt.2025.1462099. PMID: 39990169; PMCID: PMC11842382. n = 154

  109. Mahlberg, James, Bulten, Rodriguez, Kwan, Cairney (2019): Investigating the Association Between Exposure to Second Hand Smoke in utero and Developmental Coordination Disorder. Front Pediatr. 2019 Nov 5;7:438. doi: 10.3389/fped.2019.00438. eCollection 2019.

  110. Greenwood PB, DeSerisy M, Koe E, Rodriguez E, Salas L, Pereir FP, Herbstman J, Pagliaccio D, Margolis AE (2024): Combined and sequential exposure to prenatal second hand smoke and postnatal maternal distress is associated with cingulo-opercular global efficiency and attention problems in school-age children. Neurotoxicol Teratol. 2024 Feb 29:107338. doi: 10.1016/j.ntt.2024.107338. PMID: 38431065.

  111. Kaur S, Morales-Hidalgo P, Arija V, Canals J. Prenatal Exposure to Air Pollutants and Attentional Deficit Hyperactivity Disorder Development in Children: A Systematic Review. Int J Environ Res Public Health. 2023 Apr 7;20(8):5443. doi: 10.3390/ijerph20085443. PMID: 37107725; PMCID: PMC10138804. REVIEW

  112. Perera FP, Tang D, Wang S, Vishnevetsky J, Zhang B, Diaz D, Camann D, Rauh V (2012): Prenatal polycyclic aromatic hydrocarbon (PAH) exposure and child behavior at age 6-7 years. Environ Health Perspect. 2012 Jun;120(6):921-6. doi: 10.1289/ehp.1104315. PMID: 22440811; PMCID: PMC3385432.

  113. Perera FP, Chang HW, Tang D, Roen EL, Herbstman J, Margolis A, Huang TJ, Miller RL, Wang S, Rauh V (2014): Early-life exposure to polycyclic aromatic hydrocarbons and ADHD behavior problems. PLoS One. 2014 Nov 5;9(11):e111670. doi: 10.1371/journal.pone.0111670. PMID: 25372862; PMCID: PMC4221082.

  114. Pagliaccio D, Herbstman JB, Perera F, Tang D, Goldsmith J, Peterson BS, Rauh V, Margolis AE (2020): Prenatal exposure to polycyclic aromatic hydrocarbons modifies the effects of early life stress on attention and Thought Problems in late childhood. J Child Psychol Psychiatry. 2020 Nov;61(11):1253-1265. doi: 10.1111/jcpp.13189. Epub 2020 Jan 7. PMID: 31907931; PMCID: PMC7338249.

  115. Peterson, Bansal, Sawardekar, Nati, Elgabalawy, Hoepner, Garcia, Hao, Margolis, Perera, Rauh (2022): Prenatal exposure to air pollution is associated with altered brain structure, function, and metabolism in childhood. J Child Psychol Psychiatry. 2022 Feb 14. doi: 10.1111/jcpp.13578. PMID: 35165899.

  116. Perera FP, Wheelock K, Wang Y, Tang D, Margolis AE, Badia G, Cowell W, Miller RL, Rauh V, Wang S, Herbstman JB (2018): Combined effects of prenatal exposure to polycyclic aromatic hydrocarbons and material hardship on child ADHD behavior problems. Environ Res. 2018 Jan;160:506-513. doi: 10.1016/j.envres.2017.09.002. PMID: 28987706; PMCID: PMC5724364.

  117. Rezaei Kalantary, Jaffarzadeh, Rezapour, Hesami Arani (2020): Association between exposure to polycyclic aromatic hydrocarbons and attention deficit hyperactivity disorder in children: a systematic review and meta-analysis. Environ Sci Pollut Res Int. 2020 Apr;27(11):11531-11540. doi: 10.1007/s11356-020-08134-3. PMID: 32124297. n = 2.799, 6 Studien, REVIEW

  118. Emecheta EE, Borda DB, Pfohl PM, Wohlleben W,Hutzler C, Haase A, Roloff A (2022): A comparative investigation of the sorption of polycyclic aromatic hydrocarbons to various polydisperse micro- and nanoplastics using a novel third-phase partition method. Micropl.&Nanopl. 2, 29 (2022). https://doi.org/10.1186/s43591-022-00049-9

  119. Peters, Frühgeborene und Schule – Ermutigt oder ausgebremst? Kapitel 2: Das Aufmerksamkeitsdefizitsyndrom (AD(H)S), Seite 126

  120. http://www.adhs.org/genese/ mit weiteren Nachweisen

  121. van de Bor (2019): Fetal toxicology. Handb Clin Neurol. 2019;162:31-55. doi: 10.1016/B978-0-444-64029-1.00002-3.

  122. RÍsovÁ (2020): The pathway of lead through the mother’s body to the child. Interdiscip Toxicol. 2019 Sep;12(1):1-6. doi: 10.2478/intox-2019-0001. PMID: 32189981; PMCID: PMC7061448. REVIEW

  123. Cory-Slechta, Virgolini, Thiruchelvam, Weston, Bauter (2004): Maternal stress modulates the effects of developmental lead exposure. Environ Health Perspect. 2004 May;112(6):717-30.

  124. Cory-Slechta, Stern, Weston, Allen, Liu (2010): Enhanced learning deficits in female rats following lifetime pb exposure combined with prenatal stress. Toxicol Sci. 2010 Oct;117(2):427-38. doi: 10.1093/toxsci/kfq221.

  125. Sioen I, Den Hond E, Nelen V, Van de Mieroop E, Croes K, Van Larebeke N, Nawrot TS, Schoeters G (2013): Prenatal exposure to environmental contaminants and behavioural problems at age 7-8years. Environ Int. 2013 Sep;59:225-31. doi: 10.1016/j.envint.2013.06.014. PMID: 23845936. n = 270

  126. Virgolini, Rossi-George, Lisek, Weston, Thiruchelvam, Cory-Slechta (2008): CNS effects of developmental Pb exposure are enhanced by combined maternal and offspring stress. Neurotoxicology. 2008 Sep;29(5):812-27. doi: 10.1016/j.neuro.2008.03.003.

  127. Weston, Weston, Allen, Cory-Slechta (2014): Sex-dependent impacts of low-level lead exposure and prenatal stress on impulsive choice behavior and associated biochemical and neurochemical manifestations. Neurotoxicology. 2014 Sep;44:169-83. doi: 10.1016/j.neuro.2014.06.013.

  128. Austin, Curtin, Curtin, Gennings, Arora, Tammimies, Isaksson, Willfors, Bölte (2019): Dynamical properties of elemental metabolism distinguish attention deficit hyperactivity disorder from autism spectrum disorder. Transl Psychiatry. 2019 Sep 25;9(1):238. doi: 10.1038/s41398-019-0567-6.

  129. Markovac, Goldstein (1988): Picomolar concentrations of lead stimulate brain protein kinase C. Nature volume 334, pages 71–3, 1988

  130. Arnsten (2009): Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci. 2009 Jun;10(6):410-22. doi: 10.1038/nrn2648.

  131. Gedeon, Ramesh, Wellman, Jadhav (2001): Changes in mesocorticolimbic dopamine and D1/D2 receptor levels after low level lead exposure: a time course study, Toxicology Letters, Volume 123, Issues 2–3, 2001, Pages 217-226, ISSN 0378-4274, https://doi.org/10.1016/S0378-4274(01)00408-8

  132. Morgan, Garavan, Smith, Driscoll, Levitsky, Strupp (2001): Early lead exposure produces lasting changes in sustained attention, response initiation, and reactivity to errors, Neurotoxicology and Teratology, Volume 23, Issue 6, 2001, Pages 519-531, ISSN 0892-0362, https://doi.org/10.1016/S0892-0362(01)00171-4.

  133. Lidsky, Schneider (2003): Lead neurotoxicity in children: basic mechanisms and clinical correlates, Brain, Volume 126, Issue 1, January 2003, Pages 5–19, https://doi.org/10.1093/brain/awg014

  134. Cecil, Brubaker, Adler, Dietrich, Altaye, Egelhoff, Wessel, Elangovan, Hornung, Jarvis, Lanphear (2008) Decreased Brain Volume in Adults with Childhood Lead Exposure. PLoS Med 5(5): e112. https://doi.org/10.1371/journal.pmed.0050112.

  135. Nevin (2000): How Lead Exposure Relates to Temporal Changes in IQ, Violent Crime, and Unwed Pregnancy, Environmental Research, Volume 83, Issue 1, 2000, Pages 1-22, ISSN 0013-9351, https://doi.org/10.1006/enrs.1999.4045.

  136. Wright, Dietrich, Ris, Hornung, Wessel, Lanphear, Ho, Rae (2008): Association of Prenatal and Childhood Blood Lead Concentrations with Criminal Arrests in Early Adulthood. PLoS Med 5(5): e101. https://doi.org/10.1371/journal.pmed.0050101

  137. Xi, Wu (2021): A Review on the Mechanism Between Different Factors and the Occurrence of Autism and ADHD. Psychol Res Behav Manag. 2021 Apr 9;14:393-403. doi: 10.2147/PRBM.S304450. PMID: 33859505; PMCID: PMC8044340. REVIEW

  138. Ribas-Fitó N, Torrent M, Carrizo D, Júlvez J, Grimalt JO, Sunyer J (2007): Exposure to hexachlorobenzene during pregnancy and children’s social behavior at 4 years of age. Environ Health Perspect. 2007 Mar;115(3):447-50. doi: 10.1289/ehp.9314. PMID: 17431497; PMCID: PMC1849941. n = 475

  139. Forns J, Stigum H, Høyer BB, Sioen I, Sovcikova E, Nowack N, Lopez-Espinosa MJ, Guxens M, Ibarluzea J, Torrent M, Wittsiepe J, Govarts E, Trnovec T, Chevrier C, Toft G, Vrijheid M, Iszatt N, Eggesbø M (2018): Prenatal and postnatal exposure to persistent organic pollutants and attention-deficit and hyperactivity disorder: a pooled analysis of seven European birth cohort studies. Int J Epidemiol. 2018 Aug 1;47(4):1082-1097. doi: 10.1093/ije/dyy052. PMID: 29912347; PMCID: PMC6124627. n = 4.437

  140. Kyriklaki A, Vafeiadi M, Kampouri M, Koutra K, Roumeliotaki T, Chalkiadaki G, Anousaki D, Rantakokko P, Kiviranta H, Fthenou E, Bitsios P, Kyrtopoulos SA, Kogevinas M, Chatzi L (2016): Prenatal exposure to persistent organic pollutants in association with offspring neuropsychological development at 4years of age: The Rhea mother-child cohort, Crete, Greece. Environ Int. 2016 Dec;97:204-211. doi: 10.1016/j.envint.2016.09.012. PMID: 27666324. n = 689

  141. Vester, Caudle (2016): The Synapse as a Central Target for Neurodevelopmental Susceptibility to Pesticides. Toxics. 2016 Aug 26;4(3):18. doi: 10.3390/toxics4030018. PMID: 29051423; PMCID: PMC5606656. REVIEW

  142. Slotkin, Seidler (2007): Comparative developmental neurotoxicity of organophosphates in vivo: transcriptional responses of pathways for brain cell development, cell signaling, cytotoxicity and neurotransmitter systems. Brain Res Bull. 2007 May 30;72(4-6):232-74. doi: 10.1016/j.brainresbull.2007.01.005. PMID: 17452286; PMCID: PMC1945108.

  143. Rauh, Arunajadai, Horton, Perera, Hoepner, Barr, Whyatt (2011): Seven-year neurodevelopmental scores and prenatal exposure to chlorpyrifos, a common agricultural pesticide. Environ Health Perspect. 2011 Aug;119(8):1196-201. doi: 10.1289/ehp.1003160. PMID: 21507777; PMCID: PMC3237355.

  144. Bouchard, Chevrier, Harley, Kogut, Vedar, Calderon, Trujillo, Johnson, Bradman, Barr, Eskenazi (2011): Prenatal exposure to organophosphate pesticides and IQ in 7-year-old children. Environ Health Perspect. 2011 Aug;119(8):1189-95. doi: 10.1289/ehp.1003185. PMID: 21507776; PMCID: PMC3237357.

  145. Thistle, Ramos, Roell, Choi, Manley, Hall, Villanger, Cequier, Sakhi, Thomsen, Zeiner, Reichborn-Kjennerud, Øvergaard, Herring, Aase, Engel (2022): Prenatal organophosphorus pesticide exposure and executive function in preschool-aged children in the Norwegian Mother, Father and Child Cohort Study (MoBa). Environ Res. 2022 May 22:113555. doi: 10.1016/j.envres.2022.113555. PMID: 35613628.)

  146. Ho, Hoskins (1990): Dopamine in organophosphate-induced neurotoxicity. J Toxicol Sci . 1990 Dec;15 Suppl 4:159-61. doi: 10.2131/jts.15.supplementiv_159. REVIEW

  147. Manley, Villanger, Thomsen, Cequier, Sakhi, Reichborn-Kjennerud, Herring, Øvergaard, Zeiner, Roell, Engel, Kamai, Thistle, Hall, Aase, Engel (2022): Prenatal Exposure to Organophosphorus Pesticides and Preschool ADHD in the Norwegian Mother, Father and Child Cohort Study. Int J Environ Res Public Health. 2022 Jul 2;19(13):8148. doi: 10.3390/ijerph19138148. PMID: 35805806.

  148. Hall AM, Ramos AM, Drover SS, Choi G, Keil AP, Richardson DB, Martin CL, Olshan AF, Villanger GD, Reichborn-Kjennerud T, Zeiner P, Øvergaard KR, Sakhi AK, Thomsen C, Aase H, Engel SM (2022): Gestational organophosphate ester exposure and preschool attention-deficit/hyperactivity disorder in the Norwegian Mother, Father, and Child cohort study. Int J Hyg Environ Health. 2022 Nov 28;248:114078. doi: 10.1016/j.ijheh.2022.114078. PMID: 36455478.

  149. Zhou W, Deng Y, Zhang C, Dai H, Guan L, Luo X, He W, Tian J, Zhao L (2022): Chlorpyrifos residue level and ADHD among children aged 1-6 years in rural China: A cross-sectional study. Front Pediatr. 2022 Oct 14;10:952559. doi: 10.3389/fped.2022.952559. PMID: 36313880; PMCID: PMC9616114.

  150. Li H, Tong J, Wang X, Lu M, Yang F, Gao H, Gan H, Yan S, Gao G, Huang K, Cao Y, Tao F (2024): Associations of prenatal exposure to individual and mixed organophosphate esters with ADHD symptom trajectories in preschool children: The modifying effects of maternal Vitamin D. J Hazard Mater. 2024 Oct 5;478:135541. doi: 10.1016/j.jhazmat.2024.135541. PMID: 39154480.

  151. Carr RL, Alugubelly N, de Leon K, Loyant L, Mohammed AN, Patterson ME, Ross MK, Rowbotham NE (2020): Inhibition of fatty acid amide hydrolase by chlorpyrifos in juvenile rats results in altered exploratory and social behavior as adolescents. Neurotoxicology. 2020 Mar;77:127-136. doi: 10.1016/j.neuro.2020.01.002. PMID: 31931040; PMCID: PMC7986983.

  152. Hall AM, Thistle JE, Manley CK, Roell KR, Ramos AM, Villanger GD, Reichborn-Kjennerud T, Zeiner P, Cequier E, Sakhi AK, Thomsen C, Aase H, Engel SM (2022): Organophosphorus Pesticide Exposure at 17 Weeks’ Gestation and Odds of Offspring Attention-Deficit/Hyperactivity Disorder Diagnosis in the Norwegian Mother, Father, and Child Cohort Study. Int J Environ Res Public Health. 2022 Dec 15;19(24):16851. doi: 10.3390/ijerph192416851. PMID: 36554732; PMCID: PMC9778918. n = 849

  153. Dalsager, Fage-Larsen, Bilenberg, Jensen, Nielsen, Kyhl, Grandjean, Andersen (2019): Maternal urinary concentrations of pyrethroid and chlorpyrifos metabolites and attention deficit hyperactivity disorder (ADHD) symptoms in 2-4-year-old children from the Odense Child Cohort. Environ Res. 2019 Sep;176:108533. doi: 10.1016/j.envres.2019.108533.

  154. Pitzer, Williams, Vorhees (2021) Effects of pyrethroids on brain development and behavior: Deltamethrin. Neurotoxicol Teratol. 2021 Apr 20;87:106983. doi: 10.1016/j.ntt.2021.106983. PMID: 33848594. REVIEW

  155. Koff L, Di Re J, Chand S, Avchalumov Y, Nguyen NM, Baumgartner TJ, Singh AK, Goode NA, Marosi M, Hallberg LM, Ameredes BT, Green TA, Yelamanchili SV, Pendyala G, Laezza F (2025): Early Life Exposure to Deltamethrin Impairs Synaptic Function by Altering the Brain-Derived Extracellular Vesicle Proteome. Mol Cell Proteomics. 2025 Feb;24(2):100902. doi: 10.1016/j.mcpro.2024.100902. PMID: 39746543; PMCID: PMC11847076.

  156. Xi, Yang, Yu, Li, He, El-Aziz, Zhao, Cao (2022): Influence of perinatal deltamethrin exposure at distinct developmental stages on motor activity, learning and memory. Ecotoxicol Environ Saf. 2022 Apr 1;236:113460. doi: 10.1016/j.ecoenv.2022.113460. PMID: 35378399.

  157. Nguyen JH, Curtis MA, Imami AS, Ryan WG, Alganem K, Neifer KL, Saferin N, Nawor CN, Kistler BP, Miller GW, Shukla R, McCullumsmith RE, Burkett JP (2025): Developmental pyrethroid exposure disrupts molecular pathways for MAP kinase and circadian rhythms in mouse brain. Physiol Genomics. 2025 Apr 1;57(4):240-253. doi: 10.1152/physiolgenomics.00033.2024. PMID: 39961078.

  158. Buchenauer L, Haange SB, Bauer M, Rolle-Kampczyk UE, Wagner M, Stucke J, Elter E, Fink B, Vass M, von Bergen M, Schulz A, Zenclussen AC, Junge KM, Stangl GI, Polte T (2023): Maternal exposure of mice to glyphosate induces depression- and anxiety-like behavior in the offspring via alterations of the gut-brain axis. Sci Total Environ. 2023 Sep 12;905:167034. doi: 10.1016/j.scitotenv.2023.167034. PMID: 37709081.

  159. Shaw W (2024): Hypothesis: 2 Major Environmental and Pharmaceutical Factors-Acetaminophen Exposure and Gastrointestinal Overgrowth of Clostridia Bacteria Induced By Ingestion of Glyphosate-Contaminated Foods-Dysregulate the Developmental Protein Sonic Hedgehog and Are Major Causes of Autism. Integr Med (Encinitas). 2024 Jul;23(3):12-23. PMID: 39114279; PMCID: PMC11302971.

  160. Sass JB, Donley N, Freese W (2024): Neonicotinoid pesticides: evidence of developmental neurotoxicity from regulatory rodent studies. Front Toxicol. 2024 Oct 2;6:1438890. doi: 10.3389/ftox.2024.1438890. PMID: 39415959; PMCID: PMC11480014.

  161. Barrett (2019): Attention Worthy: Prenatal Phthalate Exposure and Subsequent ADHD Diagnosis Science Selection; CID: 034001https://doi.org/10.1289/EHP3815

  162. Almeida-Toledano L, Navarro-Tapia E, Sebastiani G, Ferrero-Martínez S, Ferrer-Aguilar P, García-Algar Ó, Andreu-Fernández V, Gómez-Roig MD (2024): Effect of prenatal phthalate exposure on fetal development and maternal/neonatal health consequences: A systematic review. Sci Total Environ. 2024 Nov 10;950:175080. doi: 10.1016/j.scitotenv.2024.175080. PMID: 39079634. REVIEW

  163. Kougias DG, Sellinger EP, Willing J, Juraska JM (2018): Perinatal Exposure to an Environmentally Relevant Mixture of Phthalates Results in a Lower Number of Neurons and Synapses in the Medial Prefrontal Cortex and Decreased Cognitive Flexibility in Adult Male and Female Rats. J Neurosci. 2018 Aug 1;38(31):6864-6872. doi: 10.1523/JNEUROSCI.0607-18.2018. PMID: 30012688; PMCID: PMC6070669.

  164. Radke, Braun, Nachman, Cooper (2020): Phthalate exposure and neurodevelopment: A systematic review and meta-analysis of human epidemiological evidence. Environ Int. 2020 Feb 8;137:105408. doi: 10.1016/j.envint.2019.105408. PMID: 32045779. REVIEW

  165. Minatoya, Kishi (2021): A Review of Recent Studies on Bisphenol A and Phthalate Exposures and Child Neurodevelopment. Int J Environ Res Public Health. 2021 Mar 30;18(7):3585. doi: 10.3390/ijerph18073585. PMID: 33808331. REVIEW

  166. Salazar, Villaseca, Cisternas, Inestrosa (2021). Neurodevelopmental impact of the offspring by thyroid hormone system-disrupting environmental chemicals during pregnancy. Environ Res. 2021 Jun 1;200:111345. doi: 10.1016/j.envres.2021.111345. PMID: 34087190.

  167. Elagali A, Eisner A, Tanner S, Drummond K, Symeonides C, Love C, Tang ML, Mansell T, Burgner D, Collier F, Sly PD, O’Hely M, Dunlop S, Vuillermin P, Ponsonby AL (2025): A pathway-based genetic score for inflammation: An indicator of vulnerability to phthalate-induced adverse neurodevelopment outcomes. Int J Hyg Environ Health. 2025 Mar;264:114514. doi: 10.1016/j.ijheh.2024.114514. PMID: 39721371.

  168. Ku, Tsai, Wang, Su, Sun, Wang, Wang (2019): Prenatal and childhood phthalate exposure and attention deficit hyperactivity disorder traits in child temperament: A 12-year follow-up birth cohort study. Sci Total Environ. 2019 Aug 29;699:134053. doi: 10.1016/j.scitotenv.2019.134053.

  169. Choi G, Villanger GD, Drover SSM, Sakhi AK, Thomsen C, Nethery RC, Zeiner P, Knudsen GP, Reichborn-Kjennerud T, Øvergaard KR, Herring AH, Skogan AH, Biele G, Aase H, Engel SM (2021): Prenatal phthalate exposures and executive function in preschool children. Environ Int. 2021 Apr;149:106403. doi: 10.1016/j.envint.2021.106403. PMID: 33524667; PMCID: PMC7945722.

  170. Ko MY, Park H, Chon SH, Lee BS, Cha SW, Hyun SA, Ka M (2023): Prenatal Di-methoxyethyl phthalate exposure impairs cortical neurogenesis and synaptic activity in the mice. Brain Pathol. 2023 Oct 30:e13221. doi: 10.1111/bpa.13221. PMID: 37903655.

  171. Zhang R, Manza P, Volkow ND (2022): Prenatal caffeine exposure: association with neurodevelopmental outcomes in 9- to 11-year-old children. J Child Psychol Psychiatry. 2022 May;63(5):563-578. doi: 10.1111/jcpp.13495. PMID: 34318489; PMCID: PMC9291501.

  172. Silva Bdel P, Anselmi L, Schmidt V, Santos IS (2015): Consumo de cafeína durante a gestação e transtorno de déficit de atenção e hiperatividade (TDAH): uma revisão sistemática da literatura [Caffeine consumption during pregnancy and attention deficit hyperactivity disorder (ADHD): a systematic literature review]. Cad Saude Publica. 2015 Apr;31(4):682-90. Portuguese. doi: 10.1590/0102-311x00142314. PMID: 25945978. REVIEW

  173. Linnet KM, Wisborg K, Secher NJ, Thomsen PH, Obel C, Dalsgaard S, Henriksen TB (2009): Coffee consumption during pregnancy and the risk of hyperkinetic disorder and ADHD: a prospective cohort study. Acta Paediatr. 2009 Jan;98(1):173-9. doi: 10.1111/j.1651-2227.2008.00980.x. PMID: 18764862.

  174. Bekkhus M, Skjøthaug T, Nordhagen R, Borge AI (2010): Intrauterine exposure to caffeine and inattention/overactivity in children. Acta Paediatr. 2010 Jun;99(6):925-8. doi: 10.1111/j.1651-2227.2010.01744.x. PMID: 20219037.

  175. Cortés-Albornoz, García-Guáqueta, Velez-van-Meerbeke, Talero-Gutiérrez (2021): Maternal Nutrition and Neurodevelopment: A Scoping Review. Nutrients. 2021 Oct 8;13(10):3530. doi: 10.3390/nu13103530. PMID: 34684531; PMCID: PMC8538181. REVIEW

  176. Linnet KM, Dalsgaard S, Obel C, Wisborg K, Henriksen TB, Rodriguez A, Kotimaa A, Moilanen I, Thomsen PH, Olsen J, Jarvelin MR (2003): Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry. 2003 Jun;160(6):1028-40. doi: 10.1176/appi.ajp.160.6.1028. PMID: 12777257. REVIEW

  177. Del-Ponte B, Santos IS, Tovo-Rodrigues L, Anselmi L, Munhoz TN, Matijasevich A (2016): Caffeine consumption during pregnancy and ADHD at the age of 11 years: a birth cohort study. BMJ Open. 2016 Dec 5;6(12):e012749. doi: 10.1136/bmjopen-2016-012749. PMID: 27920084; PMCID: PMC5168652.

  178. Loomans EM, Hofland L, van der Stelt O, van der Wal MF, Koot HM, Van den Bergh BR, Vrijkotte TG (2012): Caffeine intake during pregnancy and risk of problem behavior in 5- to 6-year-old children. Pediatrics. 2012 Aug;130(2):e305-13. doi: 10.1542/peds.2011-3361. PMID: 22778296.

  179. Modi H, Baranger DAA, Paul SE, Gorelik AJ, Hornstein A, Balbona JV, Agrawal A, Bijsterbosch JD, Bogdan R (2025): Associations between prenatal caffeine exposure and child development: Longitudinal results from the Adolescent Brain Cognitive Development (ABCD) Study. Neurotoxicol Teratol. 2025 Jan-Feb;107:107404. doi: 10.1016/j.ntt.2024.107404. PMID: 39592017.

  180. D’Urso S, Wootton RE, Ask H, Brito Nunes C, Andreassen OA, Hwang LD, Moen GH, Evans DM, Havdahl A (2024): Mendelian randomization analysis of maternal coffee consumption during pregnancy on offspring neurodevelopmental difficulties in the Norwegian Mother, Father and Child Cohort Study (MoBa). Psychol Med. 2024 Oct 9;54(12):1-14. doi: 10.1017/S0033291724002216. PMID: 39382486; PMCID: PMC11496242.

  181. Ouyang J, Wu P, Chen L, Tong J, Yan S, Li J, Tao F, Huang K (2025): Impact of tea and coffee consumption during pregnancy on children’s cognitive development. Sci Rep. 2025 Mar 14;15(1):8832. doi: 10.1038/s41598-025-91982-1. PMID: 40087371; PMCID: PMC11909266.

  182. Papadopoulou E, Botton J, Brantsæter AL, Haugen M, Alexander J, Meltzer HM, Bacelis J, Elfvin A, Jacobsson B, Sengpiel V (2018): Maternal caffeine intake during pregnancy and childhood growth and overweight: results from a large Norwegian prospective observational cohort study. BMJ Open. 2018 Apr 23;8(3):e018895. doi: 10.1136/bmjopen-2017-018895. PMID: 29685923; PMCID: PMC5914784.

  183. Jin F, Qiao C (2021): Association of maternal caffeine intake during pregnancy with low birth weight, childhood overweight, and obesity: a meta-analysis of cohort studies. Int J Obes (Lond). 2021 Feb;45(2):279-287. doi: 10.1038/s41366-020-0617-4. PMID: 32518355. REVIEW

  184. Nygaard, Slinning, Moe, Fjell, Walhovd (2019): Mental health in youth prenatally exposed to opioids and poly-drugs and raised in permanent foster/adoptive homes: A prospective longitudinal study. Early Hum Dev. 2019 Oct 29;140:104910. doi: 10.1016/j.earlhumdev.2019.104910.

  185. Bassalov H, Yakirevich-Amir N, Reuveni I, Monk C, Florentin S, Bonne O, Matok I (2024): Prenatal Cannabis Exposure and The Risk for Neuropsychiatric Anomalies in the Offspring: A Systematic Review and Meta-Analysis. Am J Obstet Gynecol. 2024 Jun 20:S0002-9378(24)00682-3. doi: 10.1016/j.ajog.2024.06.014. PMID: 38908654. METASTUDY

  186. Roncero, Valriberas-Herrero, Mezzatesta-Gava, Villegas, Aguilar, Grau-López (2020): Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review. Reprod Health. 2020 Feb 17;17(1):25. doi: 10.1186/s12978-020-0880-9. PMID: 32066469; PMCID: PMC7027300. REVIEW

  187. Andrade C (2025): Maternal Cannabis Use During Pregnancy and Neuropsychiatric Adverse Outcomes During Childhood and Early Adult Life. J Clin Psychiatry. 2025 Jan 6;86(1):24f15753. doi: 10.4088/JCP.24f15753. PMID: 39832340. REVIEW

  188. Young-Wolff KC, Kong K, Alexeeff SE, Croen LA, Oberman N, Kirane H, Ansley D, Davignon M, Adams SR, Avalos LA (2025): Prenatal Cannabis Use and Offspring Attention Deficit Hyperactivity Disorder and Disruptive Behavior Disorders: A Retrospective Cohort Study. J Dev Behav Pediatr. 2025 Jan-Feb 01;46(1):e25-e32. doi: 10.1097/DBP.0000000000001323. PMID: 39400201; PMCID: PMC11832326.

  189. Zhou J, Tong J, Liang C, Wu P, Ouyang J, Cai W, Sheng J, Gao G, Yan S, Tao F, Huang K (2025): Prenatal placental metal accumulation and its association with child attention deficit/hyperactivity disorder and autism spectrum disorder symptom at 3 years of age: The role of psychosocial-environmental support in infancy. Environ Res. 2025 Mar 7;274:121294. doi: 10.1016/j.envres.2025.121294. PMID: 40058545.

  190. Kim, Jang, Lim, Kim, Shin, Lee, Kim, Hong (2020): The Effect of Prenatal Cadmium Exposure on Attention-deficit/Hyperactivity Disorder in 6-Year-old Children in Korea. J Prev Med Public Health. 2020 Jan;53(1):29-36. doi: 10.3961/jpmph.19.175. PMID: 32023672; PMCID: PMC7002990.

  191. Ibiwoye MO, Snyder EA, Lyons J, Vasauskas AA, Hernandez MJ, Summerlin AR, Foster JD (2022): The Effect of Short-Term Exposure to Cadmium on the Expression of Vascular Endothelial Barrier Antigen in the Developing Rat Forebrain and Cerebellum: A Computerized Quantitative Immunofluorescent Study. Cureus. 2022 Apr 5;14(4):e23848. doi: 10.7759/cureus.23848. PMID: 35402117; PMCID: PMC8986507.

  192. Shih, Zeng, Lin, Chen, Chen, Wu, Tseng, Wu (2018): Association between peripheral manganese levels and attention-deficit/hyperactivity disorder: a preliminary meta-analysis. Neuropsychiatr Dis Treat. 2018 Jul 18;14:1831-1842. doi: 10.2147/NDT.S165378. eCollection 2018.

  193. Schildroth S, Bauer JA, Friedman A, Austin C, Coull BA, Placidi D, White RF, Smith D, Wright RO, Lucchini RG, Arora M, Horton M, Claus Henn B (2023): Early life manganese exposure and reported attention-related behaviors in Italian adolescents. Environ Epidemiol. 2023 Oct 19;7(6):e274. doi: 10.1097/EE9.0000000000000274. PMID: 38912396; PMCID: PMC11189689.

  194. Smith DR, Strupp BJ. Animal Models of Childhood Exposure to Lead or Manganese: Evidence for Impaired Attention, Impulse Control, and Affect Regulation and Assessment of Potential Therapies. Neurotherapeutics. 2023 Feb 28. doi: 10.1007/s13311-023-01345-9. PMID: 36853434.

  195. Cowell, Wright (2017): Sex-Specific Effects of Combined Exposure to Chemical and Non-chemical Stressors on Neuroendocrine Development: a Review of Recent Findings and Putative Mechanisms. Current environmental health reports, 4(4), 415-425.

  196. Fang, Strodl, Liu, Liu, Yin, Wen, Sun, Xian, Jiang, Jing, Jin, Wu, Chen (2019): Association between prenatal exposure to household inhalants exposure and ADHD-like behaviors at around 3 years of age: Findings from Shenzhen Longhua Child Cohort Study. Environ Res. 2019 Jul 26;177:108612. doi: 10.1016/j.envres.2019.108612.

  197. Forns, Sunyer, Garcia-Esteban, Porta, Ghassabian, Giorgis-Allemand, Gong, Gehring, Sørensen, Standl, Sugiri, Almqvist, Andiarena, Badaloní, Beelen, Berdel, Cesaroni, Charles, Eriksen, Estarlich, Fernandez, Forhan, Jaddoe, Korek, Lichtenstein, Lertxundi, Lopez-Espinosa, Markevych, de Nazelle, Raaschou-Nielsen, Nieuwenhuijsen, Pérez-Lobato, Philippat, Slama, Tiesler, Verhulst, von Berg, Vrijkotte, Nybo Andersen, Heude, Krämer, Heinrich, Tiemeier, Forastiere, Pershagen, Brunekreef, Guxens (2018): Air pollution exposure during pregnancy and symptoms of attention deficit and hyperactivity disorder in children in Europe. Epidemiology. 2018 Jun 19. doi: 10.1097/EDE.0000000000000874.; n = 29.127

  198. Aghaei, Janjani, Yousefian, Jamal, Yunesian (2019): Association between ambient gaseous and particulate air pollutants and attention deficit hyperactivity disorder (ADHD) in children; a systematic review. Environ Res. 2019 Mar 15;173:135-156. doi: 10.1016/j.envres.2019.03.030. REVIEW

  199. Chang YC, Chen WT, Su SH, Jung CR, Hwang BF (2022): PM2.5 exposure and incident attention-deficit/hyperactivity disorder during the prenatal and postnatal periods: A birth cohort study. Environ Res. 2022 Jun 28:113769. doi: 10.1016/j.envres.2022.113769. PMID: 35777438. n = 425.736

  200. Mortamais, Pujol, Martínez-Vilavella, Fenoll, Reynes, Sabatier, Rivas, Forns, Vilor-Tejedor, Alemany, Cirach, Alvarez-Pedrerol, Nieuwenhuijsen, Sunyer (2019): Effects of prenatal exposure to particulate matter air pollution on corpus callosum and behavioral problems in children. Environ Res. 2019 Nov;178:108734. doi: 10.1016/j.envres.2019.108734.

  201. Carll, Salatini, Pirela, Wang, Xie, Lorkiewicz, Naeem, Qian, Castranova, Godleski, Demokritou (2020): Inhalation of printer-emitted particles impairs cardiac conduction, hemodynamics, and autonomic regulation and induces arrhythmia and electrical remodeling in rats. Part Fibre Toxicol. 2020 Jan 29;17(1):7. doi: 10.1186/s12989-019-0335-z. PMID: 31996220; PMCID: PMC6990551.

  202. Weitekamp, Hofmann (2021): Effects of air pollution exposure on social behavior: a synthesis and call for research. Environ Health. 2021 Jun 25;20(1):72. doi: 10.1186/s12940-021-00761-8. PMID: 34187479; PMCID: PMC8243425. REVIEW

  203. Emam, Shahsavani, Khodagholi, Zarandi, Hopke, Hadei, Behbahani, Yarahmadi (2020): Effects of PM2.5 and gases exposure during prenatal and early-life on autism-like phenotypes in male rat offspring. Part Fibre Toxicol. 2020 Jan 29;17(1):8. doi: 10.1186/s12989-020-0336-y. PMID: 31996222; PMCID: PMC6990481.

  204. Win-Shwe, Fujitani, Kyi-Tha-Thu, Furuyama, Michikawa, Tsukahara, Nitta, Hirano (2014): Effects of diesel engine exhaust origin secondary organic aerosols on novel object recognition ability and maternal behavior in BALB/c mice. Int J Environ Res Public Health. 2014 Oct 30;11(11):11286-307. doi: 10.3390/ijerph111111286. PMID: 25361045; PMCID: PMC4245613.

  205. Patisaul (2017): Endocrine Disruption of Vasopressin Systems and Related Behaviors. Front Endocrinol (Lausanne). 2017 Jun 19;8:134. doi: 10.3389/fendo.2017.00134. PMID: 28674520; PMCID: PMC5475378.

  206. Fuertes E, Standl M, Forns J, Berdel D, Garcia-Aymerich J, Markevych I, Schulte-Koerne G, Sugiri D, Schikowski T, Tiesler CM, Heinrich J (2016): Traffic-related air pollution and hyperactivity/inattention, dyslexia and dyscalculia in adolescents of the German GINIplus and LISAplus birth cohorts. Environ Int. 2016 Dec;97:85-92. doi: 10.1016/j.envint.2016.10.017. PMID: 27835751. METASTUDIE

  207. Liu B, Fang X, Strodl E, He G, Ruan Z, Wang X, Liu L, Chen W (2022): Fetal Exposure to Air Pollution in Late Pregnancy Significantly Increases ADHD-Risk Behavior in Early Childhood. Int J Environ Res Public Health. 2022 Aug 23;19(17):10482. doi: 10.3390/ijerph191710482. PMID: 36078201; PMCID: PMC9518584. n = 26.052

  208. Yorifuji T, Kashima S, Diez MH, Kado Y, Sanada S, Doi H (2017): Prenatal exposure to outdoor air pollution and child behavioral problems at school age in Japan. Environ Int. 2017 Feb;99:192-198. doi: 10.1016/j.envint.2016.11.016. PMID: 27890345.

  209. McGuinn LA, Bellinger DC, Colicino E, Coull BA, Just AC, Kloog I, Osorio-Valencia E, Schnaas L, Wright RJ, Téllez-Rojo MM, Wright RO, Horton MK (2020): Prenatal PM2.5 exposure and behavioral development in children from Mexico City. Neurotoxicology. 2020 Dec;81:109-115. doi: 10.1016/j.neuro.2020.09.036. Epub 2020 Sep 17. PMID: 32950567; PMCID: PMC7708408.

  210. Gong T, Almqvist C, Bölte S, Lichtenstein P, Anckarsäter H, Lind T, Lundholm C, Pershagen G (2014): Exposure to air pollution from traffic and neurodevelopmental disorders in Swedish twins. Twin Res Hum Genet. 2014 Dec;17(6):553-62. doi: 10.1017/thg.2014.58. PMID: 25229653.

  211. Forns J, Sunyer J, Garcia-Esteban R, Porta D, Ghassabian A, Giorgis-Allemand L, Gong T, Gehring U, Sørensen M, Standl M, Sugiri D, Almqvist C, Andiarena A, Badaloní C, Beelen R, Berdel D, Cesaroni G, Charles MA, Eriksen KT, Estarlich M, Fernandez MF, Forhan A, Jaddoe VWV, Korek M, Lichtenstein P, Lertxundi A, Lopez-Espinosa MJ, Markevych I, de Nazelle A, Raaschou-Nielsen O, Nieuwenhuijsen M, Pérez-Lobato R, Philippat C, Slama R, Tiesler CMT, Verhulst FC, von Berg A, Vrijkotte T, Nybo Andersen AM, Heude B, Krämer U, Heinrich J, Tiemeier H, Forastiere F, Pershagen G, Brunekreef B, Guxens M (2018): Air Pollution Exposure During Pregnancy and Symptoms of Attention Deficit and Hyperactivity Disorder in Children in Europe. Epidemiology. 2018 Sep;29(5):618-626. doi: 10.1097/EDE.0000000000000874. PMID: 29923866. METASTUDIE

  212. Shih P, Huang CC, Pan SC, Chiang TL, Guo YL (2020): Hyperactivity disorder in children related to traffic-based air pollution during pregnancy. Environ Res. 2020 Sep;188:109588. doi: 10.1016/j.envres.2020.109588. PMID: 32504847.

  213. Tartaglione AM, Camoni L, Calamandrei G, Chiarotti F, Venerosi A (2024): The contribution of environmental pollutants to the risk of autism and other neurodevelopmental disorders: A systematic review of case-control studies. Neurosci Biobehav Rev. 2024 Sep;164:105815. doi: 10.1016/j.neubiorev.2024.105815. PMID: 39053787. METASTUDY

  214. Chen G, Jin Z, Li S, Jin X, Tong S, Liu S, Yang Y, Huang H, Guo Y (2018): Early life exposure to particulate matter air pollution (PM1, PM2.5 and PM10) and autism in Shanghai, China: A case-control study. Environ Int. 2018 Dec;121(Pt 2):1121-1127. doi: 10.1016/j.envint.2018.10.026. PMID: 30409451.

  215. Sentís A, Sunyer J, Dalmau-Bueno A, Andiarena A, Ballester F, Cirach M, Estarlich M, Fernández-Somoano A, Ibarluzea J, Íñiguez C, Lertxundi A, Tardón A, Nieuwenhuijsen M, Vrijheid M, Guxens M; INMA Project (2017). Prenatal and postnatal exposure to NO2 and child attentional function at 4-5years of age. Environ Int. 2017 Sep;106:170-177. doi: 10.1016/j.envint.2017.05.021. PMID: 28689118.

  216. Oudin, Frondelius, Haglund, Källén, Forsberg, Gustafsson, Malmqvist (2019): Prenatal exposure to air pollution as a potential risk factor for autism and ADHD. Environ Int. 2019 Oct 16;133(Pt A):105149. doi: 10.1016/j.envint.2019.105149.

  217. Umweltbundesamt, abgerufen 30.11.23

  218. Eubig PA, Aguiar A, Schantz SL (2010): Lead and PCBs as risk factors for attention deficit/hyperactivity disorder. Environ Health Perspect. 2010 Dec;118(12):1654-67. doi: 10.1289/ehp.0901852. PMID: 20829149; PMCID: PMC3002184. REVIEW

  219. Chishti, Fisher, Seegal (1996): Aroclors 1254 and 1260 reduce dopamine concentrations in rat striatal slices. Neurotoxicology. 1996 Fall-Winter;17(3-4):653-60.

  220. Jones, Miller (2008): The effects of environmental neurotoxicants on the dopaminergic system: A possible role in drug addiction. Biochem Pharmacol. 2008 Sep 1;76(5):569-81. doi: 10.1016/j.bcp.2008.05.010. PMID: 18555207. REVIEW

  221. Grønnestad, Schlenk, Krøkje, Jaspers, Jenssen, Coffin, Bertotto, Giroux, Lyche, Arukwe (2021): Alteration of neuro-dopamine and steroid hormone homeostasis in wild Bank voles in relation to tissue concentrations of PFAS at a Nordic skiing area. Sci Total Environ. 2021 Feb 20;756:143745. doi: 10.1016/j.scitotenv.2020.143745. PMID: 33250251.

  222. Sammi, Foguth, Nieves, De Perre, Wipf, McMurray, Lee, Cannon (2019): Perfluorooctane Sulfonate (PFOS) Produces Dopaminergic Neuropathology in Caenorhabditis elegans. Toxicol Sci. 2019 Dec 1;172(2):417-434. doi: 10.1093/toxsci/kfz191. PMID: 31428778; PMCID: PMC6876260.)

  223. Foguth, Hoskins, Clark, Nelson, Flynn, de Perre, Hoverman, Lee, Sepúlveda, Cannon (2020): Single and mixture per- and polyfluoroalkyl substances accumulate in developing Northern leopard frog brains and produce complex neurotransmission alterations. Neurotoxicol Teratol. 2020 Sep-Oct;81:106907. doi: 10.1016/j.ntt.2020.106907. PMID: 32561179.

  224. Hmila I, Hill J, Shalaby KE, Ouararhni K, Abedsselem H, Modaresi SMS, Bihaqi SW, Marques E, Sondhi A, Slitt AL, Zawia NH (2024): Perinatal exposure to PFOS and sustained high-fat diet promote neurodevelopmental disorders via genomic reprogramming of pathways associated with neuromotor development. Ecotoxicol Environ Saf. 2024 Mar 1;272:116070. doi: 10.1016/j.ecoenv.2024.116070. PMID: 38340603.

  225. Symeonides C, Aromataris E, Mulders Y, Dizon J, Stern C, Barker TH, Whitehorn A, Pollock D, Marin T, Dunlop S (2024): An Umbrella Review of Meta-Analyses Evaluating Associations between Human Health and Exposure to Major Classes of Plastic-Associated Chemicals. Ann Glob Health. 2024 Aug 19;90(1):52. doi: 10.5334/aogh.4459. PMID: 39183960; PMCID: PMC11342836.

  226. Ames JL, Sharma V, Lyall K (2025): Effects of Early-life PFAS Exposure on Child Neurodevelopment: A Review of the Evidence and Research gaps. Curr Environ Health Rep. 2025 Jan 31;12(1):9. doi: 10.1007/s40572-024-00464-5. PMID: 39888511; PMCID: PMC11785707. REVIEW

  227. Skogheim, Villanger, Weyde, Engel, Surén, Øie, Skogan, Biele, Zeiner, Øvergaard, Haug, Sabaredzovic, Aase (2019): Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children. Int J Hyg Environ Health. 2019 Oct 22. pii: S1438-4639(19)30570-X. doi: 10.1016/j.ijheh.2019.10.003.

  228. Qu, Cao, Li, Wang, Liu, Wang, Nie, Sun, Liu, Zhang (2021): The association between maternal perfluoroalkyl substances exposure and early attention deficit hyperactivity disorder in children: a systematic review and meta-analysis. Environ Sci Pollut Res Int. 2021 Jul 9. doi: 10.1007/s11356-021-15136-2. PMID: 34244930.

  229. Yao H, Fu Y, Weng X, Zeng Z, Tan Y, Wu X, Zeng H, Yang Z, Li Y, Liang H, Wu Y, Wen L, Jing C (2023): The Association between Prenatal Per- and Polyfluoroalkyl Substances Exposure and Neurobehavioral Problems in Offspring: A Meta-Analysis. Int J Environ Res Public Health. 2023 Jan 17;20(3):1668. doi: 10.3390/ijerph20031668. PMID: 36767045. REVIEW

  230. Kim JI, Kim BN, Lee YA, Shin CH, Hong YC, Døssing LD, Hildebrandt G, Lim YH (2023): Association between early-childhood exposure to perfluoroalkyl substances and ADHD symptoms: A prospective cohort study. Sci Total Environ. 2023 Mar 25:163081. doi: 10.1016/j.scitotenv.2023.163081. PMID: 36972880.

  231. Tong, Liang, Huang, Xiang, Qi, Feng, Lai, Shao, Wu, Tao (2020): Prenatal serum thallium exposure and 36-month-old children’s attention-deficit/hyperactivity disorder symptoms: Ma’anshan birth cohort study. Chemosphere. 2020 Apr;244:125499. doi: 10.1016/j.chemosphere.2019.125499. PMID: 32050328.

  232. Zhang J, Yuan M, Liu Y, Zhong X, Wu J, Chen W (2025): Bisphenol A exposure and neurodevelopmental disorders and problems in children under 12 years of age: A systematic review and meta-analysis. J Hazard Mater. 2025 Jun 15;490:137731. doi: 10.1016/j.jhazmat.2025.137731. PMID: 40054188. METASTUDY

  233. Costa HE, Cairrao E (2024): Effect of bisphenol A on the neurological system: a review update. Arch Toxicol. 2024 Jan;98(1):1-73. doi: 10.1007/s00204-023-03614-0. PMID: 37855918; PMCID: PMC10761478. REVIEW

  234. Balakrishnan B, Henare K, Thorstensen EB, Ponnampalam AP, Mitchell MD (2010): Transfer of bisphenol A across the human placenta. Am J Obstet Gynecol. 2010 Apr;202(4):393.e1-7. doi: 10.1016/j.ajog.2010.01.025. PMID: 20350650.

  235. Corbel T, Gayrard V, Puel S, Lacroix MZ, Berrebi A, Gil S, Viguié C, Toutain PL, Picard-Hagen N (2014): Bidirectional placental transfer of Bisphenol A and its main metabolite, Bisphenol A-Glucuronide, in the isolated perfused human placenta. Reprod Toxicol. 2014 Aug;47:51-8. doi: 10.1016/j.reprotox.2014.06.001. PMID: 24933518.

  236. Grandin FC, Lacroix MZ, Gayrard V, Viguié C, Mila H, de Place A, Vayssière C, Morin M, Corbett J, Gayrard C, Gely CA, Toutain PL, Picard-Hagen N (2019): Is bisphenol S a safer alternative to bisphenol A in terms of potential fetal exposure? Placental transfer across the perfused human placenta. Chemosphere. 2019 Apr;221:471-478. doi: 10.1016/j.chemosphere.2019.01.065. PMID: 30654261.

  237. Ye X, Kuklenyik Z, Needham LL, Calafat AM (2006): Measuring environmental phenols and chlorinated organic chemicals in breast milk using automated on-line column-switching-high performance liquid chromatography-isotope dilution tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 2;831(1-2):110-5. doi: 10.1016/j.jchromb.2005.11.050. PMID: 16377264.

  238. Ni Y, Hu L, Yang S, Ni L, Ma L, Zhao Y, Zheng A, Jin Y, Fu Z (2021): Bisphenol A impairs cognitive function and 5-HT metabolism in adult male mice by modulating the microbiota-gut-brain axis. Chemosphere. 2021 Nov;282:130952. doi: 10.1016/j.chemosphere.2021.130952. PMID: 34082316.

  239. Feng D, Zhang H, Jiang X, Zou J, Li Q, Mai H, Su D, Ling W, Feng X (2020): Bisphenol A exposure induces gut microbiota dysbiosis and consequent activation of gut-liver axis leading to hepatic steatosis in CD-1 mice. Environ Pollut. 2020 Oct;265(Pt A):114880. doi: 10.1016/j.envpol.2020.114880. PMID: 32540565.

  240. Lai KP, Chung YT, Li R, Wan HT, Wong CK (2016): Bisphenol A alters gut microbiome: Comparative metagenomics analysis. Environ Pollut. 2016 Nov;218:923-930. doi: 10.1016/j.envpol.2016.08.039. PMID: 27554980.

  241. Engdahl E, van Schijndel MDM, Voulgaris D, Di Criscio M, Ramsbottom KA, Rigden DJ, Herland A, Rüegg J (2021): Bisphenol A Inhibits the Transporter Function of the Blood-Brain Barrier by Directly Interacting with the ABC Transporter Breast Cancer Resistance Protein (BCRP). Int J Mol Sci. 2021 May 24;22(11):5534. doi: 10.3390/ijms22115534. PMID: 34073890; PMCID: PMC8197233.

  242. Suresh S, Singh S A, Vellapandian C (2022): Bisphenol A exposure links to exacerbation of memory and cognitive impairment: A systematic review of the literature. Neurosci Biobehav Rev. 2022 Dec;143:104939. doi: 10.1016/j.neubiorev.2022.104939. PMID: 36328120. METASTUDY

  243. Stein TP (2024): Does Bisphenol A (BPA) Exposure Cause Human Diseases? Biomedicines. 2024 Nov 25;12(12):2678. doi: 10.3390/biomedicines12122678. PMID: 39767585; PMCID: PMC11727305. REVIEW

  244. Zoppé H, Xavier J, Dupuis A, Migeot V, Bioulac S, Hary R, Bonnet-Brilhault F, Albouy M (2024): Is exposure to Bisphenol A associated with Attention-deficit hyperactivity disorder (ADHD) and associated executive or behavioral problems in children? A comprehensive systematic review. Neurosci Biobehav Rev. 2024 Dec;167:105938. doi: 10.1016/j.neubiorev.2024.105938. PMID: 39551456. REVIEW

  245. Panagiotidou, Zerva, Mitsiou, Alexis, Kitraki (2014): Perinatal exposure to low-dose bisphenol A affects the neuroendocrine stress response in rats. J Endocrinol. 2014 Jan 27;220(3):207-18. doi: 10.1530/JOE-13-0416.

  246. Gestis-Stoffdatenbank zu Bisphenol

  247. Mao, Jain, Denslow, Nouri, Chen, Wang, Zhu, Koh, Sarma, Sumner, Lei, Sumner, Bivens, Roberts, Tuteja, Rosenfeld (2020): Bisphenol A and bisphenol S disruptions of the mouse placenta and potential effects on the placenta-brain axis. Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4642-4652. doi: 10.1073/pnas.1919563117. Epub 2020 Feb 18. PMID: 32071231; PMCID: PMC7060676.

  248. Pham-The T, Nishijo M, Pham TN, Vu HT, Tran NN, Tran AH, Hoang LV, Do Q, Nishino Y, Nishijo H. (2022): Perinatal Dioxin Exposure and Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Children Living in a Dioxin Contamination Hotspot in Vietnam. Toxics. 2022 Apr 24;10(5):212. doi: 10.3390/toxics10050212. PMID: 35622626; PMCID: PMC9143824.

  249. Choi YJ, Cho J, Hong YC, Lee DW, Moon S, Park SJ, Lee KS, Shin CH, Lee YA, Kim BN, Kaminsky Z, Kim JI, Lim YH (2023): DNA methylation is associated with prenatal exposure to sulfur dioxide and childhood attention-deficit hyperactivity disorder symptoms. Sci Rep. 2023 Mar 1;13(1):3501. doi: 10.1038/s41598-023-29843-y. PMID: 36859453; PMCID: PMC9977725. n = 329

  250. Yorifuji T, Kashima S, Higa Diez M, Kado Y, Sanada S, Doi H (2016)_ Prenatal Exposure to Traffic-related Air Pollution and Child Behavioral Development Milestone Delays in Japan. Epidemiology. 2016 Jan;27(1):57-65. doi: 10.1097/EDE.0000000000000361. PMID: 26247490.

  251. Park S, Cowell W, Margolis AE, Sjodin A, Jones R, Rauh V, Wang S, Herbstman JB (2023): Prenatal exposure to polybrominated diphenyl ethers and inattention/hyperactivity symptoms in mid to late adolescents. Front Epidemiol. 2023 Jun 21;3:1061234. doi: 10.3389/fepid.2023.1061234. PMID: 38455925; PMCID: PMC10910905.

  252. Ibarluzea J, Subiza-Pérez M, Arregi A, Molinuevo A, Arranz-Freijo E, Sánchez-de Miguel M, Jiménez A, Andiarena A, Santa-Marina L, Lertxundi A. Association of maternal prenatal urinary fluoride levels with ADHD symptoms in childhood. Environ Res. 2023 Jul 19;235:116705. doi: 10.1016/j.envres.2023.116705. PMID: 37479215.

  253. Wang A, Duan L, Huang H, Ma J, Zhang Y, Ma Q, Guo Y, Li Z, Cheng X, Zhu J, Zhou G, Ba Y (2022): Association between fluoride exposure and behavioural outcomes of school-age children: a pilot study in China. Int J Environ Health Res. 2022 Jan;32(1):232-241. doi: 10.1080/09603123.2020.1747601. PMID: 32281876.

  254. Riddell JK, Malin AJ, Flora D, McCague H, Till C (2019): Association of water fluoride and urinary fluoride concentrations with attention deficit hyperactivity disorder in Canadian youth. Environ Int. 2019 Dec;133(Pt B):105190. doi: 10.1016/j.envint.2019.105190. Erratum in: Environ Int. 2022 Mar;161:107091. PMID: 31654913; PMCID: PMC8118663.

  255. Chen S, Ahlqvist VH, Sjöqvist H, Stephansson O, Magnusson C, Dalman C, Karlsson H, Lee BK, Gardner RM (2024): Maternal intrahepatic cholestasis of pregnancy and neurodevelopmental conditions in offspring: A population-based cohort study of 2 million Swedish children. PLoS Med. 2024 Jan 16;21(1):e1004331. doi: 10.1371/journal.pmed.1004331. PMID: 38227577; PMCID: PMC10790993.

  256. Tsai MM, Chang JC, Lu HY, Gau SS, Chien YH, Hwu WL, Ni YH, Chen HL, Lee NC (2025): Long-term follow-up of neurocognitive function in patients with citrin deficiency and cholestasis. Clin Exp Pediatr. 2025 Mar;68(3):257-265. doi: 10.3345/cep.2024.01102. PMID: 39608367; PMCID: PMC11884951.

  257. Tamayo JM, Osman HC, Schwartzer JJ, Ashwood P (2023): The influence of asthma on neuroinflammation and neurodevelopment: From epidemiology to basic models. Brain Behav Immun. 2023 Dec 8;116:218-228. doi: 10.1016/j.bbi.2023.12.003. PMID: 38070621. REVIEW

  258. Liu, Dalsgaard, Olsen, Li, Wright, Momen (2019): Parental asthma occurrence, exacerbations and risk of attention-deficit/hyperactivity disorder. Brain Behav Immun. 2019 Aug 30. pii: S0889-1591(19)30738-X. doi: 10.1016/j.bbi.2019.08.198. n = 961.202

  259. Cowell, Bellinger, Wright, Wright (2019): Antenatal active maternal asthma and other atopic disorders is associated with ADHD behaviors among school-aged children. Brain Behav Immun. 2019 Aug;80:871-878. doi: 10.1016/j.bbi.2019.05.040.

  260. Brown AA, Widdowson M, Brandt S, Mohammadzadeh P, Rosenberg JB, Jepsen JRM, Ebdrup BH, Hernández-Lorca M, Bønnelykke K, Chawes B, Stokholm J, Thorsen J, Ibrahimi P, Li X, Sørensen SJ, Rasmussen MA (2025): Associations of the gut microbiome and inflammatory markers with mental health symptoms: a cross-sectional study on Danish adolescents. Sci Rep. 2025 Mar 26;15(1):10378. doi: 10.1038/s41598-025-94687-7. PMID: 40140473; PMCID: PMC11947166.

  261. Kemppainen M, Gissler M, Kirjavainen T (2025): Maternal asthma during pregnancy and the likelihood of neurodevelopmental disorders in offspring. Acta Obstet Gynecol Scand. 2025 Jan;104(1):235-244. doi: 10.1111/aogs.15008. PMID: 39540656; PMCID: PMC11683540.

  262. Bernal J. Action of thyroid hormone in brain. J Endocrinol Invest. 2002 Mar;25(3):268-88. doi: 10.1007/BF03344003. PMID: 11936472. REVIEW

  263. Thompson CC, Potter GB (2000): Thyroid hormone action in neural development. Cereb Cortex. 2000 Oct;10(10):939-45. doi: 10.1093/cercor/10.10.939. PMID: 11007544. REVIEW

  264. König S, Moura Neto V (2002): Thyroid hormone actions on neural cells. Cell Mol Neurobiol. 2002 Dec;22(5-6):517-44. doi: 10.1023/a:1021828218454. PMID: 12585678. REVIEW

  265. Evans IM, Sinha AK, Pickard MR, Edwards PR, Leonard AJ, Ekins RP (1999): Maternal hypothyroxinemia disrupts neurotransmitter metabolic enzymes in developing brain. J Endocrinol. 1999 May;161(2):273-9. doi: 10.1677/joe.0.1610273. PMID: 10320825.

  266. Klein RZ, Sargent JD, Larsen PR, Waisbren SE, Haddow JE, Mitchell ML. Relation of severity of maternal hypothyroidism to cognitive development of offspring. J Med Screen. 2001;8(1):18-20. doi: 10.1136/jms.8.1.18. PMID: 11373843.

  267. Downing S, Halpern L, Carswell J, Brown RS (2012): Severe maternal hypothyroidism corrected prior to the third trimester is associated with normal cognitive outcome in the offspring. Thyroid. 2012 Jun;22(6):625-30. doi: 10.1089/thy.2011.0257. PMID: 22574629.

  268. Idris I, Srinivasan R, Simm A, Page RC (2006): Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome. Clin Endocrinol (Oxf). 2005 Nov;63(5):560-5. doi: 10.1111/j.1365-2265.2005.02382.x. PMID: 16268809.

  269. Siesser WB, Zhao J, Miller LR, Cheng SY, McDonald MP (2006): Transgenic mice expressing a human mutant beta1 thyroid receptor are hyperactive, impulsive, and inattentive. Genes Brain Behav. 2006 Apr;5(3):282-97. doi: 10.1111/j.1601-183X.2005.00161.x. Erratum in: Genes Brain Behav. 2006 Apr;5(3):298. PMID: 16594981.

  270. Modesto, Tiemeier, Peeters, Jaddoe, Hofman, Verhulst, Ghassabian (2015): Maternal Mild Thyroid Hormone Insufficiency in Early Pregnancy and Attention-Deficit/Hyperactivity Disorder Symptoms in Children. JAMA Pediatr. 2015 Sep;169(9):838-45. doi: 10.1001/jamapediatrics.2015.0498. PMID: 26146876.

  271. Hales, Taylor, Channon, McEwan, Thapar, Langley, Muller, Draman, Dayan, Gregory, Okosieme, Lazarus, Rees, Ludgate (2019): Controlled Antenatal Thyroid Screening II: effect of treating maternal sub-optimal thyroid function on child behaviour. J Clin Endocrinol Metab. 2019 Oct 29. pii: dgz098. doi: 10.1210/clinem/dgz098.

  272. Demeneix (2019): Evidence for Prenatal Exposure to Thyroid Disruptors and Adverse Effects on Brain Development. Eur Thyroid J. 2019 Dec;8(6):283-292. doi: 10.1159/000504668. PMID: 31934553; PMCID: PMC6944944.

  273. Levie, Korevaar, Mulder, Bath, Dineva, Lopez-Espinosa, Basterrechea, Santa Marina, Rebagliato, Sunyer, Rayman, Tiemeier, Peeters, Guxens (2019): Maternal Thyroid Function in Early Pregnancy and Child Attention-Deficit Hyperactivity Disorder: An Individual-Participant Meta-Analysis. Thyroid. 2019 Aug 20. doi: 10.1089/thy.2018.0794.

  274. Engel SM, Villanger GD, Herring A, Nethery RC, Drover SSM, Zoeller RT, Meltzer HM, Zeiner P, Knudsen GP, Reichborn-Kjennerud T, Longnecker MP, Aase H (2022): Gestational thyroid hormone concentrations and risk of attention-deficit hyperactivity disorder in the Norwegian Mother, Father and Child Cohort Study. Paediatr Perinat Epidemiol. 2022 Dec 8. doi: 10.1111/ppe.12941. PMID: 36482860.

  275. Umezu, Kita, Morita (2019): Hyperactive behavioral phenotypes and an altered brain monoaminergic state in male offspring mice with perinatal hypothyroidism. Toxicol Rep. 2019 Oct 7;6:1031-1039. doi: 10.1016/j.toxrep.2019.10.005. eCollection 2019.

  276. Andersen SL, Laurberg P, Wu CS, Olsen J (2014): Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study. BJOG. 2014 Oct;121(11):1365-74. doi: 10.1111/1471-0528.12681. PMID: 24605987.

  277. Lin HY, Liang CS, Tsai SJ, Hsu JW, Huang KL, Su TP, Chen TJ, Bai YM, Hsu TW, Chen MH (2024): Congenital hypothyroidism and risk of subsequent autism spectrum disorder and attention-deficit/hyperactivity disorder in Taiwan. Psychiatry Clin Neurosci. 2024 Nov;78(11):721-725. doi: 10.1111/pcn.13733. PMID: 39254145.

  278. Villanger, Ystrom, Engel, Longnecker, Pettersen, Rowe, Reichborn-Kjennerud, Aase (2020): Neonatal thyroid-stimulating hormone and association with attention-deficit/hyperactivity disorder. Paediatr Perinat Epidemiol. 2020 Sep;34(5):590-596. doi: 10.1111/ppe.12643. PMID: 32072662; PMCID: PMC7431377. n = 1.497

  279. Khan JY, Rajakumar RA, Devaskar UP, Weissfeld LA, Devaskar SU (1999): Effect of primary congenital hypothyroidism upon expression of genes mediating murine brain glucose uptake. Pediatr Res. 1999 May;45(5 Pt 1):718-25. doi: 10.1203/00006450-199905010-00019. PMID: 10231871.

  280. Buss, Entringer, Davis, Hobel, Swanson, Wadhwa, Sandman (2012): Impaired Executive Function Mediates the Association between Maternal Pre-Pregnancy Body Mass Index and Child ADHD Symptoms https://doi.org/10.1371/journal.pone.0037758

  281. Sanchez CE, Barry C, Sabhlok A, Russell K, Majors A, Kollins SH, Fuemmeler BF (2018): Maternal pre-pregnancy obesity and child neurodevelopmental outcomes: a meta-analysis. Obes Rev. 2018 Apr;19(4):464-484. doi: 10.1111/obr.12643. PMID: 29164765; PMCID: PMC6059608. Meta-Analysis

  282. Duko B, Mengistu TS, Stacey D, Moran LJ, Tessema G, Pereira G, Bedaso A, Gebremedhin AT, Alati R, Ayonrinde OT, Benyamin B, Lee SH, Hyppönen E (2024): Associations between maternal preconception and pregnancy adiposity and neuropsychiatric and behavioral outcomes in the offspring: A systematic review and meta-analysis. Psychiatry Res. 2024 Dec;342:116149. doi: 10.1016/j.psychres.2024.116149. PMID: 39278191. REVIEW, n = 3.680.937

  283. Nivins S, Kumar P, Chen X, Gissler M, Lavebratt C (2025): Prenatal exposure to maternal hypertension and higher body mass index and risks of neurodevelopmental and psychiatric disorders during childhood. Acta Obstet Gynecol Scand. 2025 Feb;104(2):319-330. doi: 10.1111/aogs.15021. PMID: 39611242; PMCID: PMC11782093.

  284. Eleftheriades A, Koulouraki S, Belegrinos A, Eleftheriades M, Pervanidou P (2025): Maternal Obesity and Neurodevelopment of the Offspring. Nutrients. 2025 Mar 2;17(5):891. doi: 10.3390/nu17050891. PMID: 40077761; PMCID: PMC11901708. REVIEW

  285. Nilsson IAK, Ozsvar J, Gissler M, Lavebratt C (2024): Maternal Eating Disorders, Body Mass Index, and Offspring Psychiatric Diagnoses. JAMA Netw Open. 2024 Oct 1;7(10):e2440517. doi: 10.1001/jamanetworkopen.2024.40517. PMID: 39436646; PMCID: PMC11581519.

  286. Jenabi, Bashirian, Khazaei, Basiri (2019): The maternal pre-pregnancy BMI and the risk of ADHD among children and adolescents: A systematic review and meta-Analysis. Korean J Pediatr. 2019 Jun 14. doi: 10.3345/kjp.2019.00185. REVIEW

  287. Robinson, Ghassabian, Sundaram, Trinh, Lin, Bell, Yeung (2020): Parental Weight Status and Offspring Behavioral Problems and Psychiatric Symptoms. J Pediatr. 2020 May;220:227-236.e1. doi: 10.1016/j.jpeds.2020.01.016. PMID: 32067780; PMCID: PMC7186145.

  288. Naef L, Srivastava L, Gratton A, Hendrickson H, Owens SM, Walker CD (2008): Maternal high fat diet during the perinatal period alters mesocorticolimbic dopamine in the adult rat offspring: reduction in the behavioral responses to repeated amphetamine administration. Psychopharmacology (Berl). 2008 Mar;197(1):83-94. doi: 10.1007/s00213-007-1008-4. PMID: 18004547.

  289. Hughes AM, Sanderson E, Morris T, Ayorech Z, Tesli M, Ask H, Reichborn-Kjennerud T, Andreassen OA, Magnus P, Helgeland Ø, Johansson S, Njølstad P, Davey Smith G, Havdahl A, Howe LD, Davies NM (2022): Body mass index and childhood symptoms of depression, anxiety, and attention-deficit hyperactivity disorder: A within-family Mendelian randomization study. Elife. 2022 Dec 20;11:e74320. doi: 10.7554/eLife.74320. PMID: 36537070; PMCID: PMC9767454. n = 40.949 Familien

  290. Zhang H, Lin J, Zhao H (2024): Impacts of Maternal Preeclampsia Exposure on Offspring Neuronal Development: Recent Insights and Interventional Approaches. Int J Mol Sci. 2024 Oct 15;25(20):11062. doi: 10.3390/ijms252011062. PMID: 39456854; PMCID: PMC11508320. REVIEW

  291. Böhm S, Curran EA, Kenny LC, O’Keeffe GW, Murray D, Khashan AS (2019): The Effect of Hypertensive Disorders of Pregnancy on the Risk of ADHD in the Offspring. J Atten Disord. 2019 May;23(7):692-701. doi: 10.1177/1087054717690230. PMID: 28162026.

  292. Dachew BA, Scott JG, Mamun A, Alati R (2019): Pre-eclampsia and the risk of attention-deficit/hyperactivity disorder in offspring: Findings from the ALSPAC birth cohort study. Psychiatry Res. 2019 Feb;272:392-397. doi: 10.1016/j.psychres.2018.12.123. PMID: 30605798.

  293. Getahun, Rhoads, Demissie, Lu, Quinn, Fassett, Wing. Jacobsen (2013): In utero exposure to ischemic-hypoxic conditions and attention-deficit/hyperactivity disorder. Pediatrics 131 1 (2013): e53-61.

  294. Maher, Dalman, O’Keeffe, Kearney, McCarthy, Kenny, Khashan (2020): Association between preeclampsia and attention-deficit hyperactivity disorder: a population-based and sibling-matched cohort study. Acta Psychiatr Scand. 2020 Feb 13. doi: 10.1111/acps.13162. PMID: 32056200. n = 2.047.619

  295. Zhen Lim TX, Pickering TA, Lee RH, Hauptman I, Wilson ML (2023): Hypertensive disorders of pregnancy and occurrence of ADHD, ASD, and epilepsy in the child: A meta-analysis. Pregnancy Hypertens. 2023 Sep;33:22-29. doi: 10.1016/j.preghy.2023.06.002. PMID: 37356382. METASTUDY

  296. Mann JR, McDermott S (2011): Are maternal genitourinary infection and pre-eclampsia associated with ADHD in school-aged children? J Atten Disord. 2011 Nov;15(8):667-73. doi: 10.1177/1087054710370566. PMID: 20837984. n = 84.721

  297. Wang H, László KD, Gissler M, Li F, Zhang J, Yu Y, Li J (2021): Maternal hypertensive disorders and neurodevelopmental disorders in offspring: a population-based cohort in two Nordic countries. Eur J Epidemiol. 2021 May;36(5):519-530. doi: 10.1007/s10654-021-00756-2. PMID: 33948753; PMCID: PMC8159819.

  298. Qian L, Xin T, Xu W, Zhu J (2025): Effect of maternal gestational diabetes mellitus on neurodevelopment in late preterm infants at the corrected age of 12 months. Sci Rep. 2025 Apr 23;15(1):14139. doi: 10.1038/s41598-025-98987-w. PMID: 40269066; PMCID: PMC12019377. n = 205

  299. Gumusoglu, Chilukuri, Santillan, Santillan, Stevens (2020): Neurodevelopmental Outcomes of Prenatal Preeclampsia Exposure. Trends Neurosci. 2020 Apr;43(4):253-268. doi: 10.1016/j.tins.2020.02.003. PMID: 32209456; PMCID: PMC7170230. REVIEW

  300. Zhao J, Xia L.(2022): Association between hypertensive disorders of pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring: a systematic review and meta-analysis. Hypertens Pregnancy. 2022 May 28:1-10. doi: 10.1080/10641955.2022.2079674. PMID: 35634947. REVIEW

  301. Ramos, de Mattos Hungria, Camerini, Suiama, Calzavara (2020): Potential beneficial effects of caffeine administration in the neonatal period of an animal model of schizophrenia. Behav Brain Res. 2020 Aug 5;391:112674. doi: 10.1016/j.bbr.2020.112674. PMID: 32417274.

  302. Triche, Grosso, Belanger, Darefsky, Benowitz, Bracken (2008): Chocolate consumption in pregnancy and reduced likelihood of preeclampsia. Epidemiology. 2008 May;19(3):459-64. doi: 10.1097/EDE.0b013e31816a1d17. PMID: 18379424; PMCID: PMC2782959.

  303. Assaf M, Rouphael M, Bou Sader Nehme S, Soufia M, Alameddine A, Hallit S, Landry M, Bitar T, Hleihel W (2024): Correlational Insights into Attention-Deficit/Hyperactivity Disorder in Lebanon. Int J Environ Res Public Health. 2024 Aug 5;21(8):1027. doi: 10.3390/ijerph21081027. PMID: 39200638; PMCID: PMC11353674.

  304. Li J, Olsen J, Vestergaard M, Obel C (2010): Attention-deficit/hyperactivity disorder in the offspring following prenatal maternal bereavement: a nationwide follow-up study in Denmark. Eur Child Adolesc Psychiatry. 2010 Oct;19(10):747-53. doi: 10.1007/s00787-010-0113-9. PMID: 20495989.

  305. Kacharava, Nemsadze, Inasaridze (2022): PRESENCE OF PRENATAL MATERNAL STRESS INCREASES THE RISK OF THE DEVELOPMENT OF ADHD SYMPTOMS IN YOUNG CHILDREN. Georgian Med News. 2022 Mar;(324):92-101. PMID: 35417868.

  306. Jallow J, Hurtig T, Kerkelä M, Miettunen J, Halt AH (2024): Prenatal maternal stress, breastfeeding and offspring ADHD symptoms. Eur Child Adolesc Psychiatry. 2024 Nov;33(11):4003-4011. doi: 10.1007/s00787-024-02451-5. PMID: 38691181; PMCID: PMC11588867. n = 7.910

  307. Manzari, Matvienko-Sikar, Baldoni, O’Keeffe, Khashan (2019): Prenatal maternal stress and risk of neurodevelopmental disorders in the offspring: a systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol. 2019 Jul 20. doi: 10.1007/s00127-019-01745-3. REVIEW

  308. Class QA, Abel KM, Khashan AS, Rickert ME, Dalman C, Larsson H, Hultman CM, Långström N, Lichtenstein P, D’Onofrio BM (2014): Offspring psychopathology following preconception, prenatal and postnatal maternal bereavement stress. Psychol Med. 2014 Jan;44(1):71-84. doi: 10.1017/S0033291713000780. PMID: 23591021; PMCID: PMC3766407.

  309. Wurmser, Rieger, Domogalla, Kahnt, Buchwald, Kowatsch, Kuehnert, Buske-Kirschbaum, Papousek, Pirke, von Voss (2006): Assiciation between life stress durcing prengnancy and infant crying in the first six months postpartum: A prospective longitudinal study. Early Human Development 82, 341-349

  310. Talge, Neal, Glover (2007): Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? J Child Psychol Psychiatry. 2007 Mar-Apr;48(3-4):245-61.

  311. von Lüpke: Die ADHS-Problematik hat eine lange Geschichte, Seite 4

  312. Bolea-Alamañac, Davies, Evans, Joinson, Pearson, Skapinakis, Emond (2019): Does maternal somatic anxiety in pregnancy predispose children to hyperactivity? Eur Child Adolesc Psychiatry. 2019 Mar 13. doi: 10.1007/s00787-019-01289-6.

  313. Lautarescu, Craig, Glover (2020): Prenatal stress: Effects on fetal and child brain development. Int Rev Neurobiol. 2020;150:17-40. doi: 10.1016/bs.irn.2019.11.002. PMID: 32204831. REVIEW

  314. Kacharava T, Nemsadze K, Inasaridze K (2024): Elevated level of prenatal testosterone and vitamin D3 deficiency during pregnancy, in the presence of prenatal maternal stress, and their association with the development of attention deficit hyperactivity disorder (ADHD)-like symptoms in toddlers. Pediatr Endocrinol Diabetes Metab. 2024;30(2):69-73. doi: 10.5114/pedm.2024.136278. PMID: 39026483; PMCID: PMC11249814.

  315. Rosenqvist, Sjölander, Ystrom, Larsson, Reichborn-Kjennerud (2018): Adverse family life events during pregnancy and ADHD symptoms in five-year-old offspring. J Child Psychol Psychiatry. 2018 Oct 27. doi: 10.1111/jcpp.12990. n = 34.751

  316. Agapaki, Papagianni, Metallinou, Valavani, Mantzou, Kanelli, Eleftheriades, Spyropoulou, Zervas, Chrousos, Pervanidou (2022): Associations between Maternal and Offspring Hair Cortisol Concentrations and Child Behavioral Symptoms in Mother-Child Pairs with Perinatal Mental Disorders. Children (Basel). 2022 May 31;9(6):810. doi: 10.3390/children9060810. PMID: 35740747; PMCID: PMC9221619.

  317. Barzilay, Lawrence, Berliner, Gur, Leventer-Roberts, Weizman, Feldman (2019): Association between prenatal exposure to a 1-month period of repeated rocket attacks and neuropsychiatric outcomes up through age 9: a retrospective cohort study. Eur Child Adolesc Psychiatry. 2019 Nov 4. doi: 10.1007/s00787-019-01426-1. n = 14.053

  318. Grizenko, Shayan, Polotskaia, Ter-Stepanian, Joober (2008): Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD; J Psychiatry Neurosci. 2008 Jan; 33(1): 10–16. PMCID: PMC2186370

  319. Glover (2015): Prenatal stress and its effects on the fetus and the child: possible underlying biological mechanisms. Adv Neurobiol. 2015;10:269-83. doi: 10.1007/978-1-4939-1372-5_13.

  320. Van den Bergh, B. R.H. and Marcoen, A. (2004), High Antenatal Maternal Anxiety Is Related to ADHD Symptoms, Externalizing Problems, and Anxiety in 8- and 9-Year-Olds. Child Development, 75: 1085–1097. doi:10.1111/j.1467-8624.2004.00727.x

  321. Andreasen JJ, Tobiasen BB, Jensen RC, Boye H, Jensen TK, Bilenberg N, Andersen MS, Glintborg D (2023): Maternal cortisol in 3rd trimester is associated with traits of neurodevelopmental disorder in offspring. Odense Child Cohort. Psychoneuroendocrinology. 2023 Aug;154:106293. doi: 10.1016/j.psyneuen.2023.106293. PMID: 37207405. n = 717 Mutter-Kind-Paare

  322. O’Donnell, Glover, Lahti, Lahti, Edgar, Räikkönen, O’Connor (2017): Maternal prenatal anxiety and child COMT genotype predict working memory and symptoms of ADHD. PLoS One. 2017 Jun 14;12(6):e0177506. doi: 10.1371/journal.pone.0177506. eCollection 2017.

  323. Choudhry, Sengupta, Grizenko, Fortier, Thakur, Bellingham, Joober (2012): LPHN3 and attention-deficit/hyperactivity disorder: interaction with maternal stress during pregnancy. J Child Psychol Psychiatry. 2012 Aug;53(8):892-902. doi: 10.1111/j.1469-7610.2012.02551.x. PMID: 22486528.

  324. Grizenko N, Paci M, Joober R (2010): Is the inattentive subtype of ADHD different from the combined/hyperactive subtype? J Atten Disord. 2010 May;13(6):649-57. doi: 10.1177/1087054709347200. PMID: 19767592.

  325. Grizenko N, Shayan YR, Polotskaia A, Ter-Stepanian M, Joober R (2008): Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD. J Psychiatry Neurosci. 2008 Jan;33(1):10-6. PMID: 18197267; PMCID: PMC2186370.

  326. Bronson, Bale (2014): Prenatal stress-induced increases in placental inflammation and offspring hyperactivity are male-specific and ameliorated by maternal antiinflammatory treatment. Endocrinology. 2014 Jul;155(7):2635-46. doi: 10.1210/en.2014-1040.

  327. Shaw, Crombie, Zakar, Palliser, Hirst (2019): Perinatal compromise contributes to programming of GABAergic and glutamatergic systems leading to long-term effects on offspring behaviour. J Neuroendocrinol. 2019 Nov 23:e12814. doi: 10.1111/jne.12814.

  328. Provençal, Arloth, Cattaneo, Anacker, Cattane, Wiechmann, Röh, Ködel, Klengel, Czamara, Müller, Lahti; PREDO team, Räikkönen, Pariante, Binder (2019): Glucocorticoid exposure during hippocampal neurogenesis primes future stress response by inducing changes in DNA methylation. Proc Natl Acad Sci U S A. 2019 Aug 9. pii: 201820842. doi: 10.1073/pnas.1820842116.

  329. Finik, Buthmann, Zhang, Go, Nomura (2020): Placental Gene Expression and Offspring Temperament Trajectories: Predicting Negative Affect in Early Childhood. J Abnorm Child Psychol. 2020 Jun;48(6):783-795. doi: 10.1007/s10802-020-00632-9. PMID: 32185610; PMCID: PMC7242121.

  330. Stonawski, Frey, Golub, Moll, Heinrich, Eichler (2018): [Epigenetic modifications in children associated with maternal emotional stress during pregnancy]. [Article in German] Z Kinder Jugendpsychiatr Psychother. 2018 Mar;46(2):155-167. doi: 10.1024/1422-4917/a000515.

  331. Suarez, Lahti, Lahti-Pulkkinen, Girchenko, Czamara, Arloth, Malmberg, Hämäläinen, Kajantie, Laivuori, Villa, Reynolds, Provençal, Binder, Räikkönen (2020): A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders. Neurobiol Stress. 2020 Nov 21;13:100275. doi: 10.1016/j.ynstr.2020.100275. PMID: 33344728; PMCID: PMC7739178. n = 814 Kinder / childs von / of n = 408 Müttern / mothers

  332. Hanć, Gomula, Nowak-Szczepanska, Chakraborty, Kozieł (2022): Prenatal and early postnatal exposure to a natural disaster and Attention-Deficit/Hyperactivity Disorder symptoms in Indian children. Sci Rep. 2022 Sep 28;12(1):16235. doi: 10.1038/s41598-022-20609-6. PMID: 36171270.

  333. Dy, Guan, Sampath-Kumar, Richardson, Yang (2008): Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth Restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery. Placenta. 2008 Feb;29(2):193-200. doi: 10.1016/j.placenta.2007.10.010. PMID: 18061258.

  334. Zhu, Wang, Zuo, Sun (2019): Mechanisms for establishment of the placental glucocorticoid barrier, a guard for life. Cell Mol Life Sci. 2019 Jan;76(1):13-26. doi: 10.1007/s00018-018-2918-5. PMID: 30225585. REVIEW

  335. Doi, Usui, Shimada (2022): Prenatal Environment and Neurodevelopmental Disorders. Front Endocrinol (Lausanne). 2022 Mar 15;13:860110. doi: 10.3389/fendo.2022.860110. PMID: 35370942; PMCID: PMC8964779., REVIEW

  336. Babenko, Kovalchuk, Metz (2015): Stress-induced perinatal and transgenerational epigenetic programming of brain development and mental health. Neurosci Biobehav Rev. 2015 Jan;48:70-91. doi: 10.1016/j.neubiorev.2014.11.013. PMID: 25464029. REVIEW

  337. Doi, Oka, Taniguchi, Sato (2021): Transient expansion of the expression region of Hsd11b1, encoding 11β-hydroxysteroid dehydrogenase type 1, in the developing mouse neocortex. J Neurochem. 2021 Nov;159(4):778-788. doi: 10.1111/jnc.15505. PMID: 34490902.

  338. Mittal VA, Ellman LM, Cannon TD (2008): Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications. Schizophr Bull. 2008 Nov;34(6):1083-94. doi: 10.1093/schbul/sbn080. PMID: 18635675; PMCID: PMC2632505. REVIEW

  339. Gustavson, Ask, Ystrom, Stoltenberg, Lipkin, Surén, Håberg, Magnus, Knudsen, Eilertsen, Bresnahan, Aase, Mjaaland, Susser, Hornig, Reichborn-Kjennerud (2019): Maternal fever during pregnancy and offspring attention deficit hyperactivity disorder. Sci Rep. 2019 Jul 2;9(1):9519. doi: 10.1038/s41598-019-45920-7.

  340. Borgert M, Melin A, Hollander AC, Rahman S (2024): Prenatal maternal PTSD as a risk factor for offspring ADHD: A register-based Swedish cohort study of 553 766 children and their mothers. Eur Psychiatry. 2024 Mar 1:1-19. doi: 10.1192/j.eurpsy.2024.21. PMID: 38425211.

  341. Heilbrun LP, Palmer RF, Jaen CR, Svoboda MD, Perkins J, Miller CS (2015): Maternal Chemical and Drug Intolerances: Potential Risk Factors for Autism and Attention Deficit Hyperactivity Disorder (ADHD). J Am Board Fam Med. 2015 Jul-Aug;28(4):461-70. doi: 10.3122/jabfm.2015.04.140192. PMID: 26152436. n = 694

  342. Palmer RF, Kattari D, Rincon R, Miller CS (2024): Assessing Chemical Intolerance in Parents Predicts the Risk of Autism and ADHD in Their Children. J Xenobiot. 2024 Mar 5;14(1):350-367. doi: 10.3390/jox14010022. PMID: 38535497; PMCID: PMC10970846. n = 6.746

  343. Şair, Sevinçok, Kutlu, Çakaloz, Sevinçok (2019): The affective temperament traits and pregnancy-related depression in mothers may constitute risk factors for their children with attention deficit and hyperactivity disorder. J Obstet Gynaecol. 2019 Dec 8:1-6. doi: 10.1080/01443615.2019.1679741.

  344. Lin YH, Tsai SJ, Bai YM, Chen TJ, Chen MH (2024): Risk of Neurodevelopmental Disorders in Offspring of Parents with Major Depressive Disorder: A Birth Cohort Study. J Autism Dev Disord. 2024 Aug 1. doi: 10.1007/s10803-024-06502-3. PMID: 39088144.

  345. Tusa BS, Alati R, Ayano G, Betts K, Weldesenbet AB, Dachew B (2024): The risk of attention deficit hyperactivity disorder symptoms in offspring of mothers with perinatal depression: A systematic review and meta-analysis. Asian J Psychiatr. 2024 Dec;102:104261. doi: 10.1016/j.ajp.2024.104261. PMID: 39405772. METASTUDY

  346. Hope H, Pierce M, Gabr H, Radojčić MR, Swift E, Taxiarchi VP, Abel KM (2024): The causal association between maternal depression, anxiety, and infection in pregnancy and neurodevelopmental disorders among 410 461 children: a population study using quasi-negative control cohorts and sibling analysis. Psychol Med. 2024 Jan 11:1-9. doi: 10.1017/S0033291723003604. PMID: 38205522. n = 410.461

  347. Maleki, Bashirian, Soltanian, Jenabi, Farhadinasab (2021): Association between polycystic ovary syndrome and risk of attention-deficit/hyperactivity disorder in offspring: a meta-analysis. Clin Exp Pediatr. 2021 Apr 15. doi: 10.3345/cep.2021.00178. PMID: 33872487. METASTUDIE

  348. Kahn LG, Hipwell AE, Charifson M, Ling R, Cajachagua-Torres KN, Ghassabian A (2025): Maternal polycystic ovarian syndrome and offspring psychopathology and neurodevelopment. Hum Reprod. 2025 Jul 1;40(7):1257-1265. doi: 10.1093/humrep/deaf079. PMID: 40380372; PMCID: PMC12222619. REVIEW

  349. Kasum, Oresković (2010): Treatment of ovarian hyperstimulation syndrome: new insights. Acta Clin Croat. 2010 Dec;49(4):421-7. PMID: 21830453. REVIEW

  350. Bracero, Zacur (2001): Polycystic ovary syndrome and hyperprolactinemia. Obstet Gynecol Clin North Am. 2001 Mar;28(1):77-84. doi: 10.1016/s0889-8545(05)70186-8. PMID: 11293005. REVIEW

  351. Dalgaard, Andersen, Jensen, Larsen, Find, Boye, Jensen, Bilenberg, Glintborg (2021): Maternal polycystic ovary syndrome and attention deficit hyperactivity disorder in offspring at 3 years of age: Odense Child Cohort. Acta Obstet Gynecol Scand. 2021 Sep 6. doi: 10.1111/aogs.14259. PMID: 34490610. n = 1.776 Mütter

  352. Zhang Y, Lu D, Guo VY, Wang Y, Qiu S, Zhang J, Zhang Y, Chen W, Wang B, Yang W (2023): Association between maternal polycystic ovary syndrome and attention-deficit/hyperactivity disorder in offspring aged 3-6 years: A Chinese population-based study. Front Public Health. 2023 Jan 9;10:1032315. doi: 10.3389/fpubh.2022.1032315. PMID: 36699874; PMCID: PMC9868860.

  353. Hergüner S, Harmancı H, Toy H. Attention deficit-hyperactivity disorder symptoms in women with polycystic ovary syndrome. Int J Psychiatry Med. 2015;50(3):317-25. doi: 10.1177/0091217415610311. PMID: 26449924. n = 80

  354. Brynge, Gardner, Sjöqvist, Karlsson, Dalman (2022): Maternal levels of acute phase proteins in early pregnancy and risk of autism spectrum disorders in offspring. Transl Psychiatry. 2022 Apr 7;12(1):148. doi: 10.1038/s41398-022-01907-z. PMID: 35393396.

  355. Galera, Heude, Forhan, Bernard, Peyre, Van der Waerden, Pryor, Bouvard, Melchior, Lioret, de Lauzon-Guillain (2018): EDEN Mother-Child Cohort Study Group. Prenatal diet and children’s trajectories of hyperactivity-inattention and conduct problems from 3 to 8 years: the EDEN mother-child cohort. J Child Psychol Psychiatry. 2018 Sep;59(9):1003-1011. doi: 10.1111/jcpp.12898. PMID: 29573342. n = 1.242 Mutter-Kind-Paare / mother-child pairs

  356. Lin PC, Liang CS, Tsai CK, Tsai SJ, Chen TJ, Bai YM, Chen MH (2022): Associations of a family history of lupus with the risks of lupus and major psychiatric disorders in first-degree relatives. QJM. 2022 Jun 27:hcac153. doi: 10.1093/qjmed/hcac153. PMID: 35758635.

  357. Libutzki B, Neukirch B, Reif A, Hartman CA (2024): Somatic burden of attention-deficit/hyperactivity disorder across the lifecourse. Acta Psychiatr Scand. 2024 Aug;150(2):105-117. doi: 10.1111/acps.13694. PMID: 38804256.

  358. Buckley D, Khashan AS, McCarthy FP, O’Connor K, Maher GM (2025): The Association between Threatened Miscarriage and Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder in Offspring by Age 14 Years. J Autism Dev Disord. 2025 Mar;55(3):1057-1066. doi: 10.1007/s10803-024-06251-3. PMID: 38281274; PMCID: PMC11828788.

  359. Dudukina E, Horváth-Puhó E, Sørensen HT, Ehrenstein V (2021): Long-term risk of epilepsy, cerebral palsy and attention-deficit/hyperactivity disorder in children affected by a threatened abortion in utero. Int J Epidemiol. 2021 Nov 10;50(5):1540-1553. doi: 10.1093/ije/dyab069. Erratum in: Int J Epidemiol. 2022 Jun 13;51(3):1034. doi: 10.1093/ije/dyac077. PMID: 33846731.

  360. Zeng, Tang, Yue, Li, Qiu, Hu, Tang, Wang, Yang, Qu, Mu (2019): Cumulative evidence for association of parental diabetes mellitus and attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev. 2019 Nov 7. pii: S0149-7634(19)30721-3. doi: 10.1016/j.neubiorev.2019.11.003.

  361. Pretorius RA, Avraam D, Guxens M, Julvez J, Harris JR, Nader JT, Cadman T, Elhakeem A, Strandberg-Larsen K, Marroun HE, Defina S, Yang TC, McEachan R, Wright J, Ibarluzea J, Santa-Marina L, Delgado JM, Rebagliato M, Charles MA, Vainqueur C, Maritano S, Zugna D, Yuan WL, Heude B, Huang RC (2025): Is maternal diabetes during pregnancy associated with neurodevelopmental, cognitive and behavioural outcomes in children? Insights from individual participant data meta-analysis in ten birth cohorts. BMC Pediatr. 2025 Jan 30;25(1):76. doi: 10.1186/s12887-024-05365-y. PMID: 39885386; PMCID: PMC11783732. METASTUDY, k = 10

  362. Damtie Y, Dachew BA, Ayano G, Tadesse AW, Betts K, Alati R (2025): The association between maternal diabetes and the risk of attention deficit hyperactivity disorder in offspring: an updated systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2025 Jan 28. doi: 10.1007/s00787-025-02645-5. PMID: 39873760. METASTUDY, k = 17, n = 18.063.336

  363. Ornoy, Becker, Weinstein-Fudim, Ergaz (2021): Diabetes during Pregnancy: A Maternal Disease Complicating the Course of Pregnancy with Long-Term Deleterious Effects on the Offspring. A Clinical Review. Int J Mol Sci. 2021 Mar 15;22(6):2965. doi: 10.3390/ijms22062965. PMID: 33803995. REVIEW

  364. Rodolaki K, Pergialiotis V, Iakovidou N, Boutsikou T, Iliodromiti Z, Kanaka-Gantenbein C (2023): The impact of maternal diabetes on the future health and neurodevelopment of the offspring: a review of the evidence. Front Endocrinol (Lausanne). 2023 Jul 3;14:1125628. doi: 10.3389/fendo.2023.1125628. PMID: 37469977; PMCID: PMC10352101. REVIEW

  365. Chen S, Persson M, Wang R, Dalman C, Lee BK, Karlsson H, Gardner RM (2023): Random capillary glucose levels throughout pregnancy, obstetric and neonatal outcomes, and long-term neurodevelopmental conditions in children: a group-based trajectory analysis. BMC Med. 2023 Jul 19;21(1):260. doi: 10.1186/s12916-023-02926-3. PMID: 37468907; PMCID: PMC10354916.

  366. Lin, Lin, Chou, Lee, Hong (2019): Infants of Mothers With Diabetes and Subsequent Attention Deficit Hyperactivity Disorder: A Retrospective Cohort Study. Front Pediatr. 2019 Nov 4;7:452. doi: 10.3389/fped.2019.00452. eCollection 2019.

  367. Kong, Nilsson, Brismar, Gissler, Lavebratt (2020): Associations of Different Types of Maternal Diabetes and Body Mass Index With Offspring Psychiatric Disorders. JAMA Netw Open. 2020 Feb 5;3(2):e1920787. doi: 10.1001/jamanetworkopen.2019.20787. PMID: 32031649. n = 649.043

  368. Li DJ, Tsai SJ, Chen TJ, Liang CS, Chen MH (2024): Risk of major mental disorders in the offspring of parents with migraine. Ann Gen Psychiatry. 2024 Jun 22;23(1):23. doi: 10.1186/s12991-024-00508-y. PMID: 38909222; PMCID: PMC11193281.

  369. Wiegersma, Dalman, Lee, Karlsson, Gardner (2019): Association of Prenatal Maternal Anemia With Neurodevelopmental Disorders. JAMA Psychiatry. 2019 Sep 18:1-12. doi: 10.1001/jamapsychiatry.2019.2309.

  370. Ayubi E, Mansori K (2023): Maternal Infection during Pregnancy and Attention-Deficit Hyperactivity Disorder in Children: A Systematic Review and Meta-Analysis. Iran J Public Health. 2022 Dec;51(12):2674-2687. doi: 10.18502/ijph.v51i12.11458. PMID: 36742242; PMCID: PMC9874197.

  371. Lin MC, Pan YJ, Wu CS, Liu CL, Chen PC, Thompson WK, Fan CC, Wang SH (2025): Prenatal and early childhood infections requiring hospitalization and risk of neurodevelopmental disorders in offspring: a population-based birth cohort study in Taiwan. Mol Psychiatry. 2025 May;30(5):1791-1800. doi: 10.1038/s41380-024-02787-z. PMID: 39390224.

  372. Borbye-Lorenzen N, Holmgaard S, Ottosson F, Nudel R, Appadurai V, Laursen TM, Bækvad-Hansen M, Bybjerg-Grauholm J, Nordentoft M, Børglum AD, Mortensen PB, Werge T, Benros ME, Hougaard DM, Skogstrand K (2025): High level of immunoglobulin G targeting mycoplasma or cytomegalovirus in the newborn increases risk of ADHD. Brain Behav Immun. 2025 Jan;123:99-107. doi: 10.1016/j.bbi.2024.09.009. PMID: 39260764.

  373. Yates EF, Mulkey SB (2024): Viral infections in pregnancy and impact on offspring neurodevelopment: mechanisms and lessons learned. Pediatr Res. 2024 Mar 20. doi: 10.1038/s41390-024-03145-z. PMID: 38509227. REVIEW

  374. Verlaet, Noriega, Hermans, Savelkoul (2014): Nutrition, immunological mechanisms and dietary immunomodulation in ADHD. Eur Child Adolesc Psychiatry. 2014 Jul;23(7):519-29. doi: 10.1007/s00787-014-0522-2. PMID: 24493267. REVIEW

  375. Hutton J (2023): Developmental Outcomes in Children Born to Women with Possible Subclinical Rubella Exposures During Pregnancy. J Med Virol. 2023 Jan 21. doi: 10.1002/jmv.28517. PMID: 36680415.

  376. Simanek AM, Meier HC (2015): Association Between Prenatal Exposure to Maternal Infection and Offspring Mood Disorders: A Review of the Literature. Curr Probl Pediatr Adolesc Health Care. 2015 Nov;45(11):325-64. doi: 10.1016/j.cppeds.2015.06.008. PMID: 26476880. REVIEW

  377. Flinkkilä E, Keski-Rahkonen A, Marttunen M, Raevuori A (2016): Prenatal Inflammation, Infections and Mental Disorders. Psychopathology. 2016;49(5):317-333. doi: 10.1159/000448054. PMID: 27529630. REVIEW

  378. Silva D, Colvin L, Hagemann E, Bower C (2014): Environmental risk factors by gender associated with attention-deficit/hyperactivity disorder. Pediatrics. 2014 Jan;133(1):e14-22. doi: 10.1542/peds.2013-1434. PMID: 24298003.

  379. Gibson B, Goodfriend E, Zhong Y, Melhem NM (2023): Fetal inflammatory response and risk for psychiatric disorders. Transl Psychiatry. 2023 Jun 24;13(1):224. doi: 10.1038/s41398-023-02505-3. PMID: 37355708; PMCID: PMC10290670.

  380. Dachew BA, Scott JG, Betts K, Mamun A, Alati R (2020): Hypertensive disorders of pregnancy and the risk of offspring depression in childhood: Findings from the Avon Longitudinal Study of Parents and Children. Dev Psychopathol. 2020 Aug;32(3):845-851. doi: 10.1017/S0954579419000944. PMID: 31345273.

  381. Nijsten, Jansen, Limpens, Finken, Koot, Grooten, Roseboom, Painter (2022): Long-term health outcomes of children born to mothers with hyperemesis gravidarum: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022 Mar 30:S0002-9378(22)00249-6. doi: 10.1016/j.ajog.2022.03.052. PMID: 35367190.

  382. Eyles, Burne, McGrath (2013): Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol. 2013 Jan;34(1):47-64. doi: 10.1016/j.yfrne.2012.07.001. PMID: 22796576. REVIEW

  383. Kesby, Eyles, Burne, McGrath (2011): The effects of vitamin D on brain development and adult brain function. Mol Cell Endocrinol. 2011 Dec 5;347(1-2):121-7. doi: 10.1016/j.mce.2011.05.014. PMID: 21664231. REVIEW

  384. Eyles, Feron, Cui, Kesby, Harms, Ko, McGrath, Burne (2009): Developmental vitamin D deficiency causes abnormal brain development, Psychoneuroendocrinology, Volume 34, Supplement 1, 2009, Pages S247-S257, ISSN 0306-4530, https://doi.org/10.1016/j.psyneuen.2009.04.015.

  385. Almeras, Eyles, Benech, Laffite, Villard, Patatian, Boucraut, Mackay‐Sim, McGrath, Féron (2007): Developmental vitamin D deficiency alters brain protein expression in the adult rat: Implications for neuropsychiatric disorders. Proteomics, 7: 769-780. https://doi.org/10.1002/pmic.200600392

  386. Chien MC, Huang CY, Wang JH, Shih CL, Wu P (2024): Effects of vitamin D in pregnancy on maternal and offspring health-related outcomes: An umbrella review of systematic review and meta-analyses. Nutr Diabetes. 2024 May 30;14(1):35. doi: 10.1038/s41387-024-00296-0. PMID: 38816412; PMCID: PMC11139885.

  387. Upadhyaya S, Ståhlberg T, Silwal S, Arrhenius B, Sourander A (2022): Maternal Vitamin D Levels during Pregnancy and Offspring Psychiatric Outcomes: A Systematic Review. Int J Mol Sci. 2022 Dec 21;24(1):63. doi: 10.3390/ijms24010063. PMID: 36613505; PMCID: PMC9820292.

  388. Kesby JP, Cui X, Ko P, McGrath JJ, Burne TH, Eyles DW (2009): Developmental vitamin D deficiency alters dopamine turnover in neonatal rat forebrain. Neurosci Lett. 2009 Sep 18;461(2):155-8. doi: 10.1016/j.neulet.2009.05.070. PMID: 19500655.

  389. Pertile RA, Cui X, Eyles DW (2016): Vitamin D signaling and the differentiation of developing dopamine systems. Neuroscience. 2016 Oct 1;333:193-203. doi: 10.1016/j.neuroscience.2016.07.020. PMID: 27450565.

  390. Sucksdorff, Brown, Chudal, Surcel, Hinkka-Yli-Salomäki, Cheslack-Postava, Gyllenberg, Sourander (2019): Maternal Vitamin D Levels and the Risk of Offspring Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2019 Dec 18. pii: S0890-8567(19)32232-4. doi: 10.1016/j.jaac.2019.11.021. n = 2.124

  391. Morales E, Julvez J, Torrent M, Ballester F, Rodríguez-Bernal CL, Andiarena A, Vegas O, Castilla AM, Rodriguez-Dehli C, Tardón A, Sunyer J (2015): Vitamin D in Pregnancy and Attention Deficit Hyperactivity Disorder-like Symptoms in Childhood. Epidemiology. 2015 Jul;26(4):458-65. doi: 10.1097/EDE.0000000000000292. PMID: 25867115.

  392. Aagaard K, Møllegaard Jepsen JR, Sevelsted A, Horner D, Vinding R, Rosenberg JB, Brustad N, Eliasen A, Mohammadzadeh P, Følsgaard N, Hernández-Lorca M, Fagerlund B, Glenthøj BY, Rasmussen MA, Bilenberg N, Stokholm J, Bønnelykke K, Ebdrup BH, Chawes B (2023): High-dose vitamin D3 supplementation in pregnancy and risk of neurodevelopmental disorders in the children at age 10: A randomized clinical trial. Am J Clin Nutr. 2023 Dec 9:S0002-9165(23)66298-7. doi: 10.1016/j.ajcnut.2023.12.002. PMID: 38072183. N = 496

  393. Sucksdorff M, Brown AS, Chudal R, Surcel HM, Hinkka-Yli-Salomäki S, Cheslack-Postava K, Gyllenberg D, Sourander A (2021): Maternal Vitamin D Levels and the Risk of Offspring Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2021 Jan;60(1):142-151.e2. doi: 10.1016/j.jaac.2019.11.021. PMID: 31863882; PMCID: PMC8330061.

  394. Thinggaard CM, Dalgård C, Möller S, Christesen HBT, Bilenberg N (2024): Vitamin D status in pregnancy and cord blood is associated with symptoms of attention-deficit hyperactivity disorder at age 5 years: Results from Odense Child Cohort. Aust N Z J Psychiatry. 2024 Aug 16:48674241272018. doi: 10.1177/00048674241272018. PMID: 39152569.

  395. Ye X, Zhou Q, Ren P, Xiang W, Xiao L. The Synaptic and Circuit Functions of Vitamin D in Neurodevelopment Disorders. Neuropsychiatr Dis Treat. 2023 Jul 3;19:1515-1530. doi: 10.2147/NDT.S407731. PMID: 37424961; PMCID: PMC10327924. REVIEW

  396. Strøm, Halldorsson, Hansen, Granström, Maslova, Petersen, Cohen, Olsen (2014): Vitamin D measured in maternal serum and offspring neurodevelopmental outcomes: a prospective study with long-term follow-up. Ann Nutr Metab. 2014;64(3-4):254-61. doi: 10.1159/000365030. n = 850

  397. López-Vicente, Sunyer, Lertxundi, González, Rodríguez-Dehli, Espada Sáenz-Torre, Vrijheid, Tardón, Llop, Torrent, Ibarluzea, Guxens (2019): Maternal circulating Vitamin D3 levels during pregnancy and behaviour across childhood. Sci Rep. 2019 Oct 15;9(1):14792. doi: 10.1038/s41598-019-51325-3.

  398. Wootton RE, Dack K, Jones HJ, Riglin L, Madley-Dowd P, Borges C, Pagoni P, Roth C, Brantsæter AL, Corfield EC, Stoltenberg C, Øyen AS, Davey Smith G, Ask H, Thapar A, Stergiakouli E, Havdahl A (2024): Testing maternal effects of vitamin-D and omega-3 levels on offspring neurodevelopmental traits in the Norwegian Mother, Father and Child Cohort Study. Psychol Med. 2024 Sep 9;54(12):1-11. doi: 10.1017/S0033291724001466. PMID: 39248077; PMCID: PMC11496238.

  399. Martins, Bandarra, Figueiredo-Braga (2019): The role of marine omega-3 in human neurodevelopment, including Autism Spectrum Disorders and Attention-Deficit/Hyperactivity Disorder – a review. Crit Rev Food Sci Nutr. 2019 Mar 18:1-16. doi: 10.1080/10408398.2019.1573800. REVIEW

  400. López-Vicente M, Ribas Fitó N, Vilor-Tejedor N, Garcia-Esteban R, Fernández-Barrés S, Dadvand P, Murcia M, Rebagliato M, Ibarluzea J, Lertxundi A, Fernández-Somoano A, Tardón A, López-Sabater MC, Romaguera D, Vrijheid M, Sunyer J, Julvez J (2019): Prenatal Omega-6:Omega-3 Ratio and Attention Deficit and Hyperactivity Disorder Symptoms. J Pediatr. 2019 Jun;209:204-211.e4. doi: 10.1016/j.jpeds.2019.02.022. PMID: 30929929.

  401. Koutra, Margetaki, Kampouri, Kyriklaki, Roumeliotaki, Vafeiadi, Bitsios, Kogevinas, Chatzi (2022) Maternal sleep disturbances during late pregnancy and child neuropsychological and behavioral development in early childhood. Eur Child Adolesc Psychiatry. 2022 Aug 4. doi: 10.1007/s00787-022-02053-z. PMID: 35927528. n = 638 Mutter-Kind-Paare / mother-child pairs

  402. Lugo-Candelas C, Hwei T, Lee S, Lucchini M, Smaniotto Aizza A, Kahn LG, Buss C, O’Connor TG, Ghassabian A, Padula AM, Aschner J, Deoni S, Margolis AE, Canino G, Monk C, Posner J, Duarte CS (2023): Prenatal sleep health and risk of offspring ADHD symptomatology and associated phenotypes: a prospective analysis of timing and sex differences in the ECHO cohort. Lancet Reg Health Am. 2023 Oct 9;27:100609. doi: 10.1016/j.lana.2023.100609. PMID: 38106969; PMCID: PMC10725065. n = 794 Mutter-Kind-Paare / mother-child pairs

  403. Bitsko RH, Holbrook JR, O’Masta B, Maher B, Cerles A, Saadeh K, Mahmooth Z, MacMillan LM, Rush M, Kaminski JW (2022): A Systematic Review and Meta-analysis of Prenatal, Birth, and Postnatal Factors Associated with Attention-Deficit/Hyperactivity Disorder in Children. Prev Sci. 2022 Mar 18:10.1007/s11121-022-01359-3. doi: 10.1007/s11121-022-01359-3. PMID: 35303250; PMCID: PMC9482663. REVIEW und METASTUDIE

  404. Takahashi N, Nishimura T, Harada T, Okumura A, Iwabuchi T, Rahman MS, Kuwabara H, Takagai S, Usui N, Makinodan M, Matsuzaki H, Ozaki N, Itoh H, Nomura Y, Newcorn JH, Tsuchiya KJ (2023): Interaction of genetic liability for attention deficit hyperactivity disorder (ADHD) and perinatal inflammation contributes to ADHD symptoms in children. Brain Behav Immun Health. 2023 May 18;30:100630. doi: 10.1016/j.bbih.2023.100630. PMID: 37251547; PMCID: PMC10213186.

  405. Gustafsson HC, Sullivan EL, Battison EAJ, Holton KF, Graham AM, Karalunas SL, Fair DA, Loftis JM, Nigg JT (2020): Evaluation of maternal inflammation as a marker of future offspring ADHD symptoms: A prospective investigation. Brain Behav Immun. 2020 Oct;89:350-356. doi: 10.1016/j.bbi.2020.07.019. PMID: 32707260; PMCID: PMC7703804.

  406. Feleder, Tseng, Calhoon, O’Donnell (2010): Neonatal intrahippocampal immune challenge alters dopamine modulation of prefrontal cortical interneurons in adult rats. Biol Psychiatry. 2010 Feb 15;67(4):386-92. doi: 10.1016/j.biopsych.2009.09.028. PMID: 19914600; PMCID: PMC2900781.

  407. Velloso FJ, Zaritsky R, Houbeika RY, Rios N, Levison SW (2025): Interleukin-6 produces behavioral deficits in pre-pubescent mice independent of neuroinflammation. Brain Behav Immun. 2025 May;126:275-288. doi: 10.1016/j.bbi.2025.02.009. PMID: 39984136.

  408. Ferreira LL, Nardi AE, Quagliato LA (2025): Are parents with bipolar disorder at higher risk of having offspring with ADHD? A systematic review. Trends Psychiatry Psychother. 2025 Jan 3. doi: 10.47626/2237-6089-2024-0797. Epub ahead of print. PMID: 39752609. REVIEW

  409. Nilsen K, Staff AC, Krogsrud SK. Paracetamol use in pregnancy: Not as safe as we may think? Acta Obstet Gynecol Scand. 2023 Mar 20. doi: 10.1111/aogs.14557. PMID: 36941046.

  410. Brandlistuen RE, Ystrom E, Nulman I, Koren G, Nordeng H. Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol. 2013 Dec;42(6):1702-13. doi: 10.1093/ije/dyt183. PubMed PMID: 24163279; PubMed Central PMCID: PMC3887567. n = 48.631

  411. Liew Z, Ritz B, Rebordosa C, Lee PC, Olsen J. Acetaminophen Use During Pregnancy, Behavioral Problems, and Hyperkinetic Disorders. JAMA Pediatr. 2014 Feb 24. doi: 10.1001/jamapediatrics.2013.4914. PubMed PMID:24566677. n = 64.322

  412. Woodbury ML, Geiger SD, Schantz SL (2024): The relationship of prenatal acetaminophen exposure and attention-related behavior in early childhood. Neurotoxicol Teratol. 2024 Jan-Feb;101:107319. doi: 10.1016/j.ntt.2024.107319. PMID: 38199313.

  413. Liew, Kioumourtzoglou, Roberts, O’Reilly, Ascherio, Weisskopf (2019): Use of Negative Control Exposure Analysis to Evaluate Confounding: An Example of Acetaminophen Exposure and Attention-Deficit/Hyperactivity Disorder in Nurses’ Health Study II. Am J Epidemiol. 2019 Apr 1;188(4):768-775. doi: 10.1093/aje/kwy288.

  414. Masarwa, Levine, Gorelik, Reif, Perlman, Matok (2019): Prenatal Exposure to Acetaminophen and Risk for Attention Deficit Hyperactivity Disorder and Autistic Spectrum Disorder: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Cohort Studies. Am J Epidemiol. 2018 Aug 1;187(8):1817-1827. doi: 10.1093/aje/kwy086. REVIEW

  415. Gilman, Hornig (2019): The Disillusionment of DOHaD Epidemiology. Am J Epidemiol. 2019 Oct 2. pii: kwz214. doi: 10.1093/aje/kwz214.

  416. Ji, Azuine, Zhang, Hou, Hong, Wang, Riley, Pearson, Zuckerman, Wang (2019): Association of Cord Plasma Biomarkers of In Utero Acetaminophen Exposure With Risk of Attention-Deficit/Hyperactivity Disorderand Autism Spectrum Disorder in Childhood. JAMA Psychiatry. 2019 Oct 30:1-11. doi: 10.1001/jamapsychiatry.2019.3259.

  417. Chen, Pan, Wang, Hsu, Huang, Su, Li, Lin, Tsai, Chen, Bai (2019): Prenatal Exposure to Acetaminophen and the Risk of Attention-Deficit/Hyperactivity Disorder: A Nationwide Study in Taiwan. J Clin Psychiatry. 2019 Sep 10;80(5). pii: 18m12612. doi: 10.4088/JCP.18m12612. n = 950 Mutter-Kind-Paare

  418. Khan, Kabiraj, Ahmed, Adam, Mannuru, Ramesh, Shahzad, Chaduvula, Khan (2022): A Systematic Review of the Link Between Autism Spectrum Disorder and Acetaminophen: A Mystery to Resolve. Cureus. 2022 Jul 18;14(7):e26995. doi: 10.7759/cureus.26995. PMID: 35989852; PMCID: PMC9385573.

  419. Ricci C, Albanese CM, Pablo LA, Li J, Fatima M, Barrett K, Levis B, Brown HK (2023): In utero acetaminophen exposure and child neurodevelopmental outcomes: Systematic review and meta-analysis. Paediatr Perinat Epidemiol. 2023 Mar 20. doi: 10.1111/ppe.12963. PMID: 36939050. Metaanalyse n = 367.775

  420. Masarwa, Platt, Filion (2020): Acetaminophen use during pregnancy and the risk of attention deficit hyperactivity disorder: A causal association or bias? Paediatr Perinat Epidemiol. 2020 Jan 9. doi: 10.1111/ppe.12615.

  421. Damkier (2020): Simple twist of fate: In utero exposure to acetaminophen and risk of childhood Attention Deficit Hyperactivity Disorder. Paediatr Perinat Epidemiol. 2020 May;34(3):230-232. doi: 10.1111/ppe.12654. PMID: 32107788.

  422. Damkier P, Gram EB, Ceulemans M, Panchaud A, Cleary B, Chambers C, Weber-Schoendorfer C, Kennedy D, Hodson K, Grant KS, Diav-Citrin O, Običan SG, Shechtman S, Alwan S (2025): Acetaminophen in Pregnancy and Attention-Deficit and Hyperactivity Disorder and Autism Spectrum Disorder. Obstet Gynecol. 2025 Feb 1;145(2):168-176. doi: 10.1097/AOG.0000000000005802. PMID: 39637384. REVIEW

  423. Worringer E, Rowland K (2024): Acetaminophen use during pregnancy was not linked to autism, ADHD, or intellectual disability in offspring. Ann Intern Med. 2024 Aug;177(8):JC95. doi: 10.7326/ANNALS-24-00960-JC. PMID: 39102714.

  424. Kougias DG, Atillasoy E, Southall MD, Scialli AR, Ejaz S, Chu C, Jeminiwa BO, Massarsky A, Unice KM, Schaeffer TH, Kovochich M (2025): A quantitative weight-of-evidence review of preclinical studies examining the potential developmental neurotoxicity of acetaminophen. Crit Rev Toxicol. 2025 Feb 21:1-55. doi: 10.1080/10408444.2024.2442344. PMID: 39982125. REVIEW

  425. Anand, Raghavan, Wang, Hong, Azuine, Pearson, Zuckerman, Xie, Wang (2021): Perinatal Acetaminophen Exposure and Childhood Attention-Deficit/Hyperactivity Disorder (ADHD): Exploring the Role of Umbilical Cord Plasma Metabolites in Oxidative Stress Pathways. Brain Sci. 2021 Sep 30;11(10):1302. doi: 10.3390/brainsci11101302. PMID: 34679367; PMCID: PMC8533963. N = 568

  426. Klein RM, Motomura VN, Debiasi JD, Moreira EG (2023): Gestational paracetamol exposure induces core behaviors of neurodevelopmental disorders in infant rats and modifies response to a cannabinoid agonist in females. Neurotoxicol Teratol. 2023 Jun 29;99:107279. doi: 10.1016/j.ntt.2023.107279. Epub ahead of print. PMID: 37391024.

  427. Spillers NJ, Talbot NC, Luther PM, Ly GH, Roberts CJ, Ahmadzadeh S, Shekoohi S, Viswanath O, Kaye AD (2024): Prenatal Acetaminophen Exposure and its Associated Risk for Attention Deficit Hyperactivity Disorder. Health Psychol Res. 2024 Nov 12;12:125267. doi: 10.52965/001c.125267. PMID: 39944717; PMCID: PMC11820131. REVIEW

  428. Klinger-Gratz PP, Ralvenius WT, Neumann E, Kato A, Nyilas R, Lele Z, Katona I, Zeilhofer HU (2018): Acetaminophen Relieves Inflammatory Pain through CB1 Cannabinoid Receptors in the Rostral Ventromedial Medulla. J Neurosci. 2018 Jan 10;38(2):322-334. doi: 10.1523/JNEUROSCI.1945-17.2017. PMID: 29167401; PMCID: PMC6596108.

  429. Halvorsen, Hesel, Østergaard, Danielsen (2019): In Utero Exposure to SSRIs and Development of Mental Disorders: A Systematic Review and Meta-analysis. Acta Psychiatr Scand. 2019 Apr 2. doi: 10.1111/acps.13030. METASTUDY

  430. Leshem R, Bar-Oz B, Diav-Citrin O, Gbaly S, Soliman J, Renoux C, Matok I (2021). Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: A True Effect or a Bias? A Systematic Review & Meta-Analysis. Curr Neuropharmacol. 2021;19(6):896-906. doi: 10.2174/1570159X19666210303121059. PMID: 33655866; PMCID: PMC8686301. METASTUDY

  431. Araujo, Delgado, Paumgartten (2020): Antenatal exposure to antidepressant drugs and the risk of neurodevelopmental and psychiatric disorders: a systematic review. Cad Saude Publica. 2020 Jan 31;36(2):e00026619. doi: 10.1590/0102-311X00026619. PMID: 32022173. REVIEW

  432. Hartwig CAM, Robiyanto R, de Vos S, Bos JHJ, van Puijenbroek EP, Hak E, Schuiling-Veninga CCM (2022): In utero antidepressant exposure not associated with ADHD in the offspring: A case control sibling design. Front Pharmacol. 2022 Nov 10;13:1000018. doi: 10.3389/fphar.2022.1000018. PMID: 36438827; PMCID: PMC9684082.

  433. Clements, Castro, Blumenthal, Rosenfield, Murphy, Fava, Erb, Churchill, Kaimal, Doyle, Robinson, Smoller, Kohane, Perlis (2015): Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system. Molecular Psychiatry volume 20, pages 727–734 (2015) n = 3620

  434. Valentino K, Teopiz KM, Kwan ATH, Le GH, Wong S, Rosenblat JD, Mansur RB, Lo HKY, McIntyre RS (2024): Anatomical, behavioral, and cognitive teratogenicity associated with valproic acid: a systematic review. CNS Spectr. 2024 Dec;29(6):604-610. doi: 10.1017/S1092852924002311. PMID: 39727238. METASTUDY

  435. Kinjo, Ito, Seki, Fukuhara, Bolati, Arai, Suzuki (2019): Prenatal exposure to valproic acid is associated with altered neurocognitive function and neurogenesis in the dentate gyrus of male offspring rats. Brain Res. 2019 Aug 22;1723:146403. doi: 10.1016/j.brainres.2019.146403.

  436. Sakade, Yamanaka, Soumiya, Furukawa, Fukumitsu (2019): Exposure to valproic acid during middle to late-stage corticogenesis induces learning and social behavioral abnormalities with attention deficit/hyperactivity in adult mice. Biomed Res. 2019;40(5):179-188. doi: 10.2220/biomedres.40.179.

  437. Baronio D, Puttonen HAJ, Sundvik M, Semenova S, Lehtonen E, Panula P (2018): Embryonic exposure to valproic acid affects the histaminergic system and the social behaviour of adult zebrafish (Danio rerio). Br J Pharmacol. 2018 Mar;175(5):797-809. doi: 10.1111/bph.14124. PMID: 29235100; PMCID: PMC5811620.

  438. Ornoy A, Echefu B, Becker M (2023): Valproic Acid in Pregnancy Revisited: Neurobehavioral, Biochemical and Molecular Changes Affecting the Embryo and Fetus in Humans and in Animals: A Narrative Review. Int J Mol Sci. 2023 Dec 27;25(1):390. doi: 10.3390/ijms25010390. PMID: 38203562; PMCID: PMC10779436.

  439. Laugesen K, Skajaa N, Petersen I, Andersen MS, Feldt-Rasmussen U, Kejlberg Al-Mashhadi S, Stewart P, Jørgensen JOL, Sørensen HT (2025): Mental Disorders Among Offspring Prenatally Exposed to Systemic Glucocorticoids. JAMA Netw Open. 2025 Jan 2;8(1):e2453245. doi: 10.1001/jamanetworkopen.2024.53245. Erratum in: JAMA Netw Open. 2025 Feb 3;8(2):e251744. doi: 10.1001/jamanetworkopen.2025.1744. PMID: 39752154; PMCID: PMC11699534. n = 1.061.548

  440. Khalife, Glover, Taanila, Ebeling, Järvelin, Rodriguez (2013): Prenatal Glucocorticoid Treatment and Later Mental Health in Children and Adolescents; Plos one, November 22, 2013; https://doi.org/10.1371/journal.pone.0081394, n = 222

  441. Kapoor, Petropoulos, Matthews (2007): Fetal programming of hypothalamic-pituitary-adrenal (HPA) axis function and behavior by synthetic glucocorticoids. Brain Res Rev. 2008 Mar;57(2):586-95.

  442. Rakers, Schleußner, Muth, Hoyer, Rupprecht, Schiecke, Groten, Dreiling, Kozik, Schwab, Hoyer, Ligges (2022): Association between antenatal glucocorticoid exposure and the activity of the stress system, cognition, and behavior in 8- to 9-year-old children: A prospective observational study. Acta Obstet Gynecol Scand. 2022 Jun 2. doi: 10.1111/aogs.14386. PMID: 35652410. n = 69

  443. Rakers F, Schleussner E, Cornelius A, Kluckow S, Muth I, Hoyer D, Rupprecht S, Schultze T, Schiecke K, Ligges C, Schwab M, Hoyer H (2024): Association between prenatal glucocorticoid exposure and adolescent neurodevelopment: An observational follow-up study. Acta Obstet Gynecol Scand. 2024 Aug;103(8):1530-1540. doi: 10.1111/aogs.14885. PMID: 38877646; PMCID: PMC11266634.

  444. Elberling F, Spulber S, Bose R, Keung HY, Ahola V, Zheng Z, Ceccatelli S (2023): Sex Differences in Long-term Outcome of Prenatal Exposure to Excess Glucocorticoids-Implications for Development of Psychiatric Disorders. Mol Neurobiol. 2023 Dec;60(12):7346-7361. doi: 10.1007/s12035-023-03522-5. PMID: 37561236; PMCID: PMC10657788.

  445. Liang, Chen, Miao, Christensen, Dalsgaard, Yuan, Li (2017): In utero exposure to β-2-adrenergic receptor agonist and attention-deficit/hyperactivity disorder in children. Eur Child Adolesc Psychiatry. 2017 Feb 9. doi: 10.1007/s00787-017-0956-4 n = 672.000

  446. Dudukina E, Szépligeti SK, Karlsson P, Asomaning K, Daltveit AK, Hakkarainen K, Hoti F, Kieler H, Lunde A, Odsbu I, Rantanen M, Reutfors J, Saarelainen L, Ehrenstein V, Toft G (2023): Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries. Drug Saf. 2023 Apr 26. doi: 10.1007/s40264-023-01307-2. Epub ahead of print. PMID: 37099261.

  447. Ai, Zhao, Shi, Zhu (2021): Antibiotic exposure and childhood attention-deficit/hyperactivity disorder: systematic review and meta-analysis. Psychopharmacology (Berl). 2021 Oct 23. doi: 10.1007/s00213-021-05989-3. PMID: 34687335.

  448. Tao Q, Shen Y, Li Y, Luo H, Yuan M, Gan J (2022): Prenatal exposure to antibiotics and risk of neurodevelopmental disorders in offspring: A systematic review and meta-analysis. Front Neurol. 2022 Nov 25;13:1045865. doi: 10.3389/fneur.2022.1045865. PMID: 36504646; PMCID: PMC9732381.

  449. Green JE, Wrobel A, Todd E, Marx W, Berk M, Lotfaliany M, Castle D, Cryan JF, Athan E, Hair C, Nierenberg AA, Jacka FN, Dawson S (2025): Early antibiotic exposure and risk of psychiatric and neurocognitive outcomes: systematic review and meta-analysis. Br J Psychiatry. 2025 Mar;226(3):171-183. doi: 10.1192/bjp.2024.121. PMID: 39658347. REVIEW

  450. Parthasarathy S, Giridharan B, Panigrahi J, Konyak LM, Jamir N, Tharumasivam SV (2025): Abnormal microbiota due to prenatal antibiotic as a possible risk factor for Attention-Deficit / Hyperactivity Disorder (ADHD). Int Rev Neurobiol. 2025;180:299-328. doi: 10.1016/bs.irn.2025.03.007. PMID: 40414636. REVIEW

  451. Baldwin, Amaro (2019): Prescription of Valproate-Containing Medicines in Women of Childbearing Potential who have Psychiatric Disorders: Is It Worth the Risk? CNS Drugs. 2019 Dec 16. doi: 10.1007/s40263-019-00694-4.

  452. Imhoff-Hasse (2013): Valproatexposition des Fetus I: Risiko für autistische Störungen ist erhöht, Dtsch Arztebl 2013; 110(9): A-386 / B-352 / C-352 unter Verweis auf Bromley, Mawer, Briggs, Cheyne, Clayton-Smith, García-Fiñana, Kneen, Lucas, Shallcross, Baker, Liverpool and Manchester Neurodevelopment Group (2013): The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013 Jun;84(6):637-43. doi: 10.1136/jnnp-2012-304270.

  453. Xu SC, Zhong Y, Jiang HY, Tang J (2024): Exposure to anti-seizure medication during pregnancy and the risk of autism and ADHD in offspring: a systematic review and meta-analysis. Front Neurol. 2024 Jul 22;15:1440145. doi: 10.3389/fneur.2024.1440145. PMID: 39105059; PMCID: PMC11298387.

  454. Steele JW, Krishnan V, Finnell RH (2024): Mechanisms of neurodevelopmental toxicity of topiramate. Crit Rev Toxicol. 2024 Aug;54(7):465-475. doi: 10.1080/10408444.2024.2368552. PMID: 38995641; PMCID: PMC11296906. REVIEW

  455. Soyer-Gobillard MO, Gaspari L, Sultan C (2025): In utero exposure to synthetic sex hormones and their multigenerational impact on neurodevelopmental disorders: Endocrine disruptors as neuroendocrine disruptors. J Neurol Sci. 2025 May 15;472:123471. doi: 10.1016/j.jns.2025.123471. PMID: 40187226. REVIEW

  456. Lau-Jensen SH, Asschenfeldt B, Evald L, Hjortdal VE (2021): Hyperactivity and Inattention in Young Patients Born With an Atrial Septal or Ventricular Septal Defect. Front. Pediatr. 9:786638. doi: 10.3389/fped.2021.786638

  457. Cheslack-Postava, Sourander, Suominen, Jokiranta-Olkoniemi, McKeague, Brown (2020): Increased Risk of ADHD at Short and Long Interpregnancy Intervals in a National Birth Cohort. Paediatr Perinat Epidemiol. 2020 Mar 12. doi: 10.1111/ppe.12657. PMID: 32162359. n = 44.043

  458. Mujtaba S, Patro IK, Patro N (2023): Multiple Early Life Stressors as Risk Factors for Neurodevelopmental Abnormalities in the F1 Wistar Rats. Brain Sci. 2023 Sep 22;13(10):1360. doi: 10.3390/brainsci13101360. PMID: 37891729; PMCID: PMC10605318.

  459. Horner D, Jepsen JRM, Chawes B, Aagaard K, Rosenberg JB, Mohammadzadeh P, Sevelsted A, Vahman N, Vinding R, Fagerlund B, Pantelis C, Bilenberg N, Pedersen CT, Eliasen A, Brandt S, Chen Y, Prince N, Chu SH, Kelly RS, Lasky-Su J, Halldorsson TI, Strøm M, Strandberg-Larsen K, Olsen SF, Glenthøj BY, Bønnelykke K, Ebdrup BH, Stokholm J, Rasmussen MA (2025): A western dietary pattern during pregnancy is associated with neurodevelopmental disorders in childhood and adolescence. Nat Metab. 2025 Mar;7(3):586-601. doi: 10.1038/s42255-025-01230-z. PMID: 40033007. n = 61.237

  460. Dingess, Thakar, Zhang, Flynn, Brown (2018): High-Salt Exposure During Perinatal Development Enhances Stress Sensitivity. Dev Neurobiol. 2018 Nov;78(11):1131-1145. doi: 10.1002/dneu.22635.

  461. Levie, Bath, Guxens, Korevaar, Dineva, Fano, Ibarluzea, Llop, Murcia, Rayman, Sunyer, Peeters, Tiemeier (2020): Maternal Iodine Status During Pregnancy Is Not Consistently Associated with Attention-Deficit Hyperactivity Disorder or Autistic Traits in Children. J Nutr. 2020 Jun 1;150(6):1516-1528. doi: 10.1093/jn/nxaa051. PMID: 32171006; PMCID: PMC7269752.

  462. Gao X, Zhao Y, Wang N, Yang L. (2022): Migration modulates the prevalence of ASD and ADHD: a systematic review and meta-analysis. BMC Psychiatry. 2022 Jun 13;22(1):395. doi: 10.1186/s12888-022-04037-4. PMID: 35698047; PMCID: PMC9195277. METASTUDIE

  463. Díaz-López A, Sans JC, Julvez J, Fernandez-Bares S, Llop S, Rebagliato M, Lertxundi N, Santa-Marina L, Guxens M, Sunyer J, Arija V (2022): Maternal iron status during pregnancy and attention deficit/hyperactivity disorder symptoms in 7-year-old children: a prospective cohort study. Sci Rep. 2022 Dec 1;12(1):20762. doi: 10.1038/s41598-022-23432-1. PMID: 36456588; PMCID: PMC9715623. n = 1.204

  464. Angel P, Hermansen M, Ramlau-Hansen CH, Gaml-Sørensen A, Kristensen DM, Lindahl-Jacobsen R (2025): Neurodevelopmental or behavioral disorders in children conceived after assisted reproductive technologies: a nationwide cohort study. Fertil Steril. 2025 Apr;123(4):665-676. doi: 10.1016/j.fertnstert.2024.10.017. PMID: 39426700.

  465. Islam MI, Chaffey OA, Chadwick V, Martiniuk A (2024): Mental health in children conceived by Assisted Reproductive Technologies (ARTs): Insights from a longitudinal study of Australian children. PLoS One. 2024 Jun 27;19(6):e0304213. doi: 10.1371/journal.pone.0304213. PMID: 38935695; PMCID: PMC11210819.

  466. Talbot C, Hodson N, Rose J, Bewley S (2024): Comparing the psychological outcomes of donor and non-donor conceived people: A systematic review. BJOG. 2024 Dec;131(13):1747-1759. doi: 10.1111/1471-0528.17892. PMID: 38936405.

  467. Lo H, Weng SF, Tsai EM (2022): Neurodevelopmental Disorders in Offspring Conceived via In Vitro Fertilization vs Intracytoplasmic Sperm Injection. JAMA Netw Open. 2022 Dec 1;5(12):e2248141. doi: 10.1001/jamanetworkopen.2022.48141. PMID: 36547980.

  468. Li, Chen, Ferber, Hirst, Odouli (2020): Association Between Maternal Exposure to Magnetic Field Nonionizing Radiation During Pregnancy and Risk of Attention-Deficit/Hyperactivity Disorder in Offspring in a Longitudinal Birth Cohort. JAMA Netw Open. 2020 Mar 2;3(3):e201417. doi: 10.1001/jamanetworkopen.2020.1417. PMID: 32207831; PMCID: PMC7093768. n = 1.454 Mutter-Kind Paare

  469. Li DK (2020): Notice of Retraction and Replacement. Li et al. Association Between Maternal Exposure to Magnetic Field Nonionizing Radiation During Pregnancy and Risk of Attention-Deficit/Hyperactivity Disorder in Offspring in a Longitudinal Birth Cohort. JAMA Netw Open. 2020;3(3):e201417. JAMA Netw Open. 2021 Feb 1;4(2):e2033605. doi: 10.1001/jamanetworkopen.2020.33605. PMID: 33599776.

  470. Hjorth, Lupattelli, Handal, Spigset, Ystrom, Nordeng (2021): Prenatal Exposure to Non-Steroidal Anti-Inflammatory Drugs and Risk of Attention-Deficit/Hyperactivity Disorder – a Follow-Up Study in the Norwegian Mother, Father and Child Cohort. Pharmacoepidemiol Drug Saf. 2021 Apr 18. doi: 10.1002/pds.5250. PMID: 33866622. n = 56 340 / 34 961

  471. Brandlistuen, Eivind Ystrom, Hernandez-Diaz, Skurtveit, Selmer, Handal, Nordeng, Sasayama (2017): Association of prenatal exposure to benzodiazepines and child internalizing problems: A sibling-controlled cohort study; PLoS One. 2017; 12(7): e0181042. doi: 10.1371/journal.pone.0181042; PMCID: PMC5528839; n = 71.996

  472. Chen VC, Wu SI, Lin CF, Lu ML, Chen YL, Stewart R (2022): Association of Prenatal Exposure to Benzodiazepines With Development of Autism Spectrum and Attention-Deficit/Hyperactivity Disorders. JAMA Netw Open. 2022 Nov 1;5(11):e2243282. doi: 10.1001/jamanetworkopen.2022.43282. PMID: 36413366; PMCID: PMC9682429. n = 1.516.846

  473. Suarez EA, Bushnell GA (2022): Association Between Attention-Deficit/Hyperactivity Disorder and Benzodiazepines and Z-Hypnotics in Pregnancy-Questions Remain. JAMA Netw Open. 2022 Dec 1;5(12):e2246896. doi: 10.1001/jamanetworkopen.2022.46896. PMID: 36520443. METASTUDIE

  474. Chan AYL, Gao L, Howard LM, Simonoff E, Coghill D, Ip P, Lau WCY, Taxis K, Wong ICK, Man KKC (2023): Maternal Benzodiazepines and Z-Drugs Use during Pregnancy and Adverse Birth and Neurodevelopmental Outcomes in Offspring: A Population-Based Cohort Study. Psychother Psychosom. 2023 Mar 10:1-11. doi: 10.1159/000529141. PMID: 36907183.

  475. Stokholm L, Juhl M, Talge NM, Gissler M, Obel C, Strandberg-Larsen K (2021): Obstetric oxytocin exposure and ADHD and ASD among Danish and Finnish children. Int J Epidemiol. 2021 May 17;50(2):446-456. doi: 10.1093/ije/dyaa076. PMID: 32535618.

  476. Instanes JT, Solberg BS, Kvalvik LG, Klungsøyr K, Posserud MR, Hartman CA, Haavik J (2024): Organic food consumption during pregnancy and symptoms of neurodevelopmental disorders at 8 years of age in the offspring: the Norwegian Mother, Father and Child Cohort Study (MoBa). BMC Med. 2024 Oct 21;22(1):482. doi: 10.1186/s12916-024-03685-5. PMID: 39428456; PMCID: PMC11492991.

  477. Camanni M, van Gelder MMHJ, Cantarutti A, Nordeng H, Lupattelli A (2025): Association of Prenatal Exposure to Triptans, Alone or Combined With Other Migraine Medications, and Neurodevelopmental Outcomes in Offspring. Neurology. 2025 Jun 24;104(12):e213678. doi: 10.1212/WNL.0000000000213678. PMID: 40397854.

  478. Liu Y, Jiang H, Nie Z, Yu B, Qiu X, Zuo H, Han S (2024): Association between maternal exercise during pregnancy and attention-deficit/hyperactivity disorder among preschool children in Southwest China. Front Public Health. 2024 Nov 27;12:1493580. doi: 10.3389/fpubh.2024.1493580. PMID: 39664546; PMCID: PMC11631731. n = 4.184

  479. Solberg BS, Kvalvik LG, Instanes JT, Hartman CA, Klungsøyr K, Li L, Larsson H, Magnus P, Njølstad PR, Johansson S, Andreassen OA, Bakken NR, Bekkhus M, Austerberry C, Smajlagic D, Havdahl A, Corfield EC, Haavik J, Gjestad R, Zayats T (2023): Maternal fiber intake during pregnancy and development of Attention-Deficit/Hyperactivity Disorder Symptoms Across Childhood: The Norwegian Mother, Father and Child Cohort Study (MoBa). Biol Psychiatry. 2023 Dec 22:S0006-3223(23)01794-8. doi: 10.1016/j.biopsych.2023.12.017. PMID: 38142720.

  480. Cendra-Duarte E, Canals J, Iglesias-Vázquez L, Jardí C, Martín-Luján F, Arija V (2024): Adherence to the Mediterranean diet during pregnancy and behavioural problems at 4 years of age. Matern Child Nutr. 2024 Oct;20(4):e13700. doi: 10.1111/mcn.13700. PMID: 38990125; PMCID: PMC11574668. n = 231